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Abstract 
The objective of this thesis was to investigate the in vitro cytotoxic, genotoxic and 
transforming effects induced by nanoparticles (NPs) of industrial interest on a range of 
cell cultures.  
The cytotoxicity of two sizes of CoFe2O4 NPs, paramagnetic particles of interest in 
different biomedical applications, was investigated using the Neutral Red uptake (NR) 
and Colony Forming Efficiency (CFE) assays using six mammalian cell lines at 
concentrations between 10 and 120 µM. More specifically, cytotoxicity was evaluated 
after 72-hour treatment of five cell lines (A549, CaCo2, HaCaT, HepG2, MDCK) with 
10, 20, 40, 60, 80, 100 and 120 µM concentrations of NPs using NR, and 10, 20, 30, 40, 
50, 60, 80, 100 and 120 µM concentrations of NPs using CFE. In parallel with these tests, 
cytotoxicity was also evaluated in mouse Balb3T3 fibroblasts using (i) NR after 72-hour 
treatment with 10, 20, 40, 60, 80, 100 and 120 µM concentrations of NPs, and (ii) CFE 
after both 72-hour treatment with 1, 5, 10, 20, 30, 40, 50, 60, 80, 100 and 120 µM 
concentrations of NPs, and 24-hour treatment with 1, 10, 60 and 120 µM concentrations 
of NPs. The cytotoxic effect exhibited a dose-effect relationship for Balb3T3 cells as 
assessed using the CFE assay. The testing of a more extensive concentration range of 
NPs in Balb3T3 cells (i.e., 1 and 5 µM in addition to the concentrations tested in the 
other five cell lines) over a 72-hour exposure time using CFE, together with the 
additional test using a 24-hour exposure time allowed appropriate concentration ranges to 
be determined for use in subsequent experiments using the Cell Transformation (CTA) 
and Cytokinesis-Block Micronucleus (CBMN) assays. 
The cell transformation capacity and genotoxicity of CoFe2O4 NPs were investigated 
using the Balb3T3 model, and assessed using the CTA (specifically at concentrations of 
1, 5, 20 and 60 µM for 72 hours of treatment) and CBMN (specifically at concentrations 
of 1, 10 and 60 µM for 24 hours of treatment). The CoFe2O4 NPs induced neither effect 
at the doses and time points investigated. 
Four sizes of Ag NPs, chosen for their antimicrobial properties, were assessed for 
cytotoxicity (using CFE at concentrations of 0.1, 0.5, 1, 5 and 10 µM for 24 hours of 
treatment and of 0.01, 0.1, 0.5, 1, 2.5, 5 and 10 µM for 72 hours of treatment), cell 
transformation capacity (using CTA at concentrations of 0.5, 2.5 and 5 µM for 72 hours 
  
of treatment) and genotoxicity to Balb3T3 mouse fibroblasts (using CBMN at 
concentrations of 1, 5 and 10 µM for 24 hours of treatment). The Ag NPs had a 
significant cytotoxic effect, but no cell transformation or genotoxic effects at the doses 
and time points investigated. 
Physicochemical characterization of the chosen NPs was performed; size distribution and 
surface charge were measured by Dynamic Light Scattering (DLS), imaging by Scanning 
Electron Microscopy (SEM), the purity and ion leakage by Inductively Coupled Plasma 
Mass Spectrometry (ICP-MS), and the sedimentation by UV-Visible spectrometry. 
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1.1 Nanotechnology products are 100–10000-fold smaller than a human cell 
(image taken from the National Cancer Institute website, 
http://nano.cancer.gov/learn/understanding/, last accessed in September 
2011). 
  
1.2 Examples of incidental and engineered NPs. Diesel exhaust particles are 
defined as particles either from unintended anthropogenic sources or of 
natural origin. Some particles, such as fullerenes and carbon nanotubes, 
are considered to be both engineered materials and incidental components 
of pollution, while dendrimers and quantum dots are considered to be 
manufactured NMs (Image from Stern & McNeil, 2008). 
  
1.3 Nanostructures in Nature. (A) Nano-crystals of hydrophobic wax on a 
Lotus leaf and drops of water; (B) the “Lotus effect” where water floats on 
a Lotus leaf  (Google images, last accessed in September 2011). 
  
1.4 Nanofilaments on the feet of Gecko lizards 
(http://www.cchem.berkeley.edu/rmgrp/about.html, last accessed in 
September 2011). 
  
1.5 Schematic representation of physicochemical properties of NMs. The 
main physicochemical properties of NMs that may influence their 
biocompatibility (including their size, shape, surface area, surface charge, 
coating, presence of contaminants and reactivity) and that should be 
considered when assessing their hazard risks (Stern & McNeil, 2008). 
  
1.6 Schematic and general representation of the in vitro approach used to 
assess cellular biokinetics of NMs at the JRC. Nanomaterials are 
chemically synthesized and radio-activated by neutron, deuteron or proton 
irradiation. The material is added to culture medium where its behaviour, 
particularly dissolution, is studied taking advantage of the possibility to 
measure radioactivity. The interaction of NMs with cells 
(adsorption/uptake) is then evaluated. Dissolution and uptake of non-
radioactive NMs can be measured by ICP-MS. The intracellular 
distribution is often studied using the TEM technique. Conventional TEM 
images, however, cannot always distinguish NPs from some small cellular 
structures (e.g., glycogen granules) so that specific additional techniques 
must be used (Mühlfeld et al., 2007). The advantage of this approach is 
that the biological effect can be correlated with the real dose of NM that 
interacts with the cells (European Commission, JRC-Ispra, 
NanoBiosciences Unit). 
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1.7 The possible fates of cultured, cytokinesis-blocked cells following 
exposure to cytotoxic/genotoxic agents. Using CBMN assay, biomarkers, 
such as the frequency of chromosome breakage (MN), chromosome loss 
(MN), and chromosome rearrangement, for example, dicentric 
chromosomes (NPB), gene amplification (NBUDs), necrosis and 
apoptosis can be measured. In addition, cytostatic effects can be estimated 
from the ratio of mono-, bi- and multinucleated cells (Fenech, 2007). 
  
1.8A, B, C, 
D, E, F, G, 
H and I 
Optical microscope images (40X) from positive control slides prepared in 
the CBMN assay using Balb3T3 mouse fibroblasts. In particular, an 
example of a mononucleated cell (A), a binucleated cell (B), a 
polynucleated cell (C), a binucleated cell with one or more micronuclei (D 
and E respectively), a binucleated cell with nuclear bud (F), a binucleated 
cell with nucleoplasmic bridge (G), a binucleated cell with double 
nucleoplasmic bridge and a micronucleus (H) and a binucleated cell with 
nucleoplasmic bridge and nuclear buds (I) (EC, JRC-Ispra, IHCP, NBS).  
To calculate the NDI, mononucleated, binucleated (with or without 
micronuclei) and polynucleated cells are scored. In this study, the 
genotoxic potential of CoFe2O4 and Ag NPs, demonstrated by the 
induction of micronuclei formation, was evaluated on Balb3T3 mouse 
fibroblasts. 
  
1.9 Mechanisms of primary and secondary genotoxicity induced by particles 
and fibres; ROS may play a major role in primary genotoxicity, whilst the 
excessive and persistent formation of ROS from inflammatory cells may 
be responsible for secondary genotoxicity (Schins, 2002). 
  
  
  
2.1   A549 cells in culture (100X magnification at the optical microscope) 
(NBS, IHCP, JRC) 
  
2.2   Balb3T3 cells in culture (100X magnification at the optical microscope) 
(NanoBioSciences Unit, IHCP, JRC). 
  
2.3   CaCo2 cells in culture (100X magnification at the optical microscope) 
(NanoBioSciences Unit, IHCP, JRC). 
  
2.4   HaCaT cells in culture (100X magnification at the optical microscope) 
(NanoBioSciences Unit, IHCP, JRC). 
  
2.5   HepG2 cells in culture (100X magnification at the optical microscope) 
(NBS, IHCP, JRC). 
  
2.6   MDCK cells in culture (100X magnification at the optical microscope) 
(NBS, IHCP, JRC). 
  
2.7A, B, C, 
D, E and F 
Images of colonies from negative controls at the end of a CFE assay: (A) 
A549 colonies (45X magnification), (B) Balb3T3 colonies (15X 
magnification), (C) CaCo2 colonies (45X magnification), (D) HaCaT 
colonies (45X magnification), (E) HepG2 colonies (15X magnification) 
and (F) MDCK colonies (15X magnification) (EC, JRC-Ispra, IHCP, 
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NBS). 
  
2.8A, B, C, 
D, E and F   
Normal and morphologically transformed Balb3T3 mouse fibroblasts as 
seen at the stereo microscopic level after the CTA: (A) negative control 
cells (45X of magnification) and some examples of type III foci from 
positive control dishes (B, C, D, E and F) (15X magnification). In the 
negative control dishes, cells grow in a monolayer as they retain their 
morphology and contact-inhibition. When cells are transformed into 
tumorigenic cells, they lose contact-inhibition and begin to grow spindle 
shaped with no ordered orientation and as a multilayer (EC, JRC-Ispra, 
IHCP, NBS). Only type III foci are scored because these alone can induce 
tumour formation in nude mice with an 85% frequency (Saffiotti et al., 
1984; IARC/INCI/EPA, 1985). 
  
2.9 A typical binucleated, micronucleated Balb3T3 cell after 24-hour 
exposure to mytomicin C (0.5 µM) as a positive control. The black arrows 
highlight micronuclei in the cytosol (400X of magnification, EC, JRC-
Ispra, NBS). In this study, the genotoxic potential of CoFe2O4 and Ag NPs 
in Balb3T3 mouse fibroblasts was indicated by the induction of 
micronuclei formation. 
  
3.1 Six cell lines exposed to dialyzed diethylene glycol (DEG) for 72 hours. 
Cytotoxicity was evaluated using Neutral Red uptake. Results are 
expressed as Cell Viability (% of control) and are a mean of three 
independent experiments, ± standard error of the mean (SEM). The red 
ring highlights the concentration of dialyzed DEG that was chosen as 
control for the solvent (Control DEG 0.1% v/v) in the experiments with 
cobalt ferrites. 
  
3.2 Six cell lines exposed to dialyzed diethylene glycol (DEG) for 72 hours. 
Cytotoxicity was evaluated by Colony Forming Efficiency (CFE). Results 
are expressed as CFE (% of control) and are the mean of three 
independent experiments, ± standard error of the mean (SEM). The red 
ring highlights the concentration of dialyzed DEG that was chosen as 
control for the solvent (control DEG 0.1 % v/v) in the experiments with 
cobalt ferrites. 
  
 3.3 Six cell lines exposed to CoFe2O4 NPs P601 for 72 hours. Cytotoxicity 
was evaluated using the Neutral Red assay. Results are expressed as Cell 
Viability (% of the dialyzed DEG 0.1% v/v) and are the mean of three 
independent experiments, ± standard error of the mean (SEM). 
  
3.4 Six cell lines exposed to CoFe2O4 NPs P601 for 72 hours. Cytotoxicity 
was evaluated using CFE. Results are expressed as Colony Forming 
Efficiency (CFE% of the solvent control, i.e., CFE% of dialyzed DEG 
0.1% v/v) and are the mean of three independent experiments, ± standard 
error of the mean (SEM). 
  
3.4A Three cell lines exposed to CoFe2O4 NPs P601 for 72 hours. The statistical 
significance was evaluated by one-way ANOVA (*p<0.05 and **p<0.01) 
with respect to dialyzed DEG 0.1% v/v control. Significant differences 
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were found in A549, Balb3T3 and CaCo2 cells when compared to 
dialyzed DEG 0.1% v/v control. Results are the mean of three independent 
experiments, ± standard error of the mean (SEM). 
  
3.4B Three cell lines exposed to CoFe2O4 NPs P601 for 72 hours. The statistical 
significance was evaluated by one-way ANOVA (*p<0.05 and **p<0.01) 
with respect to dialyzed DEG 0.1% v/v control. Significant differences 
were found in MDCK cells compared to dialyzed DEG 0.1% v/v control. 
Results are the mean of three independent experiments, ± standard error of 
the mean (SEM). 
  
3.5 Six cell lines exposed to CoFe2O4 NPs P703 for 72 hours. Cytotoxicity 
was evaluated using NR. Results are expressed as Cell Viability (% of 
dialyzed DEG 0.1% v/v control) and are the mean of three independent 
experiments, ± standard error of the mean (SEM). For ease of comparing 
the cytotoxicity results of P601 NPs to those of the P703 NPs, the 
concentrations of P703 NPs reported in the cytotoxicity graphs were the 
expected ones. 
  
 3.6 Six cell lines exposed to CoFe2O4 NPs P703 for 72 hours. Cytotoxicity 
was evaluated using CFE. Results are expressed as Colony Forming 
Efficiency (% of the dialyzed DEG 0.1% v/v control) and are the mean of 
three independent experiments, ± standard error of the mean (SEM). 
  
3.6A Three cell lines exposed to CoFe2O4 NPs P703 for 72 hours. The statistical 
significance was evaluated by one-way ANOVA (*p<0.05 and **p<0.01) 
with respect to dialyzed DEG 0.1% v/v control. Significant differences 
compared to dialyzed DEG 0.1% v/v control were found in A549 and 
Balb3T3 cells. Results are the mean of three independent experiments, ± 
standard error of the mean (SEM). 
  
 3.6B Three cell lines exposed to CoFe2O4 NPs P703 for 72 hours. The statistical 
significance was evaluated by one-way ANOVA (*p<0.05 and **p<0.01) 
with respect to dialyzed DEG 0.1% v/v control. Significant differences 
were found in HepG2 cells (p<0.05) compared to the dialyzed DEG 0.1% 
v/v control. Results are the mean of three independent experiments, ± 
standard error of the mean (SEM). 
  
3.7A and 
3.7B 
The comparison of cytotoxicity in Balb3T3 cells induced by P601 (A, 
light blue histograms) and P703 (B, dark blue histograms), NPs and Co2+ 
(A and B, yellow histograms) after 72 hours of exposure, evaluated using 
the CFE assay. Results are the mean of three independent experiments, ± 
standard error of the mean (SEM = standard deviation/√number of 
experiments or replicates). The CFE values for Co2+ treatments of 72 
hours were extrapolated from a previous study (Ponti et al., 2009). 
Concentrations indicated in the graphs are related to the expected µM 
concentrations of NPs in total fraction samples, considering 119 and 98 
mM as concentration of the stock suspensions of P601 and P703; see 
Tables B.6 and B.7 for the respective Co2+ concentrations detected in 
Balb3T3 complete culture medium after 72 hours of incubation for both 
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P601 and P703 NPs. 
The P601 NPs showed the highest cytotoxicity with respect to Co2+ at all 
doses considered; in contrast, P703 NPs showed less cytotoxicity than 
Co2+. Data were statistically analyzed using t-test 
(http://www.graphpad.com/quickcalcs/ttest1.cfm). There was no 
significant difference when P601 or P703 data were compared to those of 
Co2+. 
  
3.8A and 
3.8B 
CFE results after exposing Balb3T3 cells to P601 (A) and P703 (B) NPs 
for 72 hours. In order to define the concentrations at which the 
transformation capacity of these NPs could be assessed as accurately as 
possible, the cytotoxicity on Balb3T3 fibroblasts (in contrast to the other 
cell lines) was investigated testing additional concentrations including 1 
and 5 µM. Statistically significant differences are not shown here (please 
see Figures 3.4A and 3.6A). 
  
3.9A The cytotoxicity induced by P601 and P703 NPs after 72 hours of 
exposure, evaluated by concurrent CFE and CTA assays. Results are the 
mean of three independent experiments, ± standard error of the mean 
(SEM = standard deviation/√number of experiments or replicates). 
Statistical significance was evaluated using one-way ANOVA (*p<0.05, 
***p<0.001). 
  
3.9B The cell transformation capacity induced by P601 and P703 NPs in 
Balb3T3 cells after 72 hours of exposure, evaluated using CTA. Results 
are a mean of three independent experiments, ± standard error of the mean 
(SEM = standard deviation/√number of experiments or replicates). 
Statistical significance was evaluated by Fisher’s exact test for CTA data 
(***p<0.001). 
  
3.10 The cytotoxicity induced by P601 and P703 NPs in Balb3T3 cells after 24 
hours of exposure, evaluated by CFE. Results are the mean of three 
independent experiments, ± standard error of the mean (SEM = standard 
deviation/√number of experiments or replicates). Results of the statistical 
analysis are not shown here (please see Figure 3.11A). 
  
3.11A and 
3.11B 
The cytotoxicity (A) and genotoxicity (B) induced by P601 and P703 NPs 
after 24 hours of exposure on Balb3T3 cells evaluated by CFE and CBMN 
assays. Results are the mean of three independent experiments, ± standard 
error of the mean (SEM = standard deviation/√number of experiments or 
replicates). The statistical significance of CFE and CBMN data was 
evaluated using one-way ANOVA and Fisher’s exact test, respectively 
(***p<0.001). 
  
3.12A and 
3.12B 
The comparison between cytotoxicity induced by P601 (A, light blue 
histograms), P703 (B, dark blue histograms) NPs and Co2+ (A and B, 
yellow histograms) in Balb3T3 cells after 24 hours of exposure, evaluated 
using the CFE assay. Results are the mean of three independent 
experiments, ± standard error of the mean (SEM = standard 
deviation/√number of experiments or replicates). The CFE values for Co2+ 
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treatments of 24 hours were extrapolated from a previous study (Ponti et 
al., 2009). The concentrations shown relate to the expected µM 
concentrations of NPs in total fraction samples, considering 119 and 98 
mM as the concentration of the stock suspensions of P601 and P703, 
respectively; please see Tables B.6 & B.7 for the respective Co2+ 
concentrations detected in Balb3T3 complete culture medium after 24 
hours of incubation for both P601 and P703 NPs. 
Statistical analysis was done using the t-test 
(http://www.graphpad.com/quickcalcs/ttest1.cfm) and significant 
differences were found when comparing P601 or P703 data to those of 
Co2+ (*p<0.05; **p<0.01). 
  
3.13 The cytotoxicity of NM-300 NPs on Balb3T3 cells after 72 hours of 
exposure, assessed using CFE; the NP concentration is expressed as µM. 
Results are the mean of three independent experiments, ± standard error of 
the mean (SEM = standard deviation/√number of experiments or 
replicates). Statistical significance was evaluated using one-way ANOVA 
(*p<0.05; **p<0.01). 
  
3.14 The cytotoxicity of Ag 44 NPs on Balb3T3 cells after 72 hours of 
exposure, assessed using CFE; the NP concentration is expressed as µM. 
Results are the mean of three independent experiments, ± standard error of 
the mean (SEM = standard deviation/√number of experiments or 
replicates). Statistical significance was evaluated using one-way ANOVA 
(**p<0.01). 
  
3.15 The cytotoxicity of Ag 84 NPs on Balb3T3 cells after 72 hours of 
exposure, assessed using CFE; the NP concentration is expressed as µM. 
Results are the mean of three independent experiments, ± standard error of 
the mean (SEM = standard deviation/√number of experiments or 
replicates). Statistical significance was evaluated using one-way ANOVA 
(**p<0.01). 
  
3.16 The cytotoxicity of Ag 100 NPs on Balb3T3 cells after 72 hours of 
exposure, assessed using CFE; the NP concentration is expressed as µM. 
Results are the mean of three independent experiments, ± standard error of 
the mean (SEM = standard deviation/√number of experiments or 
replicates). Statistical significance was evaluated using one-way ANOVA 
(**p<0.01). 
  
3.17A and 
3.17B 
The cytotoxicity of Ag NPs on Balb3T3 cells after 72 hours of incubation, 
assessed using CFE and expressed as a function of the NP concentration in 
either µM (A) or the number of NPs/mL (No. NPs/mL) (B). Results are 
the mean of three independent experiments, ± standard error of the mean 
(SEM = standard deviation/√number of experiments or replicates). 
  
3.18A and 
3.18B 
The cytotoxicity and cell transformation induced by Ag NPs in Balb3T3 
cells after 72 hours of exposure as evaluated with concurrent CFE and 
CTA assays. Due to the absence of type III foci, the transformation 
frequency (x 10-4) was zero for Ag 100 nm at 2.5 and 5 µM, and zero for 
  x
Ag 44 nm at 5 µM. The results are the mean of three independent 
experiments, ± standard error of the mean (SEM = standard 
deviation/√number of experiments or replicates). Statistical significance 
was evaluated using one-way ANOVA and Fisher’s exact test for CFE and 
CTA results, respectively (***p<0.001). 
  
3.19 The cytotoxicity of Ag NPs on Balb3T3 cells after 24 hours of exposure, 
assessed using CFE. Results of the statistical analyses are shown in Figure 
3.20A. Results are the mean of three independent experiments, ± standard 
error of the mean (SEM = standard deviation/√number of experiments or 
replicates). 
  
3.20A and 
3.20B 
The cytotoxicity of Ag NPs in Balb3T3 cells after 24 hours of exposure, 
assessed using CFE (A), and genotoxicity of Ag NPs in Balb3T3 cells 
after 24 hours of exposure (B), assessed using the CBMN assay. Results 
are the mean of three independent experiments, ± standard error of the 
mean (SEM = standard deviation/√number of experiments or replicates). 
Statistical significance was evaluated by one-way ANOVA (*p<0.05; 
***p<0.001) and Fisher’s exact test for CFE and CBMN assay data, 
respectively. 
  
  
  
B.1A and 
B.1B 
DLS correlograms of basal media HAM and MEM, used to dilute 
CoFe2O4 P601 and P703 NPs for DLS sample analysis.  The correlation 
coefficient is expressed as a function of time (µs). The Y intercepts at time 
0 were lower than 0.1 and no correlogram had a sigmoid shape. These 
observations indicated that no nano-sized objects were detected in these 
samples using DLS and thus suggested they were particle-free. 
  
B.2A and 
B.2B 
DLS correlograms of basal media DMEM and NPs dispersant DEG, used 
to dilute CoFe2O4 P601 and P703 NPs for DLS sample analysis. The 
correlation coefficient is expressed as a function of time (µs). The Y 
intercepts at time 0 were lower than 0.1 and no correlogram had a sigmoid 
shape. These observations indicated that no nano-sized objects were 
detected in these samples using DLS and thus suggested they were 
particle-free. 
  
B.3 DLS correlograms of ultrapure water, used to dilute CoFe2O4 P601 and 
P703 NPs for DLS sample analysis. The correlation coefficient is 
expressed in function of time (µs). The Y intercept at time 0 was lower 
than 0.1 and the correlogram did not show a sigmoid shape. These 
observations indicated that no nano-sized objects were detected in these 
samples using DLS and thus suggested they were particle-free. 
  
B.4A and 
B.4B 
DLS correlograms of A549 and Balb3T3 complete culture media. The 
curves showed a sigmoid shape and Y intercepts at time 0 had values close 
to 1. Correlograms of this type are usually associated with samples that 
contain nano-sized objects. 
  
B.5A and DLS correlograms of CaCo2 and HaCaT complete culture media. The 
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B.5B curves showed a sigmoid shape and Y intercepts at time 0 had values close 
to 1. Correlograms of this type are usually associated with samples that 
contain nano-sized objects. 
  
B.6A and 
B.6B 
DLS correlograms of HepG2 and MDCK complete culture media. The 
curves showed a sigmoid shape and Y intercepts at time 0 had values close 
to 1. Correlograms of this type are usually associated with samples that 
contain nano-sized objects. 
  
B.7 DLS size distribution average of six measurements by intensity (upper 
graph) and volume (lower graph) of complete culture medium employed 
for A549 cells. In both graphs, the percentage values (% Intensity and % 
Volume) are shown as a function of the nanometer size. 
  
B.8 DLS size distribution average of six measurements by intensity (upper 
graph) and volume (lower graph) of complete culture medium employed 
for Balb3T3 cells. In both graphs, the percentage values (% Intensity and 
% Volume) are shown as a function of the nanometer size. 
  
B.9 DLS size distribution average of six measurements by intensity (upper 
graph) and volume (lower graph) of complete culture medium employed 
for CaCo2 cells. In both graphs, the percentage values (% Intensity and % 
Volume) are shown as a function of the nanometer size. 
  
B.10 DLS size distribution average of six measurements by intensity (upper 
graph) and volume (lower graph) of complete culture medium employed 
for HaCaT cells. In both graphs, the percentage values (% Intensity and % 
Volume) are shown as a function of the nanometer size. 
  
B.11 DLS size distribution average of six measurements by intensity (upper 
graph) and volume (lower graph) of complete culture medium employed 
for HepG2 cells. In both graphs, the percentage values (% Intensity and % 
Volume) are shown as a function of the nanometer size. 
  
B.12 DLS size distribution average of six measurements by intensity (upper 
graph) and volume (lower graph) of complete culture medium employed 
for MDCK cells. In both graphs, the percentage values (% Intensity and % 
Volume) are shown as a function of the nanometer size. 
  
B.13A and 
B.13B 
DLS measurements of P601 and P703 NPs dilutions in dialyzed DEG (2% 
v/v), ultrapure water, basal media and complete culture media (100 µM 
expected test concentration) after 72 hours of incubation in standard 
culture conditions (37°C, 5% CO2, 90% humidity). The standard deviation 
(SD) is shown. Both CoFe2O4 NPs increase in size in the basal media 
environment (>1.5 µm); neither of the P601 and P703 preparations in 
dialyzed DEG and in ultrapure water increased in size. The PdI values for 
2% v/v of P601 in dialyzed DEG and ultrapure water were 0.16 ± 0.02 and 
0.23 ± 0.06, respectively. The PdI values for all other P601 preparations 
were ≥0.3. The PdI values for P703 preparations showed behaviour 
similar to that of P601 and corresponded to 0.180 ± 0.05 in both dialyzed 
DEG and ultrapure water. 
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B.14A and 
B.14B 
DLS measurements of CoFe2O4 P601 and P703 NP (100 µM) dilutions in 
basal medium MEM and Balb3T3 complete culture medium after 0, 24 
and 72 hours of incubation, under standard culture conditions (37°C, 5% 
CO2, 90% humidity). The standard deviation (SD) is shown. Both P601 
and P703 NPs tended to form aggregates/agglomerates that were larger in 
medium without serum than those in the completed medium at all 
incubation time points studied. The PdI values for P601 were consistently 
>0.3; the PdI ranged between 0.361 ± 0.03 and 0.399 ± 0.04, and 0.468 ± 
0.01 and 0.587 ± 0.04 for samples in MEM and Balb3T3 complete 
medium, respectively. In contrast, the PdI values for P703 ranged between 
0.289 ± 0.03 and 0.390 ± 0.10, and 0.378 ± 0.05 and 0.500 ± 0.02 for 
MEM and Balb3T3 complete medium, respectively. 
  
B.15A and 
B.15B 
Some of the 144 cycles of the UV-Vis measurements in a CoFe2O4 P601 
sample (60 µM) in complete culture medium without Phenol Red at fixed 
height (upper cuvette region) made every 30 minutes over 72 hours (A), 
and normalized absorption of the same sample at 500 nm (upper cuvette 
region) (B). 
  
B.16A and 
B.16B 
Normalized absorption of a sample of CoFe2O4 P601 (A) and P703 (B) at 
a concentration of 60 µM in complete culture medium at fixed height 
(bottom cuvette region) in complete culture medium without Phenol Red 
at 500 nm. 
  
B.17A, 
B.17B, 
B.17C and 
B.17D 
Figures B.17A, B.17B, B.17C and B.17D: Mean NP diameter (nm) of all 
Ag NPs investigated in this study. DLS measurements were done for Ag 
NP dilution in ultrapure water, Phosphate Buffer Saline (PBS), MEM 
basal medium and Balb3T3 complete culture medium (100 µM for all Ag 
NPs investigated) at time 0 and after 24 and 72 hours of incubation (for 
preparations in Balb3T3 complete culture medium) under standard culture 
conditions (37°C, 90% humidity, 5% CO2). The standard deviation (SD) 
was used to assess variability in the measurements. 
  
B.18A, 
B.18B, 
B.18C and 
B.18D 
Scanning Electron Microscope images of 100 µM samples of Ag NM-300 
(A), Ag 44 nm (B), Ag 84 nm (C) and Ag 100 nm (D) prepared in 
ultrapure water.  No aggregates/agglomerates of relevance were found in 
these preparations. 
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Glossary 
 
AFM Atomic Force Microscopy 
 
 
Ag Silver 
  
A549 Human Lung Carcinoma cells 
  
APTS 3-aminopropyltriethoxysilane 
  
Balb3T3 Immortalized Mouse fibroblasts 
  
Bhas 42 Balb3T3 cells v-Ha-ras-transfected 
 
 
BHK21 Baby hamster kidney cells 
 
 
BN Binucleated cells 
 
 
BSI British Standards Institution 
 
 
CaCo2 Human Caucasian Colon adenocarcinoma cells 
  
CBMN Cytokinesis-block Micronucleus assay 
 
 
CFE Colony Forming Efficiency 
  
C3H/10T½ Mouse fibroblasts aneuploid established cell line 
 
 
CNTs Carbon nanotubes 
 
 
Co Cobalt 
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CPPs Cell penetrating peptides 
 
 
CTA Cell Transformation Assay 
  
DEG Diethylene glycol 
  
DLS Dynamic Light Scattering 
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IHCP Institute for Health and Consumer Protection 
 
 
JB6 Pre-neoplastic mouse epidermal cells 
 
 
JRC Joint Research Centre 
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MDCK Madin Darby Canine Kidney cells 
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MN Mononucleated cells 
  
MR Magnetic Resonance 
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NMs Nanomaterials 
 
 
NOs Nano-objects 
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NR Neutral Red 
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PN Polynucleated cells 
 
 
REACH Registration Evaluation and Authorization of Chemicals 
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XPS X-ray Photoelectron Spectroscopy 
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Objectives 
The main objective of this Ph.D. research project was to study and understand the in vitro 
toxicological effects induced by specific nanoparticles (NPs) of industrial and biomedical 
interest. 
Nanoparticles of both cobalt ferrites (CoFe2O4 NPs) and silver (Ag NPs) were selected 
for an in vitro study using the Balb3T3 cell model.  The model employs mouse 
fibroblasts; their A-31-1-1 clone enables a single cell type to be screened for different 
endpoints, such as cytotoxicity, cell transformation capacity and genotoxicity. 
Indeed, the A-31-1-1 clone is suitable for the Colony Forming Efficiency (CFE) assay, 
the Cell Transformation Assay (CTA) and the Cytokinesis-Block Micronucleus assay 
(CBMN), which detect cytotoxicity as inhibition of colony growth, the cell 
transformation capacity as induction of type III foci formation, and DNA damage as 
induction of micronuclei, respectively. The CFE and CTA are pre-validated assays, 
whilst the CBMN has been the object of retrospective validation by the Validation 
Management Team (VMT) of the European Centre for the Validation of Alternative 
Methods (ECVAM). These assays appear to be suitable for NP in vitro testing, since their 
endpoints can be achieved without using any dye that can potentially interact with NPs, 
thereby invalidating the results. These methods have all been recommended by the 
Registration Evaluation and Authorization of Chemicals (REACH) legislation and the 
Organization for Economic Cooperation and Development (OECD, Working Party on 
Manufactured Nanomaterials, WPMN) as promising assays for studying the toxicological 
profile of nanomaterials. 
The different sizes or synthesis of NPs and different testing methods and cell lines were 
also compared, where possible, to elucidate test limitations and the influence of NP 
physicochemical characteristics (e.g., size or synthesis) and cell type on experimental 
outcomes. Thus, two and four sizes of CoFe2O4 NPs and Ag NPs, respectively, were 
studied here. The cytotoxicity induced by CoFe2O4 NPs on other mammalian cell lines 
that model different exposure routes was also investigated using Neutral Red uptake (NR) 
and CFE tests in parallel. The six specific cell lines  tested were the: (i) A549 human lung 
carcinoma cells, (ii) Balb3T3 mouse fibroblasts, (iii) CaCo2 human Caucasian colon 
  xviii 
adenocarcinoma cells, (iv) HaCaT human keratinocytes, (v) HepG2 human hepatoma 
cells, and (vi) MDCK Madin Darby Canine Kidney cells. 
In addition, extensive physicochemical characterization of the NPs was performed to 
clarify and complete the toxicological results. 
 In summary, the Ph.D. study focused on the following three main objectives: 
(i) Assessment of cytotoxicity induced by two sizes of CoFe2O4 NPs on six 
different mammalian cell lines using CFE and NR 
(ii) Assessment of cytotoxicity, cell transformation capacity and genotoxicity 
induced by two sizes of CoFe2O4 NPs on the Balb3T3 model using the CFE, 
CTA and CBMN assays 
(iii) Assessment of cytotoxicity, cell transformation capacity and genotoxicity 
induced by four Ag NPs on the Balb3T3 model using the CFE, CTA and 
CBMN assays. 
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Chapter 1: Introduction 
 
1.1 Location and goal of the research 
The experimental work described in this PhD thesis was carried out in the 
NanoBiosciences Unit (NBS) at the Institute for Health and Consumer Protection (IHCP) 
of the European Commission’s (EC) Joint Research Centre (JRC) located in Ispra 
(Varese, Italy). The work was conducted during the period 2008-2011. 
The NBS is involved in nanotechnology research, focusing both on the production of 
nanomaterials (NMs) (nanoparticles and nanosurfaces) and the evaluation of their 
potential in vitro toxicity using in vitro cell models as alternatives to animal models 
(Russell et al., 1959). 
For this thesis, a series of established standard in vitro tests that have been proposed by 
the Registration Evaluation and Authorization of Chemicals (REACH) legislation or 
recognized in the Organization for Economic Co-operation and Development (OECD) 
guidelines for the study of the toxicological profiles of chemicals were used to investigate 
the cytotoxicity of NPs. In addition, the Neutral Red uptake (NR) and Colony Forming 
Efficiency (CFE) assays were chosen to assess the cytotoxicity induced by NMs, whilst 
their cell transformation capacity and genotoxic potential were investigated using the Cell 
Transformation Assay (CTA) and Cytokinesis-Block Micronucleus test (CBMN), 
respectively. 
The primary reason for studying the potential toxicity of NMs is that their use is 
becoming increasingly widespread and consequently there is a growing risk of 
unintentional exposure to humans and the environment (Aitken et al., 2006; Dunphy 
Guzmán et al., 2006). The special, often unique, properties of certain nanoscale materials 
make them highly attractive in many different areas of application, including consumer 
products (e.g., computers chips, cosmetics, sunscreens, food packaging, and for drug 
delivery or targeted treatment of tumours in medicine 
(http://www.nanotechproject.org/inventories/consumer/, last accessed in February 2011). 
Occupational exposure to NMs can occur during the production processes by inhalation, 
ingestion or skin contact, whilst the increasing volume of consumer products containing 
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NMs means that there is greater exposure potential directly related to the general public 
(Aitken et al., 2006). 
Although the potential benefits arising from the use of nanoproducts and nanodevices are 
well documented, much less information is available on their potential toxic effects on 
human and environmental health (Aitken et al., 2006). Whilst the volume of relevant 
scientific data is increasing gradually, it is still insufficient to perform adequate risk 
assessments. In addition, despite evidence that some NMs may be toxic, legislation 
regulating the safe production and use of such NMs is still incomplete (Oberdörster et al., 
2005).  
In order to address concerns about the potentially harmful effects of NMs on public and 
environmental health whilst promoting the secure development of nanotechnology, the 
EC has established actions that support the scientific research related to the risk 
assessment of NMs. These actions are documented in the 7th Framework Programme 
(2007-2013) and include several nanotoxicology research projects that have been 
undertaken 
(http://cordis.europa.eu/projects/index.cfm?fuseaction=app.search&TXT=nanomaterials
&FRM=1&STP=10&SIC=SICNNT&PGA=FP7-
NMP&CCY=&PCY=&SRC=&LNG=en&REF=, last accessed in February 2012). These 
aim to provide technical input for the advancement of legislation for the safe and 
responsible development of nanotechnology 
(http://cordis.europa.eu/nanotechnology/actionplan.htm, last accessed in October 2010). 
 
1.2 Nanotechnology and NMs  
The term “nanotechnology” was coined in 1974 in Japan by Norio Taniguchi, a 
researcher at the University of Tokyo (Singh et al., 2008). Nanotechnology involves the 
design, production and characterization of materials with at least one dimension in the 
nanoscale (10-9m) (Figure 1.1). 
 
 
Chapter 1: Introduction 
 3 
 
Figure 1.1: Nanotechnology products are 100–10000-fold smaller than a human cell (image taken 
from the National Cancer Institute website, http://nano.cancer.gov/learn/understanding/, last 
accessed in September 2011). 
 
Although there have been various definitions of a NM, the term “nano” is now generally 
accepted to refer to dimensions ≤100 nm. In a recent review on environmental risk 
assessment studies for NMs (Stone et al., 2009), the specific definitions for nanomaterial 
(NM), nanoobject (NO) and nanoparticles (NPs) according to the British Standards 
Institution (BSI) and the Scientific Committee on Emerging and Newly Identified Health 
Risks (SCENIHR) were discussed. More specifically, a general NM has just one 
dimension of ≤100 nm (e.g., carbon nanotubes and nano-structured surfaces), whilst NOs 
and NPs have two and three dimensions of ≤100 nm, respectively (Stone et al., 2009).  
It is now well known that matter reaching such small sizes can change its 
physicochemical properties and behave completely differently than the corresponding 
bulk material (Lu et al., 2009; Wijnhoven et al., 2009). This change in physicochemical 
properties can be explained primarily by the increase in the relative surface area (surface 
area per mass unit) and associated quantum effects (Buzea et al., 2007). Indeed, any 
increase in relative surface area corresponds to an increase in chemical reactivity, 
resistance to mechanical stress and electrical properties, making some NMs useful 
catalysts (Stone et al., 2010). Moreover, the quantum effects become so relevant at the 
nanometre level that they can influence and change the optical, magnetic and electrical 
properties of matter (Aitken et al., 2006). 
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The size-dependant properties of some compounds have been exploited unwittingly for 
years, for example, the use of gold and silver NPs as pigments in glass and ceramic 
staining since the 10th century B.C. (Min’ko et al., 2008).  
Nanomaterials can be classified into different groups according to their dimensions, 
phase composition or manufacturing processes. They can be classified into two main 
groups based on their origin, i.e., incidental NMs and engineered NMs (Oberdörster et 
al., 2005) (Figure 1.2). In fact, NMs present in the environment can have different 
origins (Borm et al., 2006). Typically, incidental NMs (e.g., diesel exhaust particles) are 
the result of unintended anthropogenic sources (e.g., combustion derived) or are produced 
by natural processes (e.g., volcanic activity, forest fires, sea spray and erosion processes) 
(Oberdörster et al., 2005) (see Figure 1.2). 
The human race has been exposed to incidental NMs throughout its evolutionary history. 
The discovery of fire meant that a million more NMs could be inhaled when starting a 
fire to cook food (The Royal Society and The Royal Academy of Engineering, 2004). 
Unsurprisingly, therefore, the human race is now surrounded by NMs; a typical room has 
been estimated to contain 1–2 x 104 NPs per cm3, whilst 5 x 104 NPs per cm3 and 105 NPs 
per cm3 can be found in woodland areas and urban streets, respectively 
(http://copublications.greenfacts.org/en/nanotechnologies/l-3/7-exposure-
nanoparticles.htm#2p0, last accessed in February 2012).  
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Figure 1.2: Examples of incidental and engineered NPs. Diesel exhaust particles are defined as 
particles either from unintended anthropogenic sources or of natural origin. Some particles, such as 
fullerenes and carbon nanotubes, are considered to be both engineered materials and incidental 
components of pollution, while dendrimers and quantum dots are considered to be manufactured 
NMs (Image from Stern & McNeil, 2008). 
 
Many examples of nanostructures can also be found in Nature, both in plants and 
animals. The Lotus leaf, for example,  is naturally water-repellent due to cone-shaped 
nano-crystals of hydrophobic wax that are distributed on its upper surface; these 
structures are so small that drops of water cannot spread and flow away, leading to a 
phenomenon known as the “Lotus effect” (Figure 1.3). Another well-known example of 
a nanostructure in Nature is the nanofilaments found on the feet of Gecko lizards (Figure 
1.4); these act like Velcro and allow this reptile to climb smooth surfaces (Buzea et al., 
2007).  
 
 
 
Figure 1.3: Nanostructures in Nature. (A) Nano-crystals of hydrophobic wax on a Lotus leaf and 
drops of water; (B) the “Lotus effect” where water floats on a Lotus leaf  (Google images, last 
accessed in September 2011).  
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Figure 1.4: Nanofilaments on the feet of Gecko lizards 
(http://www.cchem.berkeley.edu/rmgrp/about.html, last accessed in September 2011). 
 
In contrast, particles specifically produced to exploit the special properties gained at the 
nanoscale (e.g., high reactivity, optical properties) are examples of engineered NMs. 
Many products available on the market, for example sunscreens, actually claim to contain 
a component engineered by nanotechnology 
(http://www.nanotechproject.org/inventories/consumer/, last accessed in February 2011). 
Moreover, some particles can be considered to be both engineered materials and 
incidental components of pollution (e.g., fullerenes and carbon nanotubes). 
 
1.3 The potential risk of NMs for human health 
Since nanotechnology products have many areas of application, the potential benefits and 
financial profits are immense. For example, the National Science Foundation has 
estimated that 2 million people will be employed in the field of nanotechnology by 2015 
(http://www.cdc.gov/niosh/nas/RDRP/appendices/chapter7/a7-2.pdf, last accessed in 
September 2011), and 800 consumer products that claim to contain NMs are already on 
the market (Singh et al., 2009). 
Many different organizations are involved in nanotechnology research, including 
companies (pharmaceutical, high technology and cosmetic), universities and research 
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centres. Consequently, estimating the number of people potentially exposed to NMs is 
very difficult (Aitken et al., 2004).  Nevertheless, the potential risks of NMs on human 
health and the environment must be considered. Potential occupational and public NM 
exposure occurs via different exposure routes, including inhalation, oral ingestion and 
dermal absorption and by injection (Bergamaschi et al., 2006). 
The toxicity of NMs may be determined or influenced by their physicochemical 
characteristics, such as size, surface charge, presence or absence of coatings and ability to 
release ions (Elder et al., 2009). Indeed, evidence suggests that all these characteristics 
can contribute to the mechanism by which NMs may interfere in or disrupt biological 
activities (Aillon et al., 2009). Even if NMs originate from the same element, all have 
unique and diverse physicochemical properties associated with their small size 
(Oberdorster et al., 2005) that can result in different toxicological profiles (Bergamaschi 
et al., 2006).  
Since the dimensions of NMs are in the same range as many cellular components (Buzea 
et al., 2007) and NMs can interact with biological molecules, such as proteins (Lynch et 
al., 2008), it is thought that they may be able to avoid natural defences in humans and 
other species and damage cells. To endanger humans and other organisms, however, 
NMs must come into contact with and enter the body, and subsequently participate in 
cellular reactions to induce damage (Buzea et al., 2007; Singh et al., 2009). Notably, 
however, the different potential access points of the body for NMs do have efficient 
defence mechanisms 
(http://ec.europa.eu/health/scientific_committees/opinions_layman/nanomaterials/en/l-
3/4.htm, last accessed in February 2012), such as the production of mucus and presence 
of cilia in the tracheal epithelium and lung macrophages of the inhalation route (The 
Royal Society and The Royal Academy of Engineering, 2004; Kreyling et al., 2006). 
Scientific and political committees have arranged global conferences and workshops in 
order to share current knowledge on the toxicology of NMs and to agree common 
guidelines for the study of NMs (OECD, 2008).  The EC’s suggestions for a safe and 
responsible strategy to reinforce the European Union’s leading position in the Research 
and Development of nanotechnology have been reported in a communication that 
combines the “Towards a European Strategy for Nanotechnology” and “European Action 
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Plan for Nanosciences and Nanotechnologies” reports 
(http://cordis.europa.eu/nanotechnology/actionplan.htm, last accessed in February 2011).  
This communication specifically advocates an increase in nanotoxicology research using 
proper methods, as well as in vitro systems that can reduce, refine and replace animal 
testing (Hartung et al., 2004) to elucidate the mechanism of action of NMs. 
Based on these recommendations, the Joint Research Centre of the European 
Commission (DG-JRC) has developed a research plan for NM toxicology based on an 
integrated approach that combines cell-based in vitro assays with specific radiochemical 
and physicochemical techniques (Ponti, 2008). This experimental approach was used in 
this Ph.D. thesis to study specific NMs, selected according to their importance in 
industrial applications, and to determine their physicochemical characterization and 
toxicological profiles using in vitro systems that model human exposure (i.e., lung, liver, 
kidney, skin, gut and blood). 
 
1.4 NMs: production and physicochemical characterization 
Specifically synthesized NMs are classified as engineered NMs (Buzea et al., 2007). 
Metals, semiconductors, glass, ceramics and polymers theoretically can all be synthesized 
in the nanoscale dimension. Depending on the manufacturing process used, examples of 
engineered NMs that can be synthesized range from the more simple inorganic (metal 
oxides, semiconductors, alloys) or organic (polymers, dendrimers, composites) particles, 
to the crystalline or amorphous particles that are produced as powders or dispersed in a 
matrix, over colloids, suspensions and emulsions, nanolayers and films, and the more 
complex class of fullerenes and their derivatives (Rao et al., 2007). 
Rao et al. have described different synthesis techniques that have been developed to 
produce engineered NMs with specific characteristics (e.g., size, surface charge, 
coatings) (Rao et al., 2004). More recent attention has focused on the development of 
environmentally friendly synthesis protocols; some examples for those of Ag NPs have 
been reported (Begum et al., 2009; Roy et al., 2010). 
The physicochemical characterization of NMs is necessary to understand and control the 
synthesis and applications of NMs (Warheit, 2008). Moreover, correct physicochemical 
characterization of NMs is crucial in identifying variables that can affect the 
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biocompatibility of these materials (Powers et al., 2006; Maynard et al., 2007; Stern & 
McNeil, 2008). Current NM research is focused on understanding the mechanism of 
toxicity of NMs, their interaction with biomolecules or cells and the contribution of 
particle size with respect to particle composition in NM toxicity (Aillon et al., 2009). For 
example, the different forms of asbestos demonstrate the importance of the 
physicochemical properties of NMs as determinants of their respective toxicological 
potentials (Ponti et al., 2011). The surface area and effects of quantum chemistry are one 
of many characteristics that specifically affect the way in which biological systems 
function and interact with the physical world (Sweet & Strohm, 2006).  
In nanotoxicology, it is important to characterize NMs thoroughly from the time of 
synthesis onwards (Fubini et al., 2010). Indeed, NM preparations can be contaminated 
and thus lead to toxic effects that can overlap with the effects of the NMs per se. Not 
only can the shape of NMs influence their biocompatibility (Huang et al., 2011), but the 
interactions of NMs with a biological environment (e.g., culture media and biological 
fluids) are also important to study. The dissolution of NMs can cause free ions production 
that can subsequently induce toxicity (Mazzotti et al., 2002; Fubini et al., 2010). 
Compared to chemical toxicants, the quantitative and qualitative characterization of NMs 
for toxicological analysis is very complex (Powers et al., 2006). For example, it is 
important to ascertain exactly the actual dose or concentration of NMs tested, particularly 
as accurate pipetting of NM suspensions is difficult due to the solid status of NMs (Ponti 
et al., 2010). If such considerations are disregarded, the potential toxicity of a specific 
NM may be correlated with the wrong concentration of the NM. 
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Figure 1.5: Schematic representation of physicochemical properties of NMs. The main 
physicochemical properties of NMs that may influence their biocompatibility (including their size, 
shape, surface area, surface charge, coating, presence of contaminants and reactivity) and that 
should be considered when assessing their hazard risks (Stern & McNeil, 2008). 
 
 
Different techniques, therefore, should be used to obtain information on size distribution, 
surface charge, morphology and chemical composition of NMs, all of which are 
important characteristics to be considered when studying the toxicology of NMs (Figure 
1.5) (Bouwmeester et al., 2011) because the properties that make these NM materials 
invaluable in industrial and biomedical applications can also cause safety concerns (Jiang 
et al., 2009; Clark et al., 2011). 
The physicochemical characterization of NMs can be achieved using several techniques 
based primarily on material science. For example, the Scanning Electron Microscopy 
(SEM), Transmission Electron Microscopy (TEM), Atomic Force Microscopy (AFM), X-
ray Photoelectron Spectroscopy (XPS), and powder X-Ray Diffractometry (XRD) 
techniques can be used to investigate the morphology, size, shape and structure of NMs. 
These techniques, together with that of Dynamic Light Scattering (DLS), which measures 
hydrodynamic size distribution and the Z-potential, are the gold standards for the 
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evaluation of particle size distribution and shape in toxicity screening studies (Powers et 
al., 2006; Drobne, 2007).  
 
1.5 NMs: biological effects 
Between 2003 and 2008, the publication of scientific papers related to NMs and their 
potential toxicity increased by over 1100% (Card et al., 2010). Until recently, however, it 
has not been possible to identify a single physicochemical characteristic that could 
explain the toxicological effect of NMs and their interaction with biological systems 
(Bouwmeester et al., 2011).  
Clearly, the toxicological assessment of one type and source of NM is insufficient when 
evaluating the toxicity induced by a similar NM that may differ only, for example, in its 
production process (Drobne et al., 2007; Bouwmeester et al., 2011). For example, the 
coatings or other surface modifications on engineered NMs that are usually used to 
produce mono-dispersed suspensions may influence their toxicological effect whilst also 
enhancing their special properties (Drobne et al., 2007; Clift et al., 2008).  
Since NMs can differ in many characteristics, every one of which can be responsible for a 
unique biological effect, it is difficult to generalize NM-induced toxicity (Aillon et al., 
2009). Consequently, the characterization, testing and classification of different types of 
NMs are necessary. The aim in nanotoxicology, however, is not to test every variation of 
every newly-synthesized NM, but rather to identify the factors that are useful in 
understanding and predicting NM toxicity (Drobne et al., 2007). Several NP-toxicity 
screening strategies have been proposed by different research groups and discussed in a 
number of comprehensive reviews (Donaldson et al., 2004; Oberdorster et al., 2005). 
The current consensus is because the actual small physical size of an engineered 
nanostructure is similar to that of many biological molecules (e.g., antibodies, proteins) 
and structures (e.g., viruses), nanostructures can readily enter tissues, cells, organelles 
and functional biomolecular structures (i.e., DNA, ribosomes, etc.) (Elechiguerra et al., 
2005). It is thought that nanostructures entering vital biological systems could cause 
damage there and thus harm human health (Buzea et al., 2007). Both in vitro and in vivo 
studies have confirmed the ability of NMs to produce free radicals (Aillon et al., 2009; 
Stone et al., 2009) and currently, the toxicity of NMs appears to be due to the generation 
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of reactive oxygen species (ROS) after exposure of cells to particulate matter 
(Hackenberg et al., 2011; Uchino et al., 2002; Park et al., 2009). 
The importance of coatings and surface functionalization for the entry of the 
nanostructures into biological systems has been highlighted previously. For example, 
citrate-stabilized gold nanostructures have been shown to enter mammalian cells in 
endosome-like structures (Chithrani et al., 2006), and engineering the surface chemistry 
of nanostructures may enhance access to the nucleus or mitochondria (Chen et al., 2004; 
Nativo et al., 2008). Whilst the intracellular or in vivo biodistribution of NMs would be 
obtained and directed by engineered nanostructures (Chen et al., 2004;  Deng et al., 2007; 
Derfus et al., 2004; Khan et al., 2005), both the final metabolic fate and strategies to 
avoid secondary, unintentional effects remain unknown (Fischer et al., 2007). 
The delivery of NPs by liposomes or the modification of NP surfaces with short peptides 
(CPPs) to facilitate their cellular uptake are methods by which the well-established 
endosomal route of cellular uptake of NPs can be bypassed. Nuclear targeting using 
surface modification with a cocktail of CPPs and a peptide that acts as a nuclear 
localization signal has been demonstrated (Nativo et al., 2008). Surface functionalization 
with specific molecules has also been demonstrated as a method by which NMs enter the 
brain, which is normally protected by the blood-brain barrier (Liu et al., 2008).  
The relationship between physicochemical characteristics of NMs, such as size, shape, 
and surface chemistry, and their intracellular and in vivo biodistribution remain largely 
unknown. However, predictive classification procedures that have already been 
developed to evaluate this relationship for several drugs and carriers may also be useful 
for nanostructures (Fischer et al., 2007). Nevertheless, once NMs have entered the body, 
their behaviour cannot be predicted by their properties alone. 
The conventional protocols used for testing chemicals are considered to be a good 
starting point for the characterization and toxicological evaluation of NMs, but must be 
refined and specifically adjusted for NMs (Drobne et al., 2007). In order to prevent 
unwanted effects due to intentional or unintentional exposure to NMs, standard 
guidelines for toxicity testing strategies of NMs have been developed and validated by 
regulatory agencies, professional societies, the academic community, National 
Government Organizations and industry. In particular, these methods and protocols must 
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also consider the time and cost effectiveness of these analyses giving toxicological 
information for the variety of NMs (Drobne et al., 2007). 
Figure 1.6 gives a general overview of the common JRC approach for studying the 
toxicology of NMs. Nanomaterials are synthesized and physicochemically characterized, 
both as stock suspensions and after dilution in culture medium using Scanning Electron 
Microscopy (SEM) and Dynamic Light Scattering (DLS) to assess size distribution, and 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) to evaluate metal impurities 
and ion leakage. Moreover, NMs can be radio-activated; this allows their uptake to be 
quantified and intracellular fate to be estimated. One final consideration is the biological 
effect that can be related to the internal, not external, concentration of NMs. 
 
 
Figure 1.6: Schematic and general representation of the in vitro approach used to assess cellular 
biokinetics of NMs at the JRC. Nanomaterials are chemically synthesized and radio-activated by 
neutron, deuteron or proton irradiation. The material is added to culture medium where its 
behaviour, particularly dissolution, is studied taking advantage of the possibility to measure 
radioactivity. The interaction of NMs with cells (adsorption/uptake) is then evaluated. Dissolution 
and uptake of non-radioactive NMs can be measured by ICP-MS. The intracellular distribution is 
often studied using the TEM technique. Conventional TEM images, however, cannot always 
distinguish NPs from some small cellular structures (e.g., glycogen granules) so that specific 
additional techniques must be used (Mühlfeld et al., 2007). The advantage of this approach is that the 
biological effect can be correlated with the real dose of NM that interacts with the cells (European 
Commission, JRC-Ispra, NanoBiosciences Unit). 
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(binding with proteins, dissolution) 
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1.6 In vitro cell cultures and the characteristics of transformed cells 
This study assessed the in vitro toxicity induced by specific NPs using six mammalian 
cell lines (Table 1.1). These cell lines were chosen as models of the possible impact that 
the selected NPs might have on different target organs in the body.  
 
Table 1.1:  The mammalian cell lines used to assess the cytotoxicity of CoFe2O4 NPs in this study.  
Mouse Balb3T3 fibroblasts were also used as a cell model to study the concurrent cytotoxicity and 
cell transformation capacity, as well as genotoxicity induced by specific CoFe2O4 and Ag NPs.  
 
Mammalian cell lines used 
Immortalized cells Tumorigenic cells 
Bab3T3  Mouse immortalized fibroblasts A549 Human Lung Carcinoma cells 
 
 
 
 
HaCat Human immortalized keratinocyte 
cells 
CaCo2 Human Caucasian Colon adenocarcinoma 
cells 
 
 
 
 
MDCK Madin Darby Canine Kidney cells HepG2 Human hepatoma cells 
  
 
Importantly, the cell lines used in this study could be similar, but not necessarily 
identical, to the primary cells or cells in vivo. Initially, cells taken from a vertebrate 
organism and cultured in vitro multiply, but they then enter a stationary stage where they 
stop growing (Watanabe et al., 1967). The cell culture then undergoes a crisis stage 
during which many cells die; some cells may, however, survive and start to grow 
indefinitely. The ability to overcome the crisis and the time at which it occurs can differ 
for different cells from organisms of different species. For example, human cells undergo 
the crisis stage at the fortieth generation and rarely survive this stage, whilst mouse cells 
enter the crisis stage at the twelfth generation and usually survive. 
 
Cell cultures used to perform in vitro experiments can be divided into two main groups 
(Walum et al., 1990): 
 
 Primary cell cultures: these cells represent the direct progeny of cells originating 
from the donor organ; their phenotype is similar to that of the same cells in vivo, 
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but their lifetime in culture is very short because they reach the crisis stage 
quickly and then die 
 Cell line cultures: after an in vitro partial transformation, these cells can grow 
indefinitely with no alteration in phenotype. They are still, for example, anchor-
dependent, contact-inhibited and serum growth factor-dependant for growth, and 
retain the normal cytoskeleton organization that allows the cells to adhere to the 
substrate with a flat and elongated morphology. Cell lines can also be obtained by 
selecting cells that can survive to the crisis stage. Their lifetime in culture exceeds 
that of primary cultures; therefore, the transformed cells are also defined as 
“stabilized” or “immortalized” and form a cell line with an aneuploid 
chromosomal set. The immortalized cell lines are not normally tumorigenic. 
 
Tumorigenic cells are completely transformed in neoplastic cells and their morphology 
differs from normal cells. Tumorigenic cells, via a multi-stage process, can grow without 
undergoing the processes that usually regulate the cell cycle. The characteristics of the 
tumorigenic cells are summarized as follows (Walum et al., 1990):  
 
 Immortalization: apoptosis is postponed 
 Independence from growth factors: cells do not need growth factors in the culture 
medium because they drive their own synthesis 
 Independence from the anchor (for cells that usually grow whilst attached to a 
substrate): cells can grow without attaching to a substrate 
 Lose of contact inhibition: cells grow continuously even when the culture reaches 
confluence and can grow as a multi-layer 
 Metastatization: cells can colonize normal tissues, moving from the original tissue 
to any other part of the body. 
 
Cancer can occur in animals inoculated with tumorigenic cells (Walum et al., 1990). The 
transformation frequency can be increased by exposure to different carcinogenic agents 
that can be classified as “initiators” and “promoters” and include several chemical 
compounds and UV radiation (Asada et al., 2005; Sakai, 2007). In order to produce a 
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cancer, the carcinogenic agents must affect two main types of genes: the proto-oncogenes 
(responsible for cell cycle regulation and called oncogenes in the transformed cell) and 
the anti-oncogenes (so-called tumour suppressor genes because their normal function 
contrasts with unchecked growth) (Lewin, 1997). 
 
The advantages of using a stabilized cell line are as follows (Ekwall et al., 1990): 
 
 A homogeneous population of target cells that can be obtained from a single 
mother cell due to a high cloning efficiency and unlimited cell growth 
 The availability of a large stock of cells with defined characteristics 
 Ease of checking the correlation between the assay endpoint and the neoplastic 
transformation because stabilized cells require only a few stages to become 
tumorigenic 
 A higher plating efficiency, thereby saving resources and simplifying the sub-
clone isolation and evaluation of the induced transformation per survived cell 
 Simpler medium for the cell culture as these cells are adapted to the culturing 
conditions, resulting in higher reproducibility between laboratories 
 A reproducible dose-effect relationship, which is not available for diploid cells 
 Sensitivity to promoter agents, which can be exploited to enhance the sensitivity 
of cells at the transformation stage 
 
The disadvantages of using stabilized cells include (Ekwall et al., 1990): 
 
 Abnormality of target cells; target cells differ from the primary cells because they 
adapt to the culture conditions 
 Limited ability to metabolize chemical compounds because (i) most of the 
chemicals become actively carcinogenic only after being metabolized in the body, 
and (ii) the stabilized cell lines are clonal in origin and so have limited ability to 
metabolize chemicals, which reflects the ability of these cells in their original 
tissue of source 
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 Unsure origin and loss of differentiated functions; cells tend to lose the 
characteristic functions of their specific cell type after many generations in culture 
because of reversible and irreversible alterations to genetic patterns. The problems 
associated with the use of stabilized cell lines are demonstrated both by clonal 
variation and that which occurs after several passages in culture. With respect to 
clonal variation, a cell line kept in culture in one laboratory often differs from the 
very same cell line cultured in another laboratory. In addition, an increase in 
spontaneous transformation usually occurs at the later passages and can be 
avoided, therefore, by using cells produced only at earlier passages. 
 
1.7 In vitro methods to test of NMs: from cytotoxicity to genotoxicity 
In this Ph.D. research project, the effects of NPs were tested using in vitro methods 
suggested by the EC, White Paper, Strategy for a Future Chemicals Policy 
(http://cordis.europa.eu/nanotechnology/actionplan.htm). This report outlines a strategy 
for toxicological testing using in vitro methods as alternatives to animal testing for the 
Registration, Evaluation and Authorization of Chemicals (REACH) legislation. The 
estimated number of vertebrate animals (mammals, birds and fish) required for the 
toxicological assessment of chemicals is approximately 2.6 million in the range of time 
required by the REACH system (11 years). This corresponds to 2-3% of the total number 
of vertebrates used every year for experimental and scientific purposes, including 
pharmacological tests (Perdersen et al., 2003). This number is likely to increase in the 
future due to the growth in nanotechnology production and subsequent nanotoxicology 
research. The total cost of these experiments has been evaluated to be approximately 1.5 
billion Euros, 90% of which is related to studying the effects on human health. 
The development and application of accurate testing strategies may, therefore, contribute 
to a reduction in the experimental costs and number of animals used (Perdersen et al., 
2003). Clearly, the standardization of efficient screening tests based on in vitro screening 
assays is required (Ponti et al., 2006). Moreover, there is increasing interest in the 
development of alternative in vitro methods because the potential toxic effects of 
engineered NMs, their mechanisms of action and interactions with cells must be 
understood (Stern & McNeil, 2008). A potential toxic effect may not be explained solely 
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by toxicity assays because some NMs may induce inflammation and genotoxicity, but not 
cytotoxicity. This highlights the importance of studying the cell transformation capacity 
and genotoxicity as well as toxicokinetics using in vitro assays (OECD, 2008). Despite 
the obvious advantages of in vitro systems, however, these do have many limitations and 
one test alone may not suffice for risk assessment purposes (Stone et al., 2009). 
Currently, in vitro nanotoxicology research cannot replace the in vivo investigations that 
are required to verify in vitro data, and particularly to test for acute and chronic exposure 
(Clift et al., 2011). 
The most promising in vitro tests use human cell lines and can mimic in vivo conditions. 
Other cell lines, such as the immortalized mouse fibroblasts Balb3T3 (A31-1-1 clone) 
may be of interest when assessing the cell transformation capacity of chemicals or NMs. 
These cells are actually used in the Cell Transformation Assay (CTA), which is a very 
promising in vitro test for studying the cell transformation capacity of chemicals and 
NMs. The CTA was the object of a pre-validation study, the goal of which was to 
optimize and standardize the choice of cell line, methods of culture and exposure 
protocols, as well as plate reading and data analysis (Ponti, 2004). The observation that 
results obtained by screening metal compounds using the CTA correlated with cell 
transformation capacity data in humans (International Agency for Research on Cancer, 
IARC) and animals confirmed the validity of the assay as a promising in vitro method for 
the evaluation of transformation capacity. 
In this study, cytotoxicity was evaluated using the Colony Forming Efficiency (CFE) and 
Neutral Red uptake assays, and the transformation capacity was assessed using the CTA 
followed by the Cytokinesis-Block Micronucleus assay (CBMN). The CBMN is a 
specific assay for genotoxicity that can discriminate between genotoxic and non-
genotoxic compounds; it was used here to evaluate genotoxicity because this information 
cannot be obtained with the CTA. 
 
1.7.1 In vitro assays for studying cytotoxicity or viability  
Cytotoxicity is a general term commonly used to indicate the ability of chemicals or NMs 
to affect cellular structures and/or functions, leading to cell death (Singh et al., 2009). 
Cytotoxicity assays are often considered to be viability assays, even if they do not always 
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measure directly the number of living/dead cells, but a cellular function (e.g., 
mitochondrial activity or release of lactate dehydrogenase) (Stone et al., 2009). Several 
assays are now available commercially to screen in vitro cytotoxicity; however, these 
should be properly validated with pathogenic and non-pathogenic particulates before they 
are used to assess NMs (Hillegass et al., 2010). 
Among the short-term in vitro methods described in the literature and already being used 
to screen NM-induced cytotoxicity, however, are the so-called “colorimetric assays”. 
These include the Trypan Blue exclusion, Neutral Red uptake and microculture with 
tetrazolium (MTT, MTS, XTT) assays and use specific dyes to highlight the endpoint. 
The Trypan Blue assay allows unstained and viable cells to be distinguished from 
coloured dead cells because the diazo dye, Trypan Blue, can enter cells whose plasma 
membrane has been damaged. The Neutral Red and tetrazolium assays do not provide 
direct information on the total number of viable cells, but the viability of the cell 
population is considered to be directly proportional to the absorbance measured at the 
end of the experiment. Specifically, Neutral Red dye can be taken up by viable cells and 
retained by their lysozomes, whilst soluble, yellow tetrazolium dyes are usually 
metabolized by viable cells with active mitochondrial activity into an insoluble purple 
formazan product. 
Interference in the absorbance measurements of these assays can occur, however, due to 
the optical properties of some NMs and interactions between the NM/dye or NM/dye-
product. This can either invalidate these types of assays or make them inapplicable to all 
NMs unless some tricks and control experiments are included to minimize over/under-
estimation of cell viability (Stone et al., 2009). Indeed, Casey et al. have demonstrated 
interactions between single-walled carbon nanotubes (swCNTs) and different dyes, 
commonly used in cytotoxicity studies (i.e., Comassie Blue, Alamar Blue, Neutral Red, 
MTT and WST-1) using spectroscopic analysis (Casey et al., 2007). Monteiro-Riviere et 
al. obtained highly variable results due to interactions between the tested materials and 
dye/dye products when using dye-based assays to screen the toxicity of different carbon 
NMs (Monteiro-Riviere et al., 2009). It must be stressed, therefore, that whenever 
possible, more than one method and cell type should be used to accurately study and 
characterize the properties and effects of each material.  
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Amongst the cytotoxicity assays, the Colony Forming Efficiency (CFE) “clonogenic 
assay” measures the cytotoxic effect as a decrease in the number of colonies formed after 
treatment compared to a control, should also be mentioned (Hillegass et al., 2010). This 
assay is suitable for testing NMs because it does not use dyes and is usually more 
sensitive than biochemical methods as it measures cell death in general rather than a 
specific biological effect (Ponti et al., 2010).  
 
1.7.2 In vitro assays for studying the cell transformation capacity 
Carcinogenesis is a multi-step process. It is a series of genetic alterations in a target cell 
that involves the activation of oncogenes, inactivation of tumour suppressor genes and/or 
altered activation of cell cycle genes, which cause steady alterations in cell growth 
control and thus produce cells that can form malignant tumours (Schins, 2002; Lewin, 
1997). While carcinogenesis is usually associated with neoplastic fibroblasts, 
oncogenesis generally refers to any cell type that undergoes neoplastic transformation. A 
tumorigenic cell has a fully neoplastic transformed phenotype (Walum et al., 1990), and 
every substance that promotes or initiates cancer is defined as a carcinogen (Singh et al., 
2009). 
In particular, the morphological transformation in cell cultures implies changes in the 
behaviour and control of growth characterized (depending on the cellular system) by one 
or more of the following aspects (Yuspa et al., 1988): 
- Alteration of the cellular morphology 
- Unorganized growth of the colonies 
- Anchorage-independent growth. 
Experiments with animals, clinical human material and in vitro biomolecular and cellular 
methods are required to elucidate carcinogenic mechanisms. Several in vitro models have 
been proposed to determine the cell transformation capacity of a material (Combes et al., 
1999): 
 The Syrian Hamster Embryo (SHE) cells’ morphological transformation 
assay. The goal of this assay is the formation of transformed colonies by SHE 
cells, the primary culture. The SHE cells are diploid, have a short lifetime in 
culture and rarely become tumorigenic unless exposed to a carcinogen (Di 
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Paolo, 1980). First introduced by Berwald and Sachs in 1963 to test 
chemicals, this assay produces results within weeks. The results obtained after 
testing 28 chemicals have shown 78% concordance with rodent bioassays 
(Engelhardt et al., 2004) 
 The Balb3T3 (clone A31-1-1) and C3H/10T½ Cell Transformation Assay 
(CTA). This assay uses established cell lines of aneuploidy mouse fibroblasts; 
the endpoint is the loss of contact-inhibition of cell growth. Foci type III are 
scored as transformed colonies because the normal cells are usually highly 
sensitive to post-confluence inhibition. This assay can be performed using a 
standard protocol (72 hours of treatment, refreshing the medium twice weekly 
and maintaining the culture for a total of 4–6 weeks) or by following a two-
stage protocol (treatment with sub-doses of a carcinogenic compound acting 
as a tumour initiator, e.g., MCA, is followed by a second treatment with a 
carcinogen that is not genotoxic as a tumour promoter, e.g., TPA). The two-
stage protocol is similar to the in vivo two-stage carcinogenesis tests and 
detects the activity of tumour promoters; the latter are usually not genotoxic 
carcinogens and they do not produce foci in Balb3T3 culture per se (Sakai, 
2007). The Bhas 42 cell transformation assay is a variation of the two-stage 
protocol described above, where Bhas 42 cells were established by Sasaki et 
al. (Sasaki et al., 1988) and obtained after v-Ha-ras-transfection of Balb3T3 
cells (Asada et al., 2005) 
 The HaCaT cell transformation assay. This human cell line is obtained after 
the spontaneous immortalization of normal human keratinocytes, most likely 
caused by p53 gene mutations and the subsequent loss of function of 
senescence genes. The HaCaT cells are a convenient cell model for studying 
tumour progression using several carcinogenic agents (Fusening & Boukamp, 
1998). 
Other assays that detect cell transformation have been documented, such as the soft-agar 
test with BHK21 (baby hamster kidneys) and JB6 (pre-neoplastic mouse epidermal) cells, 
where the endpoint is the loss of anchorage dependence for growth (Sakai, 2007). 
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One of the most promising in vitro tests assessing the cell transformation capacity of 
different organic and inorganic compounds, however, involves the use of the Balb3T3 
clone A31-1-1 assay. These mouse fibroblasts are derived from mouse embryo cells that 
were expanded in culture over 40 years ago (Aaroson & Todaro, 1968) and then selected 
to obtain the A31-1-1 clone still used in the CTA (Kakunaga, 1973). These cells are 
contact-inhibited and show a plating efficiency of 50-60%. They can form a monolayer 
with fibroblast-like morphology and have a division period of approximately 16 hours, 
depending on the cellular density. 
Nevertheless, although Balb3T3 cells show some of the typical characteristics of 
transformed cells (e.g., immortalization, high cloning efficiency, altered morphology 
compared to the primary culture, loss of anchor-dependent growth if treated with 
carcinogenic agents and tumour formation if used to inoculate nude mice after treatment), 
their frequency of spontaneous transformation is low (about 10-5 foci per survived cells) 
(Aaroson & Todaro, 1968; Di Paolo et al., 1972). 
The CTA using Balb3T3 cells allows the simultaneous evaluation of cytotoxicity and 
morphological transformation. It takes 7-10 days and 5 weeks to determine the 
cytotoxicity and cell transformation capacity, respectively (Ponti et al., 2007). 
Cytotoxicity is evaluated by the number of colonies formed (CFE), whilst the 
transformation capacity is evaluated by the formation of type III foci. The range of 
concentrations of substances to be tested with the CTA has been defined previously by 
cytotoxicity experiments (usually corresponding to 80%, 50% and 20% of CFE). In the 
Balb3T3 assay, three different types of foci can be observed after exposure to chemicals 
and NMs: 
 
 Type I foci: colonies composed of cells with a low level of vertical growth 
and overlapping 
 Type II foci: colonies in which cells grow overlapped and form multi-layers 
and spindle cells at the boundaries 
 Type III foci: basophilic colonies with a high level of overlapping, spindle 
cells without any specific orientation at the boundaries that appear to run over 
onto a surrounding monolayer of normal cells.  
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Only type III foci are scored in this assay since it has been demonstrated that these alone 
can induce tumour formation in nude mice with 85% frequency (Saffiotti et al., 1984; 
IARC/INCI/EPA, 1985). One of the larger databases on Balb3T3 cells was developed by 
Matthews et al. (Matthews et al., 1993) and evaluated 168 chemicals, including 84 
carcinogens and 77 non-carcinogens. The Balb3T3 assay was shown to be useful in 
assessing both carcinogenic and non-carcinogenic chemicals. Notably, surveys of 
published in vitro activities of 131 chemicals, classified as group I carcinogens by the 
IARC, have shown that morphological transformation assays (in rodents and human 
cells) had a high level of predictability (IARC, 1987). This is of interest and encouraging 
for the future development of these assays for regulatory purposes. 
 
1.7.3 In vitro assays for studying genotoxicity 
The ability of a test agent, either a chemical or a NM, to damage DNA is defined as 
genotoxicity (Singh et al., 2009). Genotoxicity testing is an important part of the risk 
assessment of chemicals for regulatory purposes (DHO, 2000) and identifies chemicals 
that may damage DNA and be carcinogenic (assuming that mutagenesis plays a key role 
in the carcinogenic process). 
At least two in vitro tests are part of the first level of a standard, regulatory genotoxicity 
test procedure organized into a tier-testing scheme: a bacterial mutagenicity test (OECD 
TG 471, Ames’ test using Salmonella or E. coli) and a cytogenetic test (OECD TG 473, 
usually an analysis of the metaphase using either human lymphocytes or rodent cell lines) 
(Zeiger, 2001). The CTA performed with Balb3T3 allows carcinogens to be detected, but 
does not distinguish between genotoxic and non-genotoxic compounds. Therefore, a 
testing strategy that requires CTA experiments to be performed alongside other in vitro 
genotoxicity tests, such as the Cytokinesis-Block Micronucleus assay (CBMN), has been 
suggested (Hartung et al., 2003). 
A number of in vitro genotoxicity tests that assess the effects of NMs on the genome 
have been reported (Singh et al., 2009). The most frequently used was the Comet assay 
(19 studies, 14 of which had a positive outcome) followed by the CBMN assay (14 
studies, 12 of which had a positive outcome), whilst the Ames’ test was used less 
frequently (and almost always showed a negative outcome that may be due to the 
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bacterial cell wall acting as a barrier against NMs) (Landsiedel et al., 2008). The in vitro 
CBMN test, however, is not yet generally accepted by regulatory authorities as an 
alternative system in a test battery because it lacks formal validation. It was the object, 
therefore, of a retrospective validation study carried out by the Validation Management 
Team (VMT) of the European Centre for the Validation of Alternative Methods 
(ECVAM). The VMT evaluated existing data to assess the validity of this test when 
considering seven validity modules: 
1. Test definition 
2. Intra-laboratory reproducibility 
3. Transferability 
4. Inter-laboratory reproducibility 
5. Predictive capacity 
6. Applicability domain 
7. Minimum performance standards. 
The VMT concluded that the in vitro micronucleus test could be considered as a valid 
alternative to the in vitro chromosome aberration test for genotoxicity testing (Corvi et 
al., 2008). Moreover, following a comprehensive inter-laboratory assessment (Carter, 
1967), the OECD approved the in vitro Micronucleus Test Guideline 487 (OECD TG 
487; Parry et al., 2010), which gave specific recommendations for tests using mammalian 
cells. 
The CBMN assay protocol was improved in 2007 by Fenech (Fenech, 2007); this leads to 
the development of the Cytokinesis-Block Cytome assay. This procedure allows DNA 
misrepair, chromosome breakage, chromosome loss, non-disjunction, cytostasis, 
cytotoxicity, necrosis and apoptosis to be measured. In particular, this refined protocol 
focuses on the different types of DNA damage that can be detected as (Figure 1.7): 
 
 Micronuclei (MN): these are formed either by acentric chromosomes fragments or 
by entire chromosomes (chromosomal loss) and show the same morphology and 
nuclear staining, but are smaller and scored only in bi-nucleated cells (BN), which 
correspond to cells that have divided only once  (Figure 1.8) 
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 Nucleoplasmic bridges (NPBs): these are biomarkers of dicentric chromosomes 
resulting from telomere end fusions or DNA misrepair, and appear as narrow or 
wide stalks between the two main nuclei 
 Nuclear buds (NBUDs): these are biomarkers for the elimination of amplified 
DNA formed during S-phase, and are similar in appearance to micronuclei, but 
are linked to one of the two main nuclei with a narrow or wide stalk.  
 
The cytostatic effects are measured as the Nuclear Division Index (NDI), which is the 
ratio of mono-, bi- and poly-nucleated cells, whilst cytotoxicity is represented by the ratio 
between the necrotic and/or apoptotic cells. More information on the mechanism by 
which MN, NPBs and NBUDs are formed can be obtained using centromere and/or 
telomere probes, and specific scoring criteria have been suggested (Fenech, 2007). The 
NDI assay has been employed successfully for both the monitoring of in vivo genotoxin 
exposure (Migliore et al., 2002) and in vitro genotoxicity testing. It has also been used in 
several research fields, such as nutrigenomics and pharmacogenomics (Fenech, 2010), as 
well as to predict the sensitivity of normal and tumour tissues to radiation and cancer 
risks (Saran et al., 2008).  
 
Figure 1.7: The possible fates of cultured, cytokinesis-blocked cells following exposure to 
cytotoxic/genotoxic agents. Using CBMN assay, biomarkers, such as the frequency of chromosome 
breakage (MN), chromosome loss (MN), and chromosome rearrangement, for example, dicentric 
chromosomes (NPB), gene amplification (NBUDs), necrosis and apoptosis can be measured. In 
addition, cytostatic effects can be estimated from the ratio of mono-, bi- and multinucleated cells 
(Fenech, 2007). 
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Figures 1.8A, B, C, D, E, F, G, H and I: Optical microscope images (40X) from positive control slides 
prepared in the CBMN assay using Balb3T3 mouse fibroblasts. In particular, an example of a 
mononucleated cell (A), a binucleated cell (B), a polynucleated cell (C), a binucleated cell with one or 
more micronuclei (D and E respectively), a binucleated cell with nuclear bud (F), a binucleated cell 
with nucleoplasmic bridge (G), a binucleated cell with double nucleoplasmic bridge and a 
micronucleus (H) and a binucleated cell with nucleoplasmic bridge and nuclear buds (I) (EC, JRC-
Ispra, IHCP, NBS).  
To calculate the NDI, mononucleated, binucleated (with or without micronuclei) and polynucleated 
cells are scored. In this study, the genotoxic potential of CoFe2O4 and Ag NPs, demonstrated by the 
induction of micronuclei formation, was evaluated on Balb3T3 mouse fibroblasts. 
 
 
In addition to genotoxicity investigations, numerous studies related to oxidative stress 
and inflammation have been reported. These studies are widespread in nanotoxicology 
research because of the effort invested in understanding the mechanisms by which NMs 
may induce genetic damages.    
Two main hypotheses may explain the possible mechanisms by which NMs can induce 
DNA damage (Singh et al., 2009): 
- Once NMs have entered cells by passive diffusion, receptor-mediated endocytosis 
and/or clathrin- or caveolae-mediated endocytosis, they can pass through the 
nuclear membrane (if small enough), be transported through nuclear pores, or be 
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enclosed in the nucleus during mitosis, and thus physically interact with the DNA 
to cause genetic damage (primary genotoxicity, Figure 1.9) 
- NMs can interact with other cellular biomolecules, such as the proteins involved 
in cell division. They can also cause oxidative stress via reactive oxygen species 
(ROS) and/or free radical production, inflammation (mediated by inflammatory 
cells—macrophages and neutrophils—that secrete soluble factors, including 
cytokines and tumour necrosis factors, which can  cause secondary genotoxicity, 
Figure 1.9), and aberrant signalling responses. 
 
Electrophilic molecules (e.g., H2O2) or free radicals (e.g., OH·) containing an oxygen 
atom are usually defined as ROS and are produced by metabolic reactions or 
physicochemical insults. The different ROS species show different reactivity and thus 
have different potential toxicity profiles. Specific assays can detect the ROS produced by 
NMs due to their surface properties and thus reactions in biological media in the absence 
of cells, and to measure intra-/extra-cellular ROS species generated by cells per se 
following treatment with particulates. Assays that can detect changes in the ratio between 
the reduced form of the natural antioxidant glutathione (GSH) and its oxidized form 
(GSSG) are also available and used to study oxidative stress (Stone et al., 2009). 
Oxidative stress studies are important not only to increase understanding of 
transformation and genotoxicity, but also because they can explain toxicity results; severe 
oxidative stress per se can cause necrosis whilst moderate oxidative stress can cause 
apoptosis (Curtin et al., 2002). 
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Figure 1.9: Mechanisms of primary and secondary genotoxicity induced by particles and fibres; ROS 
may play a major role in primary genotoxicity, whilst the excessive and persistent formation of ROS 
from inflammatory cells may be responsible for secondary genotoxicity (Schins, 2002). 
 
1.8 Metal NPs investigated in this study 
This Ph.D. research study focused on assessing the potential in vitro effects induced by 
different sizes of CoFe2O4 and Ag NPs. This section describes the current knowledge on 
the biological effects of CoFe2O4 and Ag NPs. 
 
1.8.1 Cobalt ferrite NPs (CoFe2O4 NPs): biological background 
Metal oxide NPs are of huge interest because of their unusual and often mass-dependant 
optical, electronic and magnetic properties. An important group of NPs are the magnetic 
NPs. Iron oxide NPs with a specific surface chemistry appear to be suitable for several in 
vivo applications (e.g., Magnetic Resonance Imaging contrast enhancement, tissue repair, 
immunoassay, drug delivery, detoxification of biological fluids and cell separation) that 
require specific magnetic and physicochemical properties (size ≤100 nm) (Laurent et al., 
2008). 
For example, the first magnetic NPs to be developed as contrast agents for Magnetic 
Resonance Imaging (MRI), a useful diagnostic technique because it is non-invasive, were 
the iron oxide (Fe3O4) NPs. Magnetic NPs used for MRI can be injected intravenously or 
directly into a specific site in the body. Particles larger than 100 nm tend to stay into the 
vascular system, whilst smaller particles can diffuse into neighbouring tissues (Berry, 
2005). These NPs are usually coated with dextran or polyethylene glycol derivatives, 
which allow a longer circulation half-life than uncoated particles and avoid aggregation 
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(Cormode et al., 2009; Sahoo et al., 2003). The super-paramagnetic iron oxides (SPION) 
already approved for clinical use include particles larger and even smaller than 50 nm 
(Kunzmann et al., 2010). Magnetic NPs are also important for drug delivery. The 
application of an external magnetic field allows magnetic NPs to be transported to the 
specific target site and drugs released only at the target site, thereby avoiding the 
undesired effects that occur in radio- and chemo-therapy (Berry, 2005).  
Another potential use of magnetic NPs is the hyperthermic treatment of tumour cells, 
where the tumorigenic area is heated up to 42°C to selectively kill neoplastic cells 
without damaging healthy neighbouring tissues (Kita et al., 2010). In this procedure, 
microwave, ultrasound or infrared application to the magnetic NPs leads to oscillation of 
their magnetic momentum resulting in a temperature increase. The permanent irreversible 
inhibition or loss of cellular functions is caused by damage to the tumour cellular 
proteins, including the unfolding and aggregation processes (Kumar et al., 2011).  
The CoFe2O4 NPs have been shown to have higher chemical stability than iron oxide 
NPs, even at high temperatures. The magnetic momentum of CoFe2O4 NPs of similar 
size to the iron oxide NPs relaxes more slowly so that smaller amounts of NPs can be 
used; therefore, smaller devices can be made to promote cellular uptake (Brigger et al., 
2002). 
The CoFe2O4 NPs can be employed in the same ways of the iron oxide NPs described 
above. The physicochemical stability of CoFe2O4 NPs also makes them useful for audio 
and video recording. The CoFe2O4 NPs can be synthesized in different ways, including 
the sol-gel method, micro-emulsion with oil in water micelles or reverse micelles, 
aqueous precipitation and calcination, combustion, and forced hydrolysis in a polyol 
medium (Baldi et al., 2007; Tartaj et al., 2005), and the NP size is achieved by 
controlling the growth and nucleation rate (Maaz et al., 2006).  These NPs are usually 
dispersed in different solvents, such as sodium dodecyl sulphate or oleic acid, to avoid 
their oxidation by atmospheric oxygen and reduce agglomeration. 
One of the most interesting applications of CoFe2O4 NPs is in non-invasive heating in 
hyperthermic cancer treatment; indeed, most scientific research on CoFe2O4 NPs has 
focused on the use of magnetic fluids for cancer therapy. Cancer cells appear to take up 
magnetic NPs by endocytosis, a process which is greater in highly-proliferating cells. 
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Direct intra-cancer injection of biocompatible CoFe2O4 NPs used as magnetic drug 
carriers in canine breast cancers has shown that endocytosis of CoFe2O4 NPs occurs just 
one hour after administration; this non-specific endocytosis is proportional to the NP 
concentration in the extracellular matrix (Vaishnava et al., 2006). 
The cytotoxicity of various ferrite NPs was studied previously by in vitro methods as 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay) on 
established L929 fibroblasts of the connective tissue of a 100-day-old male mouse. Some 
of the ferrite NPs tested were found to be cytotoxic, but not CoFe2O4 and Co0.9Ni0.1Fe2O4 
NPs (Kim et al., 2005). More recently, the in vitro and in vivo toxicity of CoFe2O4 NPs 
was evaluated using the L929 cell line together with the MTT assay and intravenous (IV) 
injections in male ICR (Imprinting Control Region) mice. In vitro cytotoxicity was 
observed at high doses (IC50 at 2 x 103 µg/mL), while no adverse effects were found in 
vivo on mice, either as changes in growth or behaviour when comparing the test and 
control groups. Interestingly, CoFe2O4 NPs were found to be present in almost all organs, 
including the heart, kidney, liver, spleen and stomach (Kim et al., 2007). The genotoxic 
potential of three different sizes of CoFe2O4 NPs (5.6 nm, 10 µm and 120 µm) was also 
assessed on human peripheral lymphocytes by Colognato et al. using the micronucleus 
test. They found that the smaller NPs were associated with significant toxicity and 
mutagenicity, whilst only significant mutagenicity was detected with the 10 µm NPs; no 
effects were induced by the largest NPs tested (Colognato et al., 2007). 
 
1.8.2 Silver NPs (Ag NPs): biological background 
Soluble silver salts have long been used for bacterial disinfection. Metallic silver and its 
insoluble compounds do not represent a serious health risk because they are not easily 
taken up by the body. “Argyria”, the irreversible and characteristic grey pigmentation of 
the skin due to deposits of silver complexes in tissues, is the most common detrimental 
effect on health. It can be attributed to prolonged exposure to silver compounds and 
considered to be a mechanism for detoxification of silver by its sequestration as non-
toxic, silver-protein complexes or silver sulphide (Casarett and Doull, 2008). 
Nevertheless, since microbial resistance to metal ions and antibiotics is ever increasing, 
different types of metallic NPs (copper, zinc, titanium, magnesium, gold and silver 
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nanoparticles) are being investigated as alternatives, and Ag NPs seem to be valid growth 
inhibitors of various micro-organisms (Rai et al., 2009; Kim et al., 2007).  
Besides their antibacterial properties and associated use in disinfecting medical devices, 
Ag NPs have many applications, including use in home water treatments and targeted 
drug delivery. They are also used in electronics, clothing, the food industry, paints, 
sunscreens and cosmetics. Moreover, their unique plasmon-resonance properties make 
them invaluable for bio-sensing and imaging applications (Ahamed et al., 2010).  
The most common method by which Ag NPs are synthesized is the chemical reduction of 
a silver salt with a reducing agent. Since there is evidence that the antimicrobial activity 
may be influenced by particle size, efforts have been made to find synthesis methods that 
both control particle size and avoid environmental toxicity or biological hazards (Panáček 
et al., 2006). Moreover, recent attention has focused more on synthetic methods that 
produce Ag NPs of diverse shape and morphology and which are based on natural 
biomolecules, such as the aflavins from black tea leaf extract and polyphenolic 
compounds from Indian propolis (Begum et al., 2009; Roy et al., 2010).  
Another, almost unexplored field relates to the study of the interactions between metal 
NPs and viruses. Elechiguerra et al. demonstrated that PVP-coated Ag NPs with an 
average size of 6.53 nm can interact in a size dependent way with the HIV-1 virus, 
binding preferentially to the gp120 glycoprotein knobs (Elechiguerra et al., 2005).  
In addition, a colloidal aqueous suspension of spherical Ag NPs of 7-20 nm in size was 
studied for in vitro toxicity and oxidative stress on A431 human skin carcinoma and HT-
1080 human fibrosarcoma cells in order to develop a topical antimicrobial agent for the 
treatment of burn wound infections; a reduction in the GSH level and increased levels of 
ROS and lipid peroxidation were found (Arora et al., 2008). 
The same research team then tested these Ag NPs in a further study, again using primary 
mouse fibroblasts as a model of dermal exposure for the wound healing process and 
primary liver cells as a model for accumulation (Arora et al., 2009). The IC50 values 
determined by the XTT assay were 61 µg/mL and 449 µg/mL for fibroblasts and liver 
cells, respectively, indicating that fibroblasts were more sensitive to the Ag NPs tested 
and suggesting that primary cells have a higher tolerance to these NPs than the 
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concentrations found in the gel formulation (~ 20 µg/mL) of topical antimicrobial 
preparations (Arora et al., 2009). 
Foldbjerg et al. investigated in parallel the effects of Ag+ and of PVP-coated Ag NPs of 
30-50 nm in size on A549 cells, a human alveolar cell line. They found that Ag+ 
decreased mitochondrial activity to a greater extent than Ag NPs, but Ag NPs induced 
higher ROS production than Ag+, suggesting that Ag NP-induced ROS production is not 
due to the potential release of Ag+ alone. The administration of an antioxidant GSH 
precursor (NAC) was found to protect the cells against cytotoxicity in both silver 
treatments, probably due to the antioxidant ROS-scavenging action of NAC and possible 
Ag+ binding effects (Foldbjerg et al., 2011).  
Asharani et al. also observed an increase in ROS production due to treatment with Ag 
NPs; they tested starch-coated Ag NPs of 6-20 nm in size on normal human lung 
fibroblasts (IMR-90) and human glioblastoma cells (U251). Interestingly, they also 
observed a dose-dependent reduction in the ATP but increase in DNA damage (Asharani 
et al., 2009). 
In accordance with these studies, 30 nm Ag nanospheres were found to be cytotoxic and 
genotoxic on the OLHNI2 medaka fish cell line, extensively used as a model for human 
health (Wise et al., 2010). Cytotoxicity was assessed by a colony forming assay.  
In addition, Larese and colleagues demonstrated that PVP-coated Ag NPs of 25 nm were 
able to pass through intact and damaged human skin in vitro (Filon Larese et al., 2009). 
Lu et al. reported the effects of surface coating on the toxicity and genotoxicity of Ag 
NPs by the MTT and Comet assays, respectively, in HaCaT keratinocytes. Whilst 
colloidal citrate-coated Ag NPs were neither cyto- nor geno-toxic, they were both cyto- 
and geno-toxic if dried and converted into powder form. The authors suggested PVP-
coated Ag NPs were safe for use in daily life because they did not show toxicity (Lu et 
al., 2010). 
Data can still be found in the literature on the in vivo and in vitro toxicity of Ag NPs on 
mammalian cells. It is difficult, however, to compare all the scientific data as they vary 
depending on the characteristics of the NPs (e.g., surface chemistry, coatings, size, doses 
administered, exposure time, etc.), the cell types and tests employed (Ahamed et al., 
2010; Johnston et al., 2010). 
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Chapter 2: Materials and Methods 
 
2.1 Cell lines, cell culture and media 
2.1.1 A549 (source: ATCC) 
The A549 Human Lung Carcinoma cells were chosen as a model of lung toxicity. They 
were cultivated with HAM F-12 containing GlutaMAX-I (Cat N. 31765, GIBCO 
Invitrogen) medium completed with 50 mL of Newborn Calf Serum (10% v/v) (New 
Zealand origin, Cat N. 26010-074, GIBCO Invitrogen), 5 mL of penicillin/streptomycin 
(1% v/v) (104 Units/mL, Cat N.15140, GIBCO Invitrogen) and 2.5 mL of Hepes buffer 
(0.5% v/v) (Cat N. 15630, GIBCO Invitrogen). The cells were maintained as described 
below (see Sections 2.2 and 2.3). 
 
 
Figure 2.1:  A549 cells in culture (100X magnification at the optical microscope) (NBS, IHCP, JRC). 
 
2.1.2 Balb3T3 (source: Hatano Research Institute, Japan) 
These immortalized mouse fibroblasts were cultured in MEM (Minimum Essential 
Medium with Earle’s salts and L-glutamine, Cat N. 31095, GIBCO Invitrogen) with low 
glucose (1000 mg/L), L-glutamine (292 mg/L) and sodium bicarbonate (2200 mg/L) 
completed with 50 mL (10% v/v) of Foetal Bovine Serum (Australian origin, Cat N. 
10099-141, Lot N. 6792117Y, GIBCO Invitrogen) and 5 mL of penicillin/streptomycin 
(1% v/v) (104 Units/mL, Cat N.15140, GIBCO Invitrogen). The cells were maintained as 
described below (see Sections 2.2 and 2.3). 
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The Foetal Bovine Serum Lott was tested using the Colony Forming Efficiency (CFE) 
assay and the Cell Transformation Assay (CTA) before use in the Balb3T3 cell culture 
and both CFE and CTA experiments with NPs. The Lott of serum was selected both to 
maintain the normal contact-inhibited monolayer of untreated cells and support the type 
III foci formation by 3-methylcolantrene, as recommended by the IARC (IARC, 1985). 
 
 
Figure 2.2: Balb3T3 cells in culture (100X magnification at the optical microscope) (NanoBioSciences 
Unit, IHCP, JRC). 
 
2.1.3 CaCo2 (source: Istituto Superiore di Sanita’, Rome) 
Human Caucasian Colon adenocarcinoma cells were selected as a model of the intestine. 
They were maintained in culture using DMEM (Dulbecco’s Modified Eagle Medium, Cat 
N. 41965, GIBCO Invitrogen) high glucose (4500 mg/L) without sodium and magnesium 
and completed with  50 mL of Foetal Bovine Serum (10% v/v) (US origin, Cat N. 16000-
044, GIBCO Invitrogen), 12 mL of L-glutamine (4 mM) (Cat N. 25030, GIBCO 
Invitrogen), 5 mL of penicillin/streptomycin (1% v/v) (104 Units/mL, Cat N.15140, 
GIBCO Invitrogen) and 5 mL of non-essential amino acids (1% v/v) (Cat N. 11140, 
GIBCO Invitrogen). The cells were maintained as described below (see Sections 2.2 and 
2.3). 
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Figure 2.3: CaCo2 cells in culture (100X magnification at the optical microscope) (NanoBioSciences 
Unit, IHCP, JRC). 
 
2.1.4 HaCaT (source: Prof. Norbert E. Fusening, Deutsches 
Krebsforghungszentrum) 
This spontaneously immortalized human keratinocyte cell line has been used in many 
studies as a model of epidermal cells and keratinocyte functions. The HaCaT cells were 
cultured in DMEM (Dulbecco’s Modified Eagle Medium, Cat N. 41965, GIBCO 
Invitrogen) high glucose (4500 mg/L) without sodium and magnesium completed with 50 
mL of Foetal Clone II Serum (10% v/v) (Cat N. SH30066.03, HyClone), 12 mL of L-
glutamine (4 mM) (Cat N. 25030, GIBCO Invitrogen) and 5 mL of 
penicillin/streptomycin (1% v/v) (104 Units/mL, Cat N.15140, GIBCO Invitrogen). The 
cells were maintained as described below (see Sections 2.2 and 2.3). 
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Figure 2.4: HaCaT cells in culture (100X magnification at the optical microscope) (NanoBioSciences 
Unit, IHCP, JRC). 
 
2.1.5 HepG2 (source: Interlab Cell Line Collection) 
The HepG2 human hepatoma cell line has been used as an in vitro model of liver 
hepatocytes. These cells were cultured in DMEM (Dulbecco’s Modified Eagle Medium, 
Cat N. 41965, GIBCO Invitrogen) high glucose (4500 mg/L) without sodium and 
magnesium completed with 50 mL of Foetal Clone II Serum (10% v/v) (Cat N. 
SH30066.03, HyClone), 5 mL of penicillin/streptomycin (1% v/v) (104 Units/mL, Cat 
N.15140, GIBCO Invitrogen) and 5 mL of non-essential amino acids (1% v/v) (Cat N. 
11140, GIBCO Invitrogen). The cells were maintained as described below (see Sections 
2.2 and 2.3). 
 
 
Figure 2.5: HepG2 cells in culture (100X magnification at the optical microscope) (NBS, IHCP, JRC). 
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2.1.6 MDCK (source: European Collection of Cell Culture) 
The MDCK Madin Darby Canine Kidney cells are used to model the impact of NPs on 
the kidney. These cells were cultured in DMEM (Dulbecco’s Modified Eagle Medium, 
Cat N. 41965, GIBCO Invitrogen) high glucose (4500 mg/L) without sodium and 
magnesium completed with  50 mL (10% v/v) of Foetal Bovine Serum (Australian origin, 
Cat N. 10099-141, GIBCO Invitrogen), 6 mL of L-glutamine  (2 mM) (Cat N. 25030, 
GIBCO Invitrogen) and 5 mL of penicillin/streptomycin (1% v/v) (104 Units/mL, Cat 
N.15140, GIBCO Invitrogen). The cells were maintained as described below (see 
Sections 2.2 and 2.3). 
 
 
Figure 2.6: MDCK cells in culture (100X magnification at the optical microscope) (NBS, IHCP, 
JRC). 
 
2.2 Cell line maintenance 
All cell lines were maintained in culture under standard conditions (37°C, 5% CO2, 90% 
humidity) in an incubator (HERAEUS, Hera cell 150, ThermoElectron Corporation, 
Germany) and sterile conditions were preserved by performing every step under a 
laminar flow biological hood (BIOAIR S@femate 1.2, EuroClone Division, Italy). The 
cells were sub-cultured twice a week. To aid the detachment of cells from the bottom of a 
75 cm2 culture flask (Cat N. 430641, Corning plastic) using Trypsin-EDTA (Cat N. 
25300, GIBCO Invitrogen), the culture medium was removed and cells were washed 
twice with 10 mL of PBS (Phosphate Buffer Saline, 1X, without calcium, magnesium and 
sodium bicarbonate, Cat N. 20012, GIBCO Invitrogen) to remove the Ca2+ and Mg2+ ions 
involved in integrin-based binding. Cells were detached by adding 1 mL of Trypsin-
Chapter 2: Materials and Methods 
 
 38 
EDTA to the culture flask and incubating this for a period of either 1 minute (A549, 
Balb3T3 cells) or 5 minutes (CaCo2, HaCaT, HepG2 and MDCK cells). The Trypsin-
EDTA activity was stopped by harvesting the detached cells in 9 mL of fresh complete 
medium. An aliquot of 10 µL of the cell suspension was added to 90 µL of Trypan Blue 
dye (0.4% solution, CAS N. 72-57-1, Cat N.15250061 GIBCO Invitrogen) for cell 
counting in a Bürker chamber (0.0025 cm2). The number of cells/mL was calculated 
using the following formula (2.1): 
 
N = {[(a + b)/2]/ 9 x 104 x DF}       (2.1)  
where: 
N = Number of cells/mL 
a = Number of cells counted in 9 squares of the first chamber 
b = Number of cells counted in 9 squares of the second chamber 
104 = Conversion factor of the chamber volume 
DF = Dilution factor of the cell suspension (usually equal to 10 or 2) 
 
The required volume of cells was then taken directly from the cell suspension and 
cultured with 10 mL of complete culture medium. 
 
2.3 Cell freezing and thawing procedures 
Freezing. Cells were detached from the culture flask and re-suspended as described 
previously (see Section 2.2). After calculating the number of cells per mL, the number of 
cells in the total volume of the suspension was determined. In order to prepare each 
criovial (NUNC, Nalgene, Milan, Italy) with 106 cells, 0.5 mL of cell suspension was 
added to 0.5 mL of freezing solution, composed of 80% v/v of complete medium, 10% 
v/v of serum and 10% v/v of filtered dimethyl sulphoxide (DMSO, CAS N. 67-68-5, Cat 
N. D5879-100mL, Sigma Aldrich). Every criovial was labelled to indicate the cell type, 
their number, passage and the date. The criovials were then frozen at –80°C and stored in 
liquid nitrogen until use.  
Thawing. Criovials containing the cells to be used were drawn from the liquid nitrogen 
and heated to 37°C. The defrosted cells were then re-suspended in complete culture 
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medium in a 15 mL tube to a final volume of 10 mL. After 24 hours, the medium was 
replaced with 10 mL of fresh medium. When the cells reached 80% confluence in the 
culture flask, they were sub-cultured (as described in Section 2.2) three times before use 
in the cytotoxicity assays. 
 
2.4 The basis for the in vitro toxicity assays  
Incubation times of 24 and 72 hours were chosen for evaluating the cytotoxicity of 
CoFe2O4 and Ag NPs using the Colony Forming Efficiency (CFE) assay. These treatment 
times were chosen as they were involved in the following study of the NP-induced 
genotoxicity and cell transformation capacity assessed by Cytokinesis-Block 
Micronucleus assay (CBMN) and Cell Transformation Assay (CTA,) respectively. 
Before starting the experiments on the CoFe2O4 NPs, however, the maximum dose of the 
NP dispersant, dialyzed diethylene glycol (DEG), was determined. The cytotoxicity 
induced by DEG was evaluated in all six cell lines using both NR and CFE, specifically 
for 0.05, 0.1, 0.5, 1, 1.5, and 2% v/v DEG concentrations and a 72-hour exposure time. 
Thus, it was possible to select the concentration range of NPs to be tested whilst avoiding 
false positives due to effects of DEG. In particular, the effects of P601 and P703 NPs 
were tested at concentrations ranging from 10 to 120 µM for cytotoxicity. More 
specifically, cytotoxicity was evaluated after 72-hour treatment of five cell lines (A549, 
CaCo2, HaCaT, HepG2, MDCK) with 10, 20, 40, 60, 80, 100 and 120 µM concentrations 
of NPs using NR, and 10, 20, 30, 40, 50, 60, 80, 100 and 120 µM concentrations of NPs 
using CFE. In parallel with these tests, cytotoxicity was also evaluated in mouse Balb3T3 
fibroblasts using (i) NR after 72-hour treatment with 10, 20, 40, 60, 80, 100 and 120 µM 
concentrations of NPs, and (ii) CFE after both 72-hour treatment with 1, 5, 10, 20, 30, 40, 
50, 60, 80, 100 and 120 µM concentrations of NPs, and 24-hour treatment with 1, 10, 60 
and 120 µM concentrations of NPs. In addition, P601 and P703 NPs were tested from 1–
60 µM for both cell transformation capacity (specifically on Balb3T3 after 72 hours of 
treatment at concentrations of 1, 5, 20 and 60 µM and assessed using CTA) and for 
genotoxicity (specifically on Balb3T3 after 24 hours of exposure at concentrations of 1, 
10 and 60 µM and assessed using CBMN).  
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Controls of the dispersant were also considered for all Ag NPs studied. In the experiment 
done to assess the in vitro toxicity of Ag NPs using Balb3T3 fibroblasts, the chosen 
concentration range for cytotoxicity was 0.01–10 µM (specifically, the concentrations 
tested using CFE were 0.1, 0.5, 1, 5 and 10 µM for 24 hours of treatment and 0.01, 0.1, 
0.5, 1, 2.5, 5 and 10 µM for 72 hours of treatment). The transformation capacity was 
tested on Balb3T3 cells at concentrations ranging from 0.5–5 µM (specifically, the 
concentrations tested using CTA were 0.5, 2.5 and 5 µM for 72 hours of treatment), 
whilst genotoxicity was tested at concentrations ranging from 1–10 µM (specifically, 
concentrations tested using CBMN and Balb3T3 were 1, 5 and 10 µM for 24 hours of 
treatment). The dose range of Ag NPs to be screened was chosen based on data available 
in literature for Ag NPs and AgNO3. In particular, both in vivo and in vitro studies have 
described the effects induced by excessively high Ag NP doses, which are far likely to be 
encountered by humans in consumer and occupational environments (Johnston et al., 
2010). A previous in vitro investigation of AgNO3 cytotoxicity using CFE to evaluate 
concentrations of 1–100 µM of AgNO3 incubated with Balb3T3 cells for 72 hours found 
a dose-effect curve with IC50 values corresponding to 11.2 µM and complete cell death 
at higher doses (Mazzotti et al., 2002). 
The molarity of NPs test concentrations were calculated considering the molar NPs stock 
suspensions concentration, as stated by the supplier, according to the following formulas 
for the dilutions (2.2 and 2.3) 
 
Ci/Cf = DF          (2.2) 
where: 
 Ci = Initial concentration (corresponding to stock or intermediate concentrations 
of NPs) 
 Cf = Desired or final concentration (corresponding to concentrations of NPs to be 
tested) 
 DF = Dilution factor 
 
Vf/DF = volume of NPs to be added to obtain the Cf    (2.3) 
where: 
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 Vf = Final volume (corresponding to 100 µL, 3 mL, 6 mL and 4 mL in the NR, 
CFE, CTA and CBMN experiments, respectively) 
 
Moreover, for the highly concentrated NP stock suspensions (both CoFe2O4 P601 and 
P703, and Ag NM-300), intermediate NP suspensions in culture medium were prepared 
before preparation of the NP test suspensions. This approach was also used in the 
preparation of NP dilutions to be analysed in the physicochemical characterization 
experiments. 
In addition, a working stock of the different cell lines to be used in the experiments was 
created from a master stock. Cells were maintained in culture for a maximum of 10–15 
passages, after which they were disposed of and new cells were defrosted from the 
working stock for the next experiments. Defrosted cells were sub-cultured three times 
before starting toxicity experiments. This approach allowed different runs of the same 
experiment for each cell line to be compared. The Balb3T3 fibroblasts were sub-cultured 
only once before use in the CTA. 
 
2.5 In vitro toxicity assays 
2.5.1 Neutral Red uptake 
The Neutral Red (NR) assay is an in vitro colorimetric viability test, which exploits the 
ability of living cells to accumulate Neutral Red dye within their lysosomes. The NR is 
usually carried out with adherent cells. The NR dye can pass through the cell membrane 
and once inside the cell, can be accumulated in lysosomes (lysosomal pH < cytoplasmic 
pH) where it binds to the anionic sites of the lysosomal matrix (Griffon et al., 1995). Any 
modification of cellular or lysosomal membranes can cause irreversible lysosomal 
changes. The NR uptake and binding decrease when a xenobiotic induces such alterations 
in a cell. The amount of NR taken up by viable cells is measured by spectrometry at 540 
nm; the absorbance values measured are directly proportional to the number of viable 
cells. 
In order to perform the assay as accurately as possible, the optimized number of cells 
(Table 2.1) were seeded in 100 µL/well of fresh medium in a 96 well/plate (Cat 
n.353072, Falcon plastic). 
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Twenty four hours after seeding, the cells were treated with CoFe2O4 NPs test 
suspensions ranging from 10–120 µM (specifically 10, 20, 40, 60, 80, 100 and 120 µM; 4 
replicates for each concentration). For each cell line, a control for the DEG effect (0.1% 
v/v of dialyzed DEG, corresponding to the percentage of DEG present in the maximum 
dose of CoFe2O4 tested) and a positive control (Na2CrO4 10-3M, CAS N. 10034-82-9, Cat 
N. 013453, AlfaAesar, Johnson Matthey GmbH) were done in parallel. After an exposure 
time of 72 hours, the treatment was removed and every well washed twice with 100 
µL/well of PBS without calcium or magnesium. A Neutral Red (CAS N. 553-24-2, Cat 
N. N4638-1G, Sigma Aldrich) 1:40 solution was freshly prepared in the respective 
complete culture medium (1 mL of Neutral Red in PBS, 2 mg/mL of PBS), 39 mL of 
complete culture medium) and 100 µL/well were added and incubated for 2 hours under 
standard conditions. The NR solution was then removed and every well washed twice 
with 100 µL of PBS to remove excess Neutral Red from the cells. Finally, 100 µL/well of 
bleaching solution (50% v/v ethanol, CAS N. 64-17-2,  Cat N. 02860, Fluka), 49% v/v 
ultrapure water, 1% v/v acetic acid (acetic acid, glacial 99.8%, CAS N. 64-19-7, Sigma-
Aldrich)) was added. After 20 minutes, the absorbance was measured by an Omega 
Spectrophotometer at a wavelength of 544 nm (λ = 544 nm). The results were expressed 
as percentage of dialyzed DEG control viability.  
 
 
Table 2.1: Number of cells seeded per well in the Neutral Red assay for an incubation period of 72 
hours. 
Cell line Number of cells/well 
  
A549 2500 
  
Balb3T3 5000 
  
MDCK 2500 
  
CaCo2 5000 
  
HaCaT 5000 
  
HepG2 5000 
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2.5.2 Colony Forming Efficiency 
The Colony Forming Efficiency (CFE) is a sensitive clonogenic assay that can be 
performed in different adherent cell lines, provided that the cells can form colonies 
because cytotoxicity is detected as inhibition of colony growth. The CFE was employed 
previously for the successful evaluation of the toxic effects induced both by chemicals 
and NMs (Ponti et al., 2009; Ponti et al., 2010). 
On the first day, 200 cells (300 cells for A549) were seeded in 3 mL of fresh complete 
medium in each Petri dish (60 mm x 15 mm, Cat n. 353004, Falcon plastic) (3 
replicates/concentration). After 24 hours of incubation, (37°C, 5% CO2, 90% humidity), 
the treatment suspensions were added as aliquots to the cells (day 1). Concentrations of 
CoFe2O4 ranged from 10–120 µM (more specifically, 10, 20, 30, 40, 50, 60, 80, 100 and 
120 µM concentrations of NPs were tested with 72 hours treatment of five cell lines 
(A549, CaCo2, HaCaT, HepG2, MDCK); in parallel, 1, 5, 10, 20, 30, 40, 50, 60, 80, 100 
and 120 µM concentrations of NPs with 72-hour treatment, and 1, 10, 60 and 120 µM 
concentrations of NPs with 24 hour treatment were both tested using Balb3T3 
fibroblasts). For each cell line, a control for the DEG effect (0.1% v/v of dialyzed DEG, 
corresponding to the percentage of DEG present in 120 µM of CoFe2O4 tested as a 
maximum dose) and a positive control (Na2CrO4 10-3M, CAS N. 10034-82-9, Cat N. 
013453, AlfaAesar, Johnson Matthey GmbH) were done in parallel. Cells were exposed 
to the treatment for 24 or 72 hours, after which the treatment was removed and replaced 
with complete culture medium. After 72 hours, cells were fixed and stained (days 8 or 9). 
A fixing solution of 10% v/v of formaldehyde (formaldehyde 37% v/v, CAS N. 50-00-0, 
Cat N. 252549, Sigma-Aldrich) in PBS was used, whilst a staining solution of 10% v/v of 
Giemsa (GIEMSA stain modified, Cat N. GS500-500mL, Sigma-Aldrich) in ultrapure 
water was prepared and filtered (NALGENE, Nalge Nunc International, U.S.A.). Dishes 
were air-dried before colony counting. The data obtained were used to define the dose-
effect curve. 
At the stereo microscopic level, the colonies from the cell lines used appeared to differ in 
morphology and dimensions (Figures 2.7A -2.7F). 
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Figures 2.7A, B, C, D, E and F: Images of colonies from negative controls at the end of a CFE assay: 
(A) A549 colonies (45X magnification), (B) Balb3T3 colonies (15X magnification), (C) CaCo2 colonies 
(45X magnification), (D) HaCaT colonies (45X magnification), (E) HepG2 colonies (15X 
magnification) and (F) MDCK colonies (15X magnification) (EC, JRC-Ispra, IHCP, NBS). 
 
Cytotoxicity induced by treatment with CoFe2O4 NPs for 24 hours (at 1, 10, 60 and 120 
µM) was additionally investigated on Balb3T3 cells using CFE, an essential step in 
determining the dose-range for a further genotoxicity study with the Cytokinesis-Block 
Micronucleus assay (CBMN). 
The CFE was also used as an in vitro assay to detect the cytotoxicity induced in Balb3T3 
mouse fibroblasts by Ag NPs at concentrations of 0.01–10 µM (specifically 0.01, 0.1, 
0.5, 1, 2.5, 5 and 10 µM) and 0.1–10 µM (specifically 0.1, 0.5, 1, 5 and 10 µM) for 
treatment times of 72 and 24 hours, respectively. The CFE protocol employed was the 
same as described previously (see Section 2.5.2) and appropriate controls for the Ag NPs 
dispersant were done.  
The CFE results were expressed as CFE% of the solvent control (mean of three 
independent experiments) ± SEM (standard error of the mean = standard 
deviation/√number of replicates) following formula (2.4) 
 
CFE% (of solvent control) = (A/ B) x 100      (2.4) 
 
where:  
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 A = Number of colonies counted per dish 
 B = The average of colonies counted in three replicates of the solvent control 
 
Cytotoxicity data produced by NR and CFE were both statistically analyzed using one-
way ANOVA using GraphPadPrism4 statistical software (GraphPad Inc., CA, USA) to 
highlight results significantly different (p<0.05) from the respective solvent control. For 
more information, please see Section 2.6. 
 
2.5.3 Cell Transformation Assay 
The Cell Transformation Assay (CTA) is a two-step assay because the procedure requires 
a cytotoxicity assay (CFE) to be performed in parallel. This simple assay allows the 
transformation capacity of different chemicals and NMs to be assessed without using 
time-consuming and expensive procedures. Here, the CTA was performed using Balb3T3 
mouse fibroblasts. 
On Day 0, 2 x 104 cells were seeded in 6 mL of complete fresh medium (MEM 
completed as described in Section 2.1.2) in each Petri dish (100 mm x 20 mm, Cat n. 
353003, Falcon plastic) (5 replicates/concentration). After 24 hours, the chosen 
concentrations of treatment (corresponding to 1, 5, 20, 60 µM for CoFe2O4 NPs, and 0.5, 
2.5 and 5 µM for Ag NPs) were achieved by adding aliquots of NP preparations. Cells 
were either untreated or treated with a well-known carcinogenic compound (3-
methylcholanthrene, MCA, CAS N. 56-49-5, Cat N.213942-100mg, Sigma-Aldrich stock 
solution prepared in DMSO at the concentration of 0.8 mg/mL) (4 µg/mL final 
concentration) as negative and positive controls, respectively. In addition, a control for 
the dispersant effect was done (dialyzed DEG for CoFe2O4 NPs and the appropriate 
dispersants for Ag NPs) for each NP preparation. 
After 72 hours of exposure (Day 4), the treatment was removed and replaced with fresh 
complete medium, DMEM/F12 (Dulbecco's modified Eagle's medium/F12, Cat. N. 
31330-038, GIBCO Invitrogen) with high glucose (3151 mg/L), L-glutamine (365 mg/L) 
and sodium bicarbonate (1200 mg/L) levels, and supplemented with 2% v/v Foetal 
Bovine Serum-Australian Origin (Cat. N. 10099-141; Lot N. 6792117Y, GIBCO 
Invitrogen), 2 µg/mL Insulin (Cat. N. I5500, Sigma-Aldrich) and 1% v/v antibiotics (104 
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Units/mL penicillin and 104 µg/mL streptomycin, Cat. N. 15140-122; Lot N. 708414, 
GIBCO Invitrogen). 
The medium was then changed twice a week. During the last week of the CTA (days 24–
31), the culture medium was left unchanged so that after 5 weeks (Day 31), cells were 
fixed with 10% v/v of formaldehyde in PBS. Cells were then stained with a 10% v/v 
Giemsa solution in ultrapure water for 1 hour. The dishes were air-dried and studied at 
the stereo microscopic level to detect and quantify only type III foci, as described by the 
International Agency for Cancer Research Working-Group (IARC/NCI/EPA Working-
Group, 1985). 
Transformation results were expressed as Transformation frequency (Tf) (average of 
three independent experiments) ± SEM using the following formula (2.5):  
 
Tf = A/B                         (2.5) 
where: 
A = Total number of type III foci per treatment  
B = Number of surviving cells 
 
The number of surviving cells for each treatment and control was calculated using the 
following formula (2.6): 
Surviving number of cells = [(2x104) x 5x CFE%]/100 x (Plating Efficiency/100)
 (2.6) 
where:  
 2x104 = Number of cells seeded per dish 
 5 = Number of replicates per treatment 
 CFE% = see formula (2.4) 
 Plating Efficiency = (Number of colonies formed in the control/Number of cells 
seeded in one CFE dish) x 100. 
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Data were analysed and statistical significance was calculated using Fishers’ exact test 
(http://www.langsrud.com/fisher.htm) to highlight results significantly different (p<0.05) 
to the respective solvent controls. For more information, please see Section 2.6. 
 
 
Figures 2.8A, B, C, D, E and F: Normal and morphologically transformed Balb3T3 mouse fibroblasts 
as seen at the stereo microscopic level after the CTA: (A) negative control cells (45X of 
magnification) and some examples of type III foci from positive control dishes (B, C, D, E and F) 
(15X magnification). In the negative control dishes, cells grow in a monolayer as they retain their 
morphology and contact-inhibition. When cells are transformed into tumorigenic cells, they lose 
contact-inhibition and begin to grow spindle shaped with no ordered orientation and as a multilayer 
(EC, JRC-Ispra, IHCP, NBS). Only type III foci are scored because these alone can induce tumour 
formation in nude mice with an 85% frequency (Saffiotti et al., 1984; IARC/INCI/EPA, 1985). 
 
2.5.4 Cytokinesis-Block Micronucleus assay 
The Cytokinesis-Block Micronucleus assay (CBMN) is a reliable standard and 
reproducible assay for testing genotoxicity in both human and mammalian cells. When 
counting micronuclei, only once-divided, binucleated cells are considered. These are 
obtained by blocking cytokinesis with cytochalasin B, which specifically inhibits the 
assembly of the microfilament ring required for completion of cytokinesis. Micronuclei 
are scored only in binucleated cells in order to avoid the effects caused by suboptimal or 
altered cell division kinetics (Fenech, 2007). 
On Day 0, 3 x 105 Balb3T3 mouse fibroblasts were seeded in 4 mL of complete medium 
in each well (1 replicate/concentration) of a 6 well/plate (Cat n. 3506, Corning plastic). 
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Twenty four hours after seeding (Day 1), cells were treated with NP suspensions and 
incubated for 24 hours (concentrations of 1, 10, 60 µM and 1, 5, 10 µM were used for 
CoFe2O4 and Ag NPs, respectively). As a positive control, 0.5 µM of mitomycin C 
(MMC, CAS N. 50-07-7, Cat N. L01DC03, Kyowa Italiana Farmaceutici) was used and 
dispersant controls were done for all NPs investigated. On Day 2, the treatment was 
removed and each well was washed twice with Phosphate Buffer Saline (PBS). In order 
to block cell division, 4.5 µg/mL of cytochalasin B (cytochalasin B from Dreschslera 
dematioidea, CAS N. 14930-96-2, Cat N. C6762-5MG, Sigma-Aldrich) were then added 
to 4 mL of fresh complete culture medium per each well. After 24 hours of incubation 
(Day 3), cells were detached and harvested in PBS. The cell suspensions were 
centrifuged (250 G) and the cell pellets were treated first with a prefixing solution (3:5) 
followed by a fixing (6:1) solution prepared with different methanol (CAS N. 67-56-1, 
Lot N. 34885, Sigma-Aldrich): acetic acid (acetic acid, glacial 99.8%, CAS N. 64-19-7, 
Sigma-Aldrich) ratios. The solutions obtained were dropped onto glass slides and dried 
overnight at room temperature. The slides (two replicates for each sample) were stained 
with a 2% v/v of Giemsa solution in ultrapure water and air-dried. 
Binucleated cells with micronuclei were scored under an optical microscope, and the NDI 
(Nuclear Division Index) was calculated using the following formula (2.7): 
 
NDI = [(MNx1)+(BNx2)+(PNx3)]/500       (2.7) 
where: 
MN = Mononucleated cells 
BN = Binucleated cells with or without micronuclei 
PN = Polynucleated cells. 
 
Statistical analysis was conducted using the Fisher exact test 
(http://www.langsrud.com/fisher.htm) to identify statistically significant differences 
(p<0.05) between solvent control and NP-treated samples. For more information, please 
see Section 2.6. 
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Figure 2.9: A typical binucleated, micronucleated Balb3T3 cell after 24-hour exposure to mytomicin 
C (0.5 µM) as a positive control. The black arrows highlight micronuclei in the cytosol (400X of 
magnification, EC, JRC-Ispra, NBS). In this study, the genotoxic potential of CoFe2O4 and Ag NPs in 
Balb3T3 mouse fibroblasts was indicated by the induction of micronuclei formation. 
 
2.6 Statistical data analysis  
A description of the statistics used in the analysis of toxicity data obtained by NR, CFE, 
CTA and CBMN now follows. Computer programmes were used for all the statistical 
analyses performed. 
 
2.6.1 Statistical methods 
Student t-test. The Student t-test is a parametric test commonly used to compare the 
means of two groups (e.g., untreated/control group vs. treated group) when data follow a 
Gaussian (or normal) distribution. This distribution is symmetrical and the data spread 
around the true value is caused by random effects (e.g., imprecise pipetting, use of 
different media/reagents, etc.). If the data to be analysed are not Gaussian-distributed, 
they can be normalized before the statistical analysis by mathematical transformation that 
limits data to a defined interval of values (e.g., 0-100). For example, data related to the 
“control/untreated” group can be defined as 100, while those related to a “treated” group 
can be expressed as percentage of the control. Therefore, raw data are not necessary for 
this statistical method and statistical calculations can be made using the mean, standard 
error of the mean (SEM) and sample size for each group. 
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There are two types of t-test: the “unpaired t-test”, used when the two data groups to be 
compared are independently collected, and the “paired t-test”, which is used to analyse 
two groups of data with matched samples (e.g., before and after treatment/measurement) 
(Motulsky, 1995). Here, the unpaired t-test was used to compare the CFE% (of the 
solvent control) values obtained by treating Balb3T3 cells with CoFe2O4 NPs for 24 and 
72 hours, and the CFE%  (of the negative control) values from a previous study where the 
same cell line was treated with soluble CoCl2 for the same exposure time (Ponti et al., 
2009). More specifically, this statistical analysis was done to calculate the probability that 
the difference in the CFE% values observed between the two groups (NP-treated and ion-
treated cells, respectively) were due to chance. 
Before the statistical analysis, the mean CFE values (of at least three runs in total) related 
to CoFe2O4 NPs were normalized and expressed as a percentage of the CFE solvent 
control mean to obtain CFE%  values. Only after mathematical transformation these data 
were statistically compared using the unpaired t-test for CFE% values (of at least three 
runs in total) corresponding to concentrations of CoCl2 similar to those of Co ions 
released by the CoFe2O4 NPs. Results with p<0.05 were considered to be statistically 
significant with respect to the CoCl2 treatment and meant that the probability of a 
difference between NPs and ion treatment due to chance was less than 5%. 
One-way ANOVA. It has been suggested that when more than two groups of data are 
collected, they should be compared using one-way ANOVA instead of separate t-tests for 
each pair of groups. In fact, the one-way ANOVA analysis also allows the comparison of 
more than two groups with the same mean, thereby avoiding the 5% chance that each 
comparison result is significant, as would be found after separate t-test comparisons. 
The one-way ANOVA is a parametric test, which means that data to be analysed (as for 
the t-test) follow a Gaussian distribution. As described above for the Student t-test, data 
that are not Gaussian distributed can be normalized to approximate a Gaussian 
distribution before statistical analysis. If the collected data are matched (e.g., they 
represent measures before, during and after treatment), the repeated-measures ANOVA 
should be used so that the difference between the ordinary and repeated-measures 
ANOVA resembles that of the unpaired and paired t-test. 
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The Bonferroni post-test is one of the multiple comparison posts-tests available after 
ANOVA to compare all pairs of groups (Motulsky, 1995). The one-way ANOVA with 
the Bonferroni post-test was chosen to calculate the statistically significant differences 
between treatment and solvent control values (normalized absorbance in NR and CFE% 
in CFE experiments, respectively) and to compare cytotoxicity results obtained from 
different cell lines (NR and CFE with CoFe2O4 NPs). All data were normalized prior to 
statistical analysis. Results with p<0.05 were considered to be statistically different from 
those of the solvent control, meaning that the probability of a difference between NP-
treatment and solvent control being due to chance is less than 5%. This statistical method 
was used previously by Ponti et al. (Ponti et al., 2010) with the same experimental 
procedures and objectives as described here. 
Fisher’s exact test. The Fisher’s exact test is a non-parametric test and can, therefore, be 
used when data do not follow a Gaussian distribution. It is used to compare two unpaired 
groups when analysing moderate-sized data (<100) (Motulsky, 1995). This statistical 
analysis was used to determine if the morphological cell transformation and the 
micronuclei observed after NP-treatment in the CTA and the CBMN assays, respectively, 
were significantly different to those observed in the solvent control. 
In particular, morphological transformation (CTA) data were statistically analysed to 
compare both the number of surviving cells (calculated using formula 2.6) and the 
respective total number of type III foci formed in the solvent control to the corresponding 
values of the NP treatment. The statistical significance of genotoxicity results (CBMN) 
was calculated by comparing the total number of binucleated cells with micronuclei 
found per 1000 binucleated cells scored in the solvent control to those found in the NP 
treatments. Results with p<0.05 were considered to be significantly different from those 
of the solvent control, indicating that the probability of a difference between NP 
treatment and solvent control due to chance is less than 5%. This statistical method was 
used previously by Ponti et al. (Ponti et al., 2010) with the same experimental procedures 
and objectives as described here. 
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2.6.2 Experimental procedures  
Here, each assay (NR, CFE, CTA and CBMN) was performed at least three times (three 
independent experiments) and replicas for each concentration (or experimental point) 
were done in every experiment (e.g., 4 wells/concentration for NR, 3 Petri 
dishes/concentration for the CFE, 5 Petri dishes/concentration for the CTA, 2 
slides/concentration for the CBMN). 
Data obtained from the NR and CFE experiments were normalized prior to statistical 
analysis. In particular, the mean absorbance of the blank was subtracted from the 
absorbance of the solvent control and treatments values (raw data-blank average) in the 
NR. The absorbance was then expressed as a percentage of the solvent control average; 
these absorbance values were then analysed using one-way ANOVA. In the CFE 
experiments, colonies scored in each dish were expressed as a percentage of the average 
of colonies in the solvent control (CFE% of solvent control) and these values were used 
for the ANOVA calculations. 
Data from the CTA and CBMN experiments were not normalised here. The surviving 
number of cells (calculated using formula 2.6) together with the total number of type III 
foci scored in each concentration, and the number of binucleated, micronucleated cells 
together with the total number of binucleated cells scored per slide, respectively, as 
determined using CTA and CBMN, were the input data for the Fisher’s analysis. The 
statistical significance with respect to the proper solvent control was considered to be 
p<0.05 and indicated in graphs by star symbols (e.g., *p<0.05). 
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Table 2.2: A summary of statistical methods and experimental procedures used to analyse toxicity 
data. 
 
Assay Experiments Replicas Normalization Statistics Data input Data output 
       
NR 3 4 yes ANOVA Normalized 
absorbance 
p<0.05 
       
CFE 3 3 yes ANOVA,  
t-test 
CFE%  p<0.05 
       
CTA 3 5 no Fisher’s Surviving cells, 
total type III 
foci 
p<0.05 
   no    
CBMN 3 2 no Fisher’s Binucleated 
micronucleated 
cells, total 
binucleated cells 
scored 
p<0.05 
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Appendix A: Materials and Methods for the physicochemical 
characterization of NPs 
 
A. 1 Nanoparticles tested 
A.1.1 Cobalt ferrites nanoparticles (CoFe2O4 NPs) 
The following uncoated/functionalized CoFe2O4 NPs were used in this study: 
P601: supplied by Colorobbia (Colorobbia S.p.A., Vinci, Italy) and made available as a 
120 mM suspension of CoFe2O4 in 100% diethylene glycol (DEG); particle sizes 
provided by the supplier on the material data sheet and determined using Dynamic Light 
Scatter (DLS) were 28.81 nm for particles in DEG and 13.56 nm for particles in ultrapure 
water; 
P703: supplied by Colorobbia (Colorobbia S.p.A., Vinci, Italy) and made available as a 
118 mM suspension of CoFe2O4 in 100% DEG; particle sizes provided by the supplier on 
the material data sheet and determined using DLS were 83.22 nm for particles in DEG 
and 63.62 nm for particles in ultrapure water. 
Dialyzed DEG was also provided by the NP supplier to be used as a control for the NP 
dispersant in the biological experiments. Testing the dialyzed DEG prior to the NPs 
allowed the concentration range of NPs to be selected for the study, thereby avoiding 
false positives due to potential effects of DEG.  
Since there is still no consensus on how to express nanomaterial (NM) concentrations, a 
selection of the possible methods for P601 and P703 NPs are shown in Table B.3, found 
in “Appendix B: Results for the physicochemical characterization of NPs”, Section 
B.1.3. 
 
A.1.2 Silver nanoparticles (Ag NPs) 
The following uncoated/functionalized Ag NPs were used in this study: 
NM-300: supplied by OECD and made available as an aqueous dispersion containing 
stabilizing agents, 4% each of polyoxyethylene glycerol trioleate and polyxyethylene (20) 
sorbitan mono-laurate (Tween 20), 10.16% w/w of silver (105 ppm of silver, 
corresponding to 930 mM). The particle size provided by the supplier on the material 
data sheet and determined using Transmission Electron Microscope (TEM) was <20 nm;  
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Ag 44 nm: synthesized in the JRC chemistry laboratory by Thierry Darmanin, Ph.D., and 
made available as an aqueous dispersion containing 0.25% w/v D-lactose as a stabilizing 
agent and 1 mM of silver. The particle size provided on the material data sheet and 
determined using DLS was 44 nm; 
Ag 84 nm: synthesized in the JRC chemistry laboratory by Thierry Darmanin, Ph.D., and 
made available as an aqueous dispersion containing 0.18% w/v D-(+)-maltose as a 
stabilizing agent and 1 mM of silver. The particle size provided on the material data sheet 
and determined using DLS was 84 nm; 
Ag 100 nm: synthesized in the JRC chemistry laboratory by Thierry Darmanin, Ph.D., 
and made available as an aqueous dispersion containing 0.15% w/v L-(+)-arabinose as a 
stabilizing agent and 1 mM of silver. The particle size provided on the material data sheet 
and determined using DLS was 100 nm. 
The NP dispersants used for each Ag NP were also provided to be used as controls for 
dispersant toxicity in the biological experiments, thereby avoiding false positive results 
due to dispersant effects. 
Table B.12, found in “Appendix B: Results for the physicochemical characterization of 
NPs”, Section B.2.4, shows the different ways in which Ag NP concentrations are tested. 
 
The terms “NP dispersant” and “NP solvent” used in this study refer to both types of NPs 
studied (CoFe2O4 and Ag), and are synonyms for the liquid phase free of NPs in a NP 
stock suspension. 
Section 2.4 “Premise to the in vitro toxicity assays” of “Chapter 2: Materials and 
Methods” describes how the molarity of the NP dilutions to be tested for the 
physicochemical characterization of NPs was calculated. 
 
A.2 Characterization of the NPs  
A.2.1 Zeta Potential assessment using Dynamic Light Scattering 
When a particle is dispersed in an aqueous solution, charge can distribute on its surface. 
The charged particle can then generate an ion distribution in the surrounding region, 
leading to an increase of oppositely charged ions next to its surface. The film of liquid 
around the particle is composed by two regions: the inner, so-called “Stern layer” where 
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ions are strongly bound, and an external, so-called “diffuse layer”, where interactions are 
weaker. The combination of these regions results in a double electrical layer around each 
particle. A theoretical boundary, in which ions and particles form stable entities, can be 
identified on the diffuse layer; when the particle moves, ions found in this area move 
together with the particle, whilst ions outside this region do not. This boundary is called 
“slipping plane”. The potential corresponding to this boundary is known as the Zeta 
potential (Z-potential). 
Measurements of the Z-potential provide information about chemical and physical 
characteristics of particles in suspension. A high Z-potential value (more positive than 
+30 mV or more negative than -30 mV) is usually associated with moderate or high 
dispersion stability since electrostatic repulsions between the particles are strong. In 
contrast, a low Z-potential value (between -30 and +30 mV) indicates 
aggregate/agglomerate formation, causing colloidal instability 
(http://www.malvern.com/LabEng/technology/zeta_potential/zeta_potential_LDE.htm, 
last accessed in September 2011). 
In general, the Z-potential is useful in determining the surface charge of NPs suspended 
in ultrapure water. The surface charge should change when NPs are in culture medium 
(with or without serum).  
Here, samples were prepared by diluting aliquots of CoFe2O4 P601 and P703 NP stock 
suspensions up to 2 mL to achieve a concentration of 100 µM in ultrapure water and 
basal media (HAM, MEM and DMEM; for more information on media, please see 
Section 2.1, “Cell lines, cell culture and media”) without serum. Similar samples of Ag 
NPs in ultrapure water were prepared and measured. 
All samples were vortexed and then immediately tested using DLS (Nano-ZS, Malvern 
Instruments).  
 
Samples were prepared by Francesca Broggi and data were generated by Guido Giudetti, 
Ph.D. 
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A.2.2 Size distribution assessed using Dynamic Light Scattering 
Particles in suspension move by Brownian motion, which is the result of the particles’ 
thermal energy and also occurs when particles collide with solvent molecules that are 
also moving. Particles or molecules can scatter light when illuminated by a laser. The 
fluctuations of the light intensity vary depending on particle size. In particular, after 
collision with solvent molecules, smaller particles can move faster than larger particles. 
Analysis of the fluctuations of the light intensity allows the rate of particles and thus their 
size to be determined using the Stokes-Einstein relationship 
(http://www.malvern.com/LabEng/technology/dynamic_light_scattering/dynamic_light_s
cattering.htm, last accessed in September 2011). 
Dynamic Light Scattering can be used to measure the particle hydrodynamic diameter, 
which corresponds to that of a sphere with the same translational diffusion coefficient. 
The size, core and surface structure of a particle together with the type of solvent used all 
influence the translational diffusion coefficient. Therefore, the particle size measured 
with DLS can be larger than that determined by electron microscopy. In fact, in the latter 
procedure, particles are removed from the solution and analysed as dried samples. The 
DLS technique was used to determine the size distribution profile of suspensions of the 
NPs investigated here in different solvent/media. Together with the DLS technique, 
therefore, the aggregation/agglomeration state of the NP preparations could be checked. 
Firstly, DLS measurements were made for HAM, MEM, DMEM, dialyzed DEG and the 
six complete culture media, in order to verify the absence of NPs and to exclude any 
background. Samples of P601 and P703 NPs prepared in basal and completed Balb3T3 
media, which were considered as baseline references of the behaviour of NPs as a 
function of time under standard cell culture conditions (37°C, 5% CO2, 90% humidity), 
were measured after 0, 24 and 72 hours of incubation. These media were chosen as 
reference points, since Balb3T3 cells are used in the subsequent Cell Transformation 
Assay (CTA) and the Cytokinesis-Block Micronucleus assay (CBMN). 
The P601 and P703 NP stock suspensions were then diluted to obtain a final 
concentration of 2% v/v in dialyzed DEG and of 100 µM in ultrapure water, basal media 
without serum (HAM, DMEM) and complete media (for A549, CaCo2, HaCaT, HepG2 
and MDCK cells culture; please see Section 2.1 “Cell lines, cell culture and media). 
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These samples were analysed after 72 hours of incubation under standard culture 
conditions and vortexed before analysis using DLS.  
The results were analysed with respect to the correlogram, the polydispersity index (PdI) 
and the comparison of particle size measured by intensity, and the respective particle size 
measured by volume. Conventionally and in accordance to the International Organization 
for Standardization directive ISO 22412:2008(E) for Particle size analysis-Dynamic 
Light Scattering (DLS), data with PdI ≥0.1 are considered to be unreliable because the 
samples are too polydispersed.  
Dynamic Light Scattering measurements were also made for Ag NP preparations in 
ultrapure water, Phosphate Buffer Saline solution (PBS), MEM basal medium and 
Balb3T3 complete culture medium. All Ag NP samples were analysed at time 0 hours 
and even after 24 and 72 hours of incubation under standard culture conditions (37°C, 5% 
CO2, 90% humidity) in the Balb3T3 culture medium.  
All the samples were tested using a DLS instrument (Nano-ZS, Malvern Instruments). 
The refractive index and absorption coefficient were set at 1.71 and 0.90 for CoFe2O4 NP 
samples, respectively, and at 0.560 and 4.27 for Ag NP samples, respectively (as 
suggested by the user manual from Malvern Instruments). 
 
Samples were prepared by Francesca Broggi and data were generated by Guido Giudetti, 
Ph.D. 
 
A.2.3 Size distribution by Nanoparticle Tracking Analysis 
The Nanoparticle Tracking Analysis (NTA) is a useful technique that allows the 
hydrodynamic size of NPs to be measured in a liquid environment. The basic principle is 
that the NPs in a liquid medium are subject to Brownian motion; when a laser illuminates 
the NPs, the intensity of the particle-scattered light can be used to analyse the path 
followed by the particles and subsequently to determine the hydrodynamic size of the 
NPs. The advantage of NTA compared to DLS is its ability to track and size single NPs 
or single aggregates/agglomerates: moreover, signals arising from smaller NPs are not 
hidden by those of larger NPs (http://www.nanosight.com, last accessed in September 
2011).  
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The Ag NP samples in ultrapure water were vortexed and immediately analysed with the 
instrument set at standard acquisition parameters (Nanoparticle Analysis System, LM20-
20X-FT, Nanosight Salisbury, UK). 
 
Samples were prepared by Francesca Broggi and data were generated by Guido Giudetti, 
Ph.D. 
 
A.2.4 Quantification of cobalt and silver in stock suspensions and determination of the 
release of ions by Inductively Coupled Plasma Mass Spectrometry 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is a sensitive technique that 
allows the presence of inorganic substances in a sample to be determined with a 
sensitivity in the range of parts per billion (ppb = parts per billion, which correspond to 
µg/L). 
Here, the ICP-MS technique was used to identify and quantify possible metal impurities 
in the stock suspensions of NPs and to quantify cobalt (Co) and silver (Ag) in their 
respective stock suspensions. This technique was also useful when measuring the 
presence of Co2+ or Ag+ ions released by NPs in culture medium after different 
incubation times relevant to the toxicity experiments, and detected these ions as Co or Ag 
following separation from NPs by centrifugal filtration. 
The CoFe2O4 P601 and P703 NP preparations of 20, 40, 60, 120 µM (2 mL samples for 
each concentration) in MEM and Balb3T3 culture medium were incubated for 0 and 72 
hours under standard cell culture conditions (37°C, 5% CO2, 90% humidity) in an 
incubator (HERAEUS, Hera cell 150, ThermoElectron Corporation, Germany). Similar 
samples of P601 and P703 NPs at concentrations of 1, 10 and 60 µM were also incubated 
for 0 and 24 hours. After incubation, two fractions were prepared for each sample: an 
unfiltered aliquot (1 mL) and a filtered aliquot (1 mL). The unfiltered samples were used 
to quantify the total amount of NPs diluted from the stock suspension, as an indicator of 
the pipetting accuracy. The filtered samples were obtained by centrifugation (3000 rpm 
corresponding to 1810 G for 20 min) in 4 mL membrane tubes (104 K, Amicon® Ultra-4, 
Millipore) and the filtered liquids were analysed. Prior to the ICP-MS analysis 
(PerkinElmer, ELAN DRC II SCIEX™ - Ontario, Canada), an aliquot of each CoFe2O4 
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NP sample was mineralized with concentrated nitric acid (nitric acid ultrapure RS, 
408051, Carlo Erba) and then suitably diluted with ultrapure water to achieve a final 
acidity of 5% and a maximum Co concentration <100 ppb. 
An example of a nominal 60 µM Co sample preparation (not-filtered): 
Aliquot from the sample = 50 µL 
Nitric acid added = 500 µL 
Final volume = 10 mL 
Obtained dilution = 200. 
Results expressed as Co ppb were converted into Co µM concentration. 
Toxicity data were elucidated by determining the release of ions. Here, ion release was 
calculated as the difference between the amount of Co detected in filtered fractions at 24 
or 72 hours and the amount of Co detected at time 0. 
A similar approach was employed in the Ag NP study in order to quantify Ag in the NP 
stock suspensions and detect all impurities present. The Ag+ ion leakage was investigated 
by analysing 10 µM Ag NP preparations in MEM basal medium and Balb3T3 complete 
culture medium after different incubation times (0, 24 and 72 hours) under standard 
culture condition (37°C, 5% CO2, 90% humidity). For all Ag NPs samples, 1 mL was 
mineralized with concentrated nitric acid and digestion was achieved using a microwave 
oven (CEM Explorer) at a temperature of 200°C and pressure of 140 PSI (Pounds per 
Square Inch, 1 PSI = 0.069 bar) maintained for 5 minutes. The Ag NP samples were then 
analysed using ICP-MS (Agilent Technologies, 7700 series, Canada, for Ag NPs 
analyses).  
 
Samples were prepared by Francesca Broggi and data were generated by Fabio Franchini, 
Ph.D. 
 
A.2.5 Sedimentation assessed using UV-Vis Spectroscopy 
The UV-Vis spectroscopy is a simple technique that was used to obtain information on 
the sedimentation of NP preparations in culture medium during a test period of 72 hours. 
In fact, considering the Lambert-Beer law (A.1): 
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A=ελCl           (A.1) 
where:  
  A = Absorbance 
  ελ = Molar absorption coefficient 
  C = Molar concentration 
  l = Sample depth, 
 
the absorbance measured at a certain height of the sample or liquid column is considered 
to be directly proportional to the concentration of the sample in that region. Therefore, 
any changes in the concentration at a certain height of a sample over a chosen time can be 
detected. 
The sedimentation/precipitation of the NPs was determined by preparing samples of both 
CoFe2O4 P601 and P703 NPs by diluting aliquots of the stock suspensions in Balb3T3 
complete culture medium w/o Phenol Red (thus avoiding interference in the wavelength 
range of 400-700 nm) to a final concentration of 60 µM. The UV-Vis spectra were 
recorded every 30 minutes over 72 hours (144 total cycles) using spectrophotometery 
(Nicolet Evolution 300, Thermo Electron Corporation) at constant room temperature. The 
sample size of both P601 and P703 NPs for all UV-Vis measurements was always 1 mL. 
 
Samples were prepared by Francesca Broggi and data were generated by Hubert 
Rauscher, Ph.D. 
 
A.2.6 NP imaging using Scanning Electron Microscopy 
The Scanning Electron Microscopy (SEM) allows heterogeneous organic or inorganic 
objects with dimensions in the range of a nanometer to micrometer to be observed and 
characterized. Typical SEM images are three-dimensional and are obtained by irradiating 
the sample with a finely focused, high energy electron beam. The electrons of the beam 
interact with the sample atoms, scanning it and thus producing signals that arise primarily 
from secondary electrons other than x-rays and photons of various energies. These 
signals are converted into images containing information on the surface topography or the 
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composition of the sample (Goldstein et al., 2003). The sample is usually prepared 
completely dry, since the specimen chamber is at high vacuum. 
The Ag NP samples of 100 µM prepared in ultrapure water were investigated using this 
imaging technique. The SiO2 wafers were previously cleaned via 30 minutes of 
ultrasonication in ethanol followed by 30 minutes of sterilization under a UV lamp. A 
solution of 1% v/v 3-aminopropyltriethoxysilane (APTS, CAS N. 919-30-2, Sigma 
Aldrich) in ethanol was freshly prepared and used to incubate SiO2 substrates for 30 
minutes. The substrates were then rinsed twice in ethanol (10 minutes per wash). The Ag 
NP samples were spotted on these surfaces and after 5-10 minutes, any drops still 
remaining were blown away with nitrogen at room temperature. 
The preparations were studied in the Scanning Electron Microscope (FEI NOVA nanolab 
600I) using relatively low voltages (5 KV) to avoid excessive scattering and enabling the 
in-lens detector to be used. 
 
Samples were prepared by Guido Giudetti, Ph.D. and images were generated by Cesar 
Pascual Garcia, Ph.D. 
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Chapter 3: Results 
 
3.1 In vitro toxicity of CoFe2O4 NPs  
3.1.1 Toxicity of the dispersant DEG 
The stock suspensions of the CoFe2O4 NPs selected for study were supplied in diethylene 
glycol (DEG). In order to select an appropriate concentrations range of test NPs and to 
avoid false positive results due to the dispersant, the potential effect of DEG was assessed 
using dialyzed DEG provided by the supplier of the CoFe2O4 NPs. 
The cytotoxicity induced by 72-hour treatment with dialyzed DEG was investigated using 
the NR and CFE assays at concentrations of 0.05, 0.1, 0.5, 1, 1.5, and 2% v/v; the results 
obtained are shown in Figures 3.1 and 3.2, respectively. 
In the NR experiments (Figure 3.1), no toxic effects of 0.05% v/v of dialyzed DEG on 
any of the cell lines employed were observed. In fact, at this concentration of dialyzed 
DEG, the viability was almost 100% when compared to the negative control for the six 
cell lines. At 0.1% v/v of dialyzed DEG, the toxic effect induced by the dispersant on 
HepG2 and MDCK increased; viability was approximately 90% and 80%, respectively, 
when compared to the negative control, whilst the toxic effects on the other cell types 
were unchanged. At 0.5% v/v of dialyzed DEG, CaCo2 and MDCK showed a viability of 
40% and 25%, respectively, when compared to the negative control, and these values 
were not acceptable for subsequent NP tests. The maximum dose of dispersant that was 
chosen to be administered to the six cell lines with the NP treatment in the NR 
experiments was 0.1% v/v of dialyzed DEG (highlighted by the red ring in Figure 3.1) 
instead of 0.05% v/v. This allowed NP toxicity to be tested at concentrations of up to120 
µM instead of 60 µM using the NR assay. 
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Figure 3.1: Six cell lines exposed to dialyzed diethylene glycol (DEG) for 72 hours. Cytotoxicity was 
evaluated using Neutral Red uptake. Results are expressed as Cell Viability (% of control) and are a 
mean of three independent experiments, ± standard error of the mean (SEM). The red ring 
highlights the concentration of dialyzed DEG that was chosen as control for the solvent (Control 
DEG 0.1% v/v) in the experiments with cobalt ferrites. 
 
In the CFE assay (Figure 3.2), at 0.05% v/v of dialyzed DEG, all the cell lines tested 
showed viability of 90–100% when compared to the negative control. Similar viability 
values were observed when 0.1% v/v of dialyzed DEG was tested, with the exception of 
MDCK cells where viability decreased to 80%. Based on the comparisons of toxicity data 
obtained for dialyzed DEG using NR and CFE, the maximum dose of dialyzed DEG 
selected for administration to cells during treatment with NPs in both assays was 0.1% 
v/v. This allowed the cells treated with NPs to reach the same maximum concentration 
(120 µM) in both assays. In particular, the cytotoxicity of the P601 and P703 CoFe2O4 
NPs was evaluated at concentrations of 10–120 µM. In fact, the highest CoFe2O4 
concentration (120 µM) tested used 0.1% v/v of DEG. The toxic effect due to the 
dispersant was then considered in the statistical data analysis for CoFe2O4 NPs (one-way 
ANOVA was used to compare NP treatments with the dialyzed DEG 0.1% v/v control 
with significance of p<0.05). 
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Figure 3.2: Six cell lines exposed to dialyzed diethylene glycol (DEG) for 72 hours. Cytotoxicity was 
evaluated by Colony Forming Efficiency (CFE). Results are expressed as CFE (% of control) and are 
the mean of three independent experiments, ± standard error of the mean (SEM). The red ring 
highlights the concentration of dialyzed DEG that was chosen as control for the solvent (control DEG 
0.1 % v/v) in the experiments with cobalt ferrites. 
 
3.1.2 Cytotoxicity induced by P601  
The results obtained after treating cells for 72 hours with CoFe2O4 NPs P601 at 
concentrations of 10, 20, 40, 60, 80, 100 and 120 µM and 10, 20, 30, 40, 50, 60, 80, 100 
and 120 µM in the NR and CFE experiments, respectively, are shown in Figure 3.3 for 
NR and Figure 3.4 for CFE. None of the cell lines used to evaluate the cytotoxic effect of 
CoFe2O4 P601 using NR decreased to a viability of 50% of the solvent control at the 
concentrations tested (Figure 3.3).  
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Figure 3.3: Six cell lines exposed to CoFe2O4 NPs P601 for 72 hours. Cytotoxicity was evaluated using 
the Neutral Red assay. Results are expressed as Cell Viability (% of the dialyzed DEG 0.1% v/v) and 
are the mean of three independent experiments, ± standard error of the mean (SEM). 
 
In the NR experiments, it was not possible to define an IC50 value for the cell lines 
studied. Statistical analysis of the NR data using one-way ANOVA did not highlight any 
significant differences compared to the dialyzed DEG control. 
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Figure 3.4: Six cell lines exposed to CoFe2O4 NPs P601 for 72 hours. Cytotoxicity was evaluated using 
CFE. Results are expressed as Colony Forming Efficiency (CFE% of the solvent control, i.e., CFE% 
of dialyzed DEG 0.1% v/v) and are the mean of three independent experiments, ± standard error of 
the mean (SEM). 
 
In the CFE experiments (Figure 3.4A and 3.4B), a significant toxic effect (* p<0.05 and 
**p<0.01) of P601 NPs was observed in three cell lines: A549 (80, 100, 120 µM), 
Balb3T3 (20, 30, 40, 50, 60, 80, 100, 120 µM) and CaCo2 (60, 100, 120 µM), but only 
for Balb3T3 was it possible to determine an IC50 value (35 µM; determined graphically, 
see Figure 3.8A). The MDCK cells showed a significant response to P601 NPs with 
respect to the DEG control at two concentrations (40 and 50 µM), while no significant 
effects were found in HaCaT and HepG2 cells. 
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Figure 3.4A: Three cell lines exposed to CoFe2O4 NPs P601 for 72 hours. The statistical significance 
was evaluated by one-way ANOVA (*p<0.05 and **p<0.01) with respect to dialyzed DEG 0.1% v/v 
control. Significant differences were found in A549, Balb3T3 and CaCo2 cells when compared to 
dialyzed DEG 0.1% v/v control. Results are the mean of three independent experiments, ± standard 
error of the mean (SEM).  
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Figure 3.4B: Three cell lines exposed to CoFe2O4 NPs P601 for 72 hours. The statistical significance 
was evaluated by one-way ANOVA (*p<0.05 and **p<0.01) with respect to dialyzed DEG 0.1% v/v 
control. Significant differences were found in MDCK cells compared to dialyzed DEG 0.1% v/v 
control. Results are the mean of three independent experiments, ± standard error of the mean 
(SEM).  
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3.1.3 Cytotoxicity induced by P703  
Parallel NR and CFE experiments were also performed to assess the cytotoxicity of 
CoFe2O4 NPs P703 (at concentrations of 10, 20, 40, 60, 80, 100, 120 µM and 10, 20, 30, 
40, 50, 60, 80, 100, 120 µM for the NR and CFE experiments, respectively) (Figures 3.5 
and 3.6 for NR and CFE, respectively). The following graphs show P703 NP 
concentrations as expected test concentrations to allow an easy comparison of the toxicity 
data of both P601 and P703 NPs. In the NR experiments with CoFe2O4 P703, it was not 
possible to identify IC50 values since all cell lines showed a viability of at least 70% at 
the concentration ranges tested. 
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Figure 3.5: Six cell lines exposed to CoFe2O4 NPs P703 for 72 hours. Cytotoxicity was evaluated using 
NR. Results are expressed as Cell Viability (% of dialyzed DEG 0.1% v/v control) and are the mean 
of three independent experiments, ± standard error of the mean (SEM). For ease of comparing the 
cytotoxicity results of P601 NPs to those of the P703 NPs, the concentrations of P703 NPs reported in 
the cytotoxicity graphs were the expected ones. 
 
 
Chapter 3: Results 
 70 
0
20
40
60
80
100
120
140
Control
DEG
0.1%v/v
10 20 30 40 50 60 80 100 120
Concentration P703 (µM)
CF
E 
(%
 
o
f t
he
 
so
lv
en
t c
o
n
tr
o
l)
A549 Balb3T3 CaCo2 HaCaT HepG2 MDCK
 
Figure 3.6: Six cell lines exposed to CoFe2O4 NPs P703 for 72 hours. Cytotoxicity was evaluated using 
CFE. Results are expressed as Colony Forming Efficiency (% of the dialyzed DEG 0.1% v/v control) 
and are the mean of three independent experiments, ± standard error of the mean (SEM). 
 
In CFE experiments, P703 induced significant toxicity (*p<0.05 and **p<0.01) in A549 
(120 µM), Balb3T3 (30, 40, 50, 60, 80, 100, 120 µM) and HepG2 (60 µM) cells (Figures 
3.6A and 3.6B for NR and CFE, respectively). The IC50 value could only be derived 
using the graph for Balb3T3 fibroblasts and corresponded to 50 µM (as expected 
concentration on the graph in Figure 3.8B, but corresponding to real 41.53 µM as 
reported in Table B.3). 
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Figure 3.6A: Three cell lines exposed to CoFe2O4 NPs P703 for 72 hours. The statistical significance 
was evaluated by one-way ANOVA (*p<0.05 and **p<0.01) with respect to dialyzed DEG 0.1% v/v 
control. Significant differences compared to dialyzed DEG 0.1% v/v control were found in A549 and 
Balb3T3 cells. Results are the mean of three independent experiments, ± standard error of the mean 
(SEM). 
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Figure 3.6B: Three cell lines exposed to CoFe2O4 NPs P703 for 72 hours. The statistical significance 
was evaluated by one-way ANOVA (*p<0.05 and **p<0.01) with respect to dialyzed DEG 0.1% v/v 
control. Significant differences were found in HepG2 cells (p<0.05) compared to the dialyzed DEG 
0.1% v/v control. Results are the mean of three independent experiments, ± standard error of the 
mean (SEM). 
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Amongst all the cell lines tested by CFE, the Balb3T3 cells were found to be the most 
sensitive to CoFe2O4 NPs. The CFE data were compared to data previously reported on 
CoCl2-treated Balb3T3 cells (Ponti et al., 2009) in order to determine if the observed 
cytotoxicity could be attributed only to P601 and P703 NPs or whether the Co2+ ion 
release also contributed. This comparison was possible due to the data produced by ICP-
MS analysis of P601 and P703 NPs samples diluted in Balb3T3 complete culture medium 
(Table B.6 and B.7), taking into account the amount of Co detected in filtered fractions 
after 72 hours of incubation, and using these values as reference concentrations to 
determine the corresponding CFE% values reported by Ponti et al. (Ponti et al. 2009). 
This approach was also used when interpreting the cytotoxicity data produced by CFE 
after 24 hours of treatment with the NPs (see Section 3.1.4 and Figure 3.9A and B). The 
comparisons between cytotoxicity results obtained after 72 hours of exposure to P601 and 
P703 NPs and Co2+ (for information on Co2+ toxicity, please refer to Ponti et al., 2009) on 
Balb3T3 cells using CFE assays are shown in Figures 3.7A and 3.7B. Viability is 
expressed as CFE% of the solvent control for both P601 and P703 NPs and as CFE% of 
the negative control for Co2+. To simplify the data presentation, the concentrations related 
to the NPs, as expected in the total fractions, are shown in Figures 3.7A and 3.7B, whilst 
data for the corresponding Co2+ concentrations, detected by ICP-MS in filtered fractions, 
are presented in Tables B.6 and B.7.  
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Figures 3.7A and 3.7B. The comparison of cytotoxicity in Balb3T3 cells induced by P601 (A, light 
blue histograms) and P703 (B, dark blue histograms), NPs and Co2+ (A and B, yellow histograms) 
after 72 hours of exposure, evaluated using the CFE assay. Results are the mean of three independent 
experiments, ± standard error of the mean (SEM = standard deviation/√number of experiments or 
replicates). The CFE values for Co2+ treatments of 72 hours were extrapolated from a previous study 
(Ponti et al., 2009). Concentrations indicated in the graphs are related to the expected µM 
concentrations of NPs in total fraction samples, considering 119 and 98 mM as concentration of the 
stock suspensions of P601 and P703; see Tables B.6 and B.7 for the respective Co2+ concentrations 
detected in Balb3T3 complete culture medium after 72 hours of incubation for both P601 and P703 
NPs. 
The P601 NPs showed the highest cytotoxicity with respect to Co2+ at all doses considered; in 
contrast, P703 NPs showed less cytotoxicity than Co2+. Data were statistically analyzed using t-test 
(http://www.graphpad.com/quickcalcs/ttest1.cfm). There was no significant difference when P601 or 
P703 data were compared to those of Co2+. 
 
Since the P601 NPs have shown CFE values lower than those of Co2+, this suggests that 
P601 NPs may have a higher toxic effect on Balb3T3 cells than that of ion release alone. 
In contrast, P703 NPs have shown higher CFE values than those of Co2+, suggesting that 
P703 NPs are less toxic than Co2+. In this context, it should be noted that for the test 
CoFe2O4 NPs, generally both the NPs and ions ultimately released in the stock 
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suspensions (the amounts of which could not be measured) were tested at the same time. 
Therefore, the effects that were attributed to the NPs were actually due to NPs and ions 
present in the stock suspension. Statistical analysis was performed using the t-test 
(http://www.graphpad.com/quickcalcs/ttest1.cfm). There was no statistically significant 
difference in toxicity of either P601 or P703 compared to that Co2+. 
 
3.1.4 Cell transformation capacity and genotoxicity induced by P601 and P703 
The transformation capacity of both CoFe2O4 NPs was studied using concurrent CFE and 
CTA tests on the Balb3T3 model after 72 hours of exposure at concentrations of 1, 5, 20, 
60 µM. In order to define this concentration range as accurately as possible, the 
cytotoxicity induced by both CoFe2O4 NPs was investigated in earlier CFE experiments 
considering only to Balb3T3 fibroblasts, by contrast to the other cell lines, additional 
concentrations (including 1 and 5 µM) so that 1, 5, 10, 20, 30, 40, 50, 60, 80, 100 and 
120 µM were the concentrations tested by CFE to Balb3T3 with 72 hours of exposure 
(see Figure 3.8A and B). Therefore 1, 5, 20 and 60 µM were chosen as the 
concentrations to be tested for assessing the transformation capacity and corresponded to 
viability values higher, similar and lower than those indicated by IC50 values (CFE% of 
50).  
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Figure 3.8A and 3.8B: CFE results after exposing Balb3T3 cells to P601 (A) and P703 (B) NPs for 72 
hours. In order to define the concentrations at which the transformation capacity of these NPs could 
be assessed as accurately as possible, the cytotoxicity on Balb3T3 fibroblasts (in contrast to the other 
cell lines) was investigated testing additional concentrations including 1 and 5 µM. Statistically 
significant differences are not shown here (please see Figures 3.4A and 3.6A).    
 
Results from concurrent CFE and CTA assays are shown in Figures 3.9A and 3.9B. 
Cytotoxicity data were statistically analyzed using one-way ANOVA. Significant 
differences with respect to the control DEG were found in the CFE for both P601 and 
P703 at 20 and 60 µM (Figure 3.9A) and confirmed the cytotoxic potential of these NPs. 
No statistically significant differences between NP treatments and DEG control were 
found in the CTA results using Fisher’s exact test, suggesting that both P601 and P703 
NPs had not transformation capacity across the selected concentration range (Figure 
3.9B). 
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Figure 3.9A: The cytotoxicity induced by P601 and P703 NPs after 72 hours of exposure, evaluated 
by concurrent CFE and CTA assays. Results are the mean of three independent experiments, ± 
standard error of the mean (SEM = standard deviation/√number of experiments or replicates). 
Statistical significance was evaluated using one-way ANOVA (*p<0.05, ***p<0.001). 
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Figure 3.9B: The cell transformation capacity induced by P601 and P703 NPs in Balb3T3 cells after 
72 hours of exposure, evaluated using CTA. Results are a mean of three independent experiments, ± 
standard error of the mean (SEM = standard deviation/√number of experiments or replicates). 
Statistical significance was evaluated by Fisher’s exact test for CTA data (***p<0.001). 
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Cytotoxicity studies using CFE were done for both P601 and P703 NPs at concentrations 
of 1, 10, 60 and 120 µM and 24 hours of exposure (Figure 3.10) in order to determine the 
concentrations to be tested in subsequent CBMN experiments.  
The potential genotoxicity of CoFe2O4 NPs on Balb3T3 was then investigated using the 
CBMN assay at concentrations of 1, 10, 60 µM for both CoFe2O4 NPs.  
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Figure 3.10: The cytotoxicity induced by P601 and P703 NPs in Balb3T3 cells after 24 hours of 
exposure, evaluated by CFE. Results are the mean of three independent experiments, ± standard 
error of the mean (SEM = standard deviation/√number of experiments or replicates). Results of the 
statistical analysis are not shown here (please see Figure 3.11A). 
 
Concentrations of 1, 10 and 60 µM of both CoFe2O4 NPs were selected for testing in the 
CBMN experiments because they corresponded with viabilities that were higher, similar 
and lower than the IC50. Both the P601 and P703 NPs were significantly cytotoxic 
compared to the solvent control after 24 hours of incubation (Figure 3.11A), but did not 
show a significant induction of micronuclei across the concentration range studied 
(Figure 3.11B). 
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Figure 3.11A and 3.11B: The cytotoxicity (A) and genotoxicity (B) induced by P601 and P703 NPs 
after 24 hours of exposure on Balb3T3 cells evaluated by CFE and CBMN assays. Results are the 
mean of three independent experiments, ± standard error of the mean (SEM = standard 
deviation/√number of experiments or replicates). The statistical significance of CFE and CBMN data 
was evaluated using one-way ANOVA and Fisher’s exact test, respectively (***p<0.001).  
 
As described previously for cytotoxicity after 72 hours of exposure, the CFE results 
obtained by treating Balb3T3 cells for 24 hours with P601 and P703 NPs were compared 
to those of Ponti et al. (Ponti et al., 2009) (Figure 3.12A and 3.12B). Both P601 NPs and 
P703 NPs showed the greatest cytotoxicity with respect to Co2+ at two of the doses 
studied (9.92 and 59.63 µM and 8.31 and 49.85 µM, respectively). Statistical analysis of 
these data using the t-test showed that the difference between the CFE% value for P601 
and the corresponding value for Co2+ at 59.63 µM was statistically significant 
(**p<0.01), and also the difference between CFE% of P703 and Co2+ was statistically 
significant (*p<0.05). 
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Figure 3.12A and 3.12B: The comparison between cytotoxicity induced by P601 (A, light blue 
histograms), P703 (B, dark blue histograms) NPs and Co2+ (A and B, yellow histograms) in Balb3T3 
cells after 24 hours of exposure, evaluated using the CFE assay. Results are the mean of three 
independent experiments, ± standard error of the mean (SEM = standard deviation/√number of 
experiments or replicates). The CFE values for Co2+ treatments of 24 hours were extrapolated from a 
previous study (Ponti et al., 2009). The concentrations shown relate to the expected µM 
concentrations of NPs in total fraction samples, considering 119 and 98 mM as the concentration of 
the stock suspensions of P601 and P703, respectively; please see Tables B.6 & B.7 for the respective 
Co2+ concentrations detected in Balb3T3 complete culture medium after 24 hours of incubation for 
both P601 and P703 NPs. 
Statistical analysis was done using the t-test (http://www.graphpad.com/quickcalcs/ttest1.cfm) and 
significant differences were found when comparing P601 or P703 data to those of Co2+ (*p<0.05; 
**p<0.01). 
 
3.2 In vitro toxicity of Ag NPs  
3.2.1 Cytotoxicity of Ag NPs  
Cytotoxicity induced by 0.01, 0.1, 0.5, 1, 2.5, 5 and 10 µM of Ag NPs on Balb3T3 
fibroblasts was assessed after 72 hours of exposure using CFE. The dose-effect curves 
from these experiments are shown in Figures 3.13, 3.14, 3.15 and 3.16 for NM-300, Ag 
44 nm, Ag 84 nm and Ag 100 nm, respectively. Statistical analysis of the data by one-
way ANOVA showed a significant cytotoxic effect in respect to the dispersant control for 
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NM-300 (at concentrations of 0.5, 1, 2.5, 5 and 10 µM), Ag 44 nm (1, 2.5, 5 and 10 µM), 
Ag 84 nm (2.5, 5 and 10 µM) and Ag 100 nm (2.5, 5 and 10 µM). 
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Figure 3.13: The cytotoxicity of NM-300 NPs on Balb3T3 cells after 72 hours of exposure, assessed 
using CFE; the NP concentration is expressed as µM. Results are the mean of three independent 
experiments, ± standard error of the mean (SEM = standard deviation/√number of experiments or 
replicates). Statistical significance was evaluated using one-way ANOVA (*p<0.05; **p<0.01). 
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Figure 3.14: The cytotoxicity of Ag 44 NPs on Balb3T3 cells after 72 hours of exposure, assessed 
using CFE; the NP concentration is expressed as µM. Results are the mean of three independent 
experiments, ± standard error of the mean (SEM = standard deviation/√number of experiments or 
replicates). Statistical significance was evaluated using one-way ANOVA (**p<0.01). 
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Figure 3.15: The cytotoxicity of Ag 84 NPs on Balb3T3 cells after 72 hours of exposure, assessed 
using CFE; the NP concentration is expressed as µM. Results are the mean of three independent 
experiments, ± standard error of the mean (SEM = standard deviation/√number of experiments or 
replicates). Statistical significance was evaluated using one-way ANOVA (**p<0.01). 
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Figure 3.16: The cytotoxicity of Ag 100 NPs on Balb3T3 cells after 72 hours of exposure, assessed 
using CFE; the NP concentration is expressed as µM. Results are the mean of three independent 
experiments, ± standard error of the mean (SEM = standard deviation/√number of experiments or 
replicates). Statistical significance was evaluated using one-way ANOVA (**p<0.01). 
 
It was thought to be of interest to present the above cytotoxicity data both as µM and the 
number of NPs per mL (Figure 3.17A and 3.17B). When the CFE results were shown as 
a function of Ag NP concentration expressed as µM, the dose-effect curves covered the 
same concentration range, and the smaller Ag NPs (e.g., NM-300 and Ag 44 nm) 
appeared to be more toxic than the larger ones since the IC50 values (~1.5 µM for NM-
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300, ~1.7 µM for Ag 44 nm, ~1.9 µM for Ag 84 nm and ~3.2 µM for Ag 100 nm) 
increase with NP size (Figure 3.17A). In contrast, when the concentration of Ag NP was 
expressed as the number of particles (see formula B.1 and Section B.2.4), the dose-effect 
curves shifted and did not cover exactly the same Ag concentration range for all the NPs. 
This also resulted in a change in IC50 values since smaller NPs appeared to be less toxic 
than the larger ones (Figure 3.17B).  
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Figures 3.17A and 3.17B: The cytotoxicity of Ag NPs on Balb3T3 cells after 72 hours of incubation, 
assessed using CFE and expressed as a function of the NP concentration in either µM (A) or the 
number of NPs/mL (No. NPs/mL) (B). Results are the mean of three independent experiments, ± 
standard error of the mean (SEM = standard deviation/√number of experiments or replicates). 
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3.2.2 Cell transformation capacity and genotoxicity of Ag NPs 
 
The transformation capacity and genotoxic potential of all the Ag NPs studied here was 
investigated using Balb3T3 mouse fibroblasts. The cell transformation capacity was 
assessed using CTA after exposing cells to Ag NPs for 72 hours at concentrations ranging 
from 0.5 to 5 µM (specifically 0.5, 2.5 and 5 µM) and previously selected by CFE, as 
concentrations with CFE% values higher, near and lower than the IC50. Results from 
concurrent CFE and CTA procedures are shown in Figure 3.18A and 3.18B. Both NM-
300 and Ag 44 nm induced a statistically significant toxic effect on Balb3T3 cells in 
respect to the appropriate NP dispersant control at concentrations of 2.5 and 5 µM, whilst 
Ag 84 nm and Ag 100 nm did so at 5 µM. Since no type III foci were observed, the 
transformation frequency (x 10-4) was zero for Ag 100 nm at 2.5 and 5 µM, and zero for 
Ag 44 nm at 5 µM. Statistical analysis with Fisher’s exact test showed no significant cell 
transformation capacity with respect to the appropriate solvent control. 
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Figures 3.18A and 3.18B: The cytotoxicity and cell transformation induced by Ag NPs in Balb3T3 
cells after 72 hours of exposure as evaluated with concurrent CFE and CTA assays. Due to the 
absence of type III foci, the transformation frequency (x 10-4) was zero for Ag 100 nm at 2.5 and 5 
µM, and zero for Ag 44 nm at 5 µM. The results are the mean of three independent experiments, ± 
standard error of the mean (SEM = standard deviation/√number of experiments or replicates). 
Statistical significance was evaluated using one-way ANOVA and Fisher’s exact test for CFE and 
CTA results, respectively (***p<0.001). 
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The genotoxic potential of all Ag NPs on Balb3T3 fibroblasts, indicated by the induction 
of micronuclei in binucleated cells, was evaluated using the CBMN assay. The 
concentrations of Ag NPs investigated in the CBMN assay (1, 5 and 10 µM) were 
selected after CFE experiments in which Balb3T3 were treated for 24 hours at Ag NP 
concentrations of 0.1, 0.5, 1, 5 and 10 µM (Figure 3.19).  
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Figure 3.19: The cytotoxicity of Ag NPs on Balb3T3 cells after 24 hours of exposure, assessed using 
CFE. Results of the statistical analyses are shown in Figure 3.20A. Results are the mean of three 
independent experiments, ± standard error of the mean (SEM = standard deviation/√number of 
experiments or replicates).  
 
Statistical analysis of CFE data using one-way ANOVA showed significant toxicity 
compared to the appropriate solvent controls at Ag NP concentrations of 1, 5 and 10 µM 
for NM-300, 5 and 10 µM for Ag 44 nm and Ag 100 nm, and 10 µM for Ag 84 nm 
(Figure 3.20A). In contrast, statistical analysis of CBMN data using Fisher’s exact test 
showed no significant differences, suggesting that the Ag NPs have no genotoxic 
potential over the concentration range investigated (Figure 3.20B). 
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Figures 3.20A and 3.20B: The cytotoxicity of Ag NPs in Balb3T3 cells after 24 hours of exposure, 
assessed using CFE (A), and genotoxicity of Ag NPs in Balb3T3 cells after 24 hours of exposure (B), 
assessed using the CBMN assay. Results are the mean of three independent experiments, ± standard 
error of the mean (SEM = standard deviation/√number of experiments or replicates). Statistical 
significance was evaluated by one-way ANOVA (*p<0.05; ***p<0.001) and Fisher’s exact test for 
CFE and CBMN assay data, respectively. 
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Appendix B: Results for the physicochemical characterization of NPs 
 
B.1 The characterization of CoFe2O4 NPs  
B.1.1 Zeta potential 
The Z-potential results for CoFe2O4 P601 and P703 NPs preparations in ultrapure water 
and in the three basal media (HAM, MEM and DMEM without serum and other 
additives) at time 0 are shown in Table B.1. The Z-potential in ultrapure water was 40 ± 
0.31 mV and 35 ± 0.55 mV for 100 µM of both P601 and P703 NPs, respectively, which 
suggested that these particles were stable in ultrapure water. The Z-potential values for 
both P601 and P703 NPs dilutions in the three basal media all ranged from +30 mV to -
30 mV. This suggested that CoFe2O4 NPs were unstable and tended to aggregate and/or 
agglomerate when suspended in culture media, probably due to the salts, glucose or 
glutamine commonly found in cell culture media.  
  
 
Table B.1: The Z-potential measurements of CoFe2O4 P601 and P703 NPs dilutions (100 µM) in 
ultrapure water and in the three cell culture media used for the toxicological studies. Values are 
expressed in mV ± standard deviation (SD). 
 
Sample name Zpot (mV) ± SD
P601 prepared in:
ultrapure water 40 ± 0.31
HAM -12 ± 0.95
MEM -6.10 ± 0.11
DMEM -7.63 ± 0.94
P703 prepared in:
ultrapure water 35 ± 0.55
HAM -12.9 ± 0.75
MEM -6.24 ± 0.23
DMEM -7.05 ± 0.12
 
 
 
 
B.1.2 Size distribution 
The DLS results obtained from the three cell culture media, the dialyzed DEG (NPs 
dispersant), and the ultrapure water are summarized in Figures B.1A-B, B.2A-B and 
B.3. 
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Figure B.1A and B.1B: DLS correlograms of basal media HAM and MEM, used to dilute CoFe2O4 
P601 and P703 NPs for DLS sample analysis.  The correlation coefficient is expressed as a function of 
time (µs). The Y intercepts at time 0 were lower than 0.1 and no correlogram had a sigmoid shape. 
These observations indicated that no nano-sized objects were detected in these samples using DLS 
and thus suggested they were particle-free.   
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Figure B.2A and B.2B: DLS correlograms of basal media DMEM and NPs dispersant DEG, used to 
dilute CoFe2O4 P601 and P703 NPs for DLS sample analysis. The correlation coefficient is expressed 
as a function of time (µs). The Y intercepts at time 0 were lower than 0.1 and no correlogram had a 
sigmoid shape. These observations indicated that no nano-sized objects were detected in these 
samples using DLS and thus suggested they were particle-free.   
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Figure B.3: DLS correlograms of ultrapure water, used to dilute CoFe2O4 P601 and P703 NPs for 
DLS sample analysis. The correlation coefficient is expressed in function of time (µs). The Y intercept 
at time 0 was lower than 0.1 and the correlogram did not show a sigmoid shape. These observations 
indicated that no nano-sized objects were detected in these samples using DLS and thus suggested 
they were particle-free.   
 
The Y intercepts for all basal media (HAM, MEM, DMEM), ultrapure water and DEG 
were always below 0.1 and no correlogram had a sigmoid shape. These findings both 
indicated that the DLS technique did not detect any nano-sized objects in the samples, 
suggesting that they were actually particle-free.  
The DLS measurements of the completed culture media used for the six cell lines showed 
a sigmoid-shaped correlogram with Y intercept values between 0.8 and 1.0 at time 0 
(Figures B.4A-B, B.5A-B and B.6A-B). This suggested that nano-sized objects were 
present in these media, possibly due to additives used to complete them for the cell 
culturing (e.g., serum proteins, glutamine, etc.).  
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Figures B.4A and B.4B: DLS correlograms of A549 and Balb3T3 complete culture media. The curves 
showed a sigmoid shape and Y intercepts at time 0 had values close to 1. Correlograms of this type 
are usually associated with samples that contain nano-sized objects. 
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Figures B.5A and B.5B: DLS correlograms of CaCo2 and HaCaT complete culture media. The 
curves showed a sigmoid shape and Y intercepts at time 0 had values close to 1. Correlograms of this 
type are usually associated with samples that contain nano-sized objects. 
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Figures B.6A and B.6B: DLS correlograms of HepG2 and MDCK complete culture media. The 
curves showed a sigmoid shape and Y intercepts at time 0 had values close to 1. Correlograms of this 
type are usually associated with samples that contain nano-sized objects. 
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The presence of nano-sized objects in these media resulted in subsequent analysis of their 
corresponding size distribution graphs. Figures B.7 to B.12 show the size distribution by 
both intensity and volume for each complete culture medium. The peaks in intensity were 
likely to be associated with the presence of cell culture medium components. In fact, a 
peak of approximately 8 nm was observed for all the complete media in the size 
distribution by volume graphs. This peak in volume might have been due to the bovine 
serum albumin, which is one of the most abundant proteins in sera used for cell culture 
(Foster, 1977). 
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Figure B.7: DLS size distribution average of six measurements by intensity (upper graph) and 
volume (lower graph) of complete culture medium employed for A549 cells. In both graphs, the 
percentage values (% Intensity and % Volume) are shown as a function of the nanometer size. 
Appendix B: Results for the physicochemical  characterization of NPs 
 95 
0
2
4
6
8
0.1 1 10 100 1000 10000
In
te
n
si
ty
 
(%
)
Size (d.nm)
Size Distribution by Intensity
Record 124: medium 10% serum 1
0
5
10
15
20
0.1 1 10 100 1000 10000
Vo
lu
m
e 
(%
)
Size (d.nm)
Size Distribution by Volume
Record 124: medium 10% serum 1
Balb3T3 complete medium
Size distri ution by Intensity
Size distri ution by Volume
In
te
n
si
ty
 
(%
)
Vo
lu
m
e 
(%
)
In
te
n
si
ty
 
(%
)
Vo
lu
m
e 
(%
)
 
Figure B.8: DLS size distribution average of six measurements by intensity (upper graph) and 
volume (lower graph) of complete culture medium employed for Balb3T3 cells. In both graphs, the 
percentage values (% Intensity and % Volume) are shown as a function of the nanometer size. 
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Figure B.9: DLS size distribution average of six measurements by intensity (upper graph) and 
volume (lower graph) of complete culture medium employed for CaCo2 cells. In both graphs, the 
percentage values (% Intensity and % Volume) are shown as a function of the nanometer size. 
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Figure B.10: DLS size distribution average of six measurements by intensity (upper graph) and 
volume (lower graph) of complete culture medium employed for HaCaT cells. In both graphs, the 
percentage values (% Intensity and % Volume) are shown as a function of the nanometer size. 
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Figure B.11: DLS size distribution average of six measurements by intensity (upper graph) and 
volume (lower graph) of complete culture medium employed for HepG2 cells. In both graphs, the 
percentage values (% Intensity and % Volume) are shown as a function of the nanometer size. 
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Figure B.12: DLS size distribution average of six measurements by intensity (upper graph) and 
volume (lower graph) of complete culture medium employed for MDCK cells. In both graphs, the 
percentage values (% Intensity and % Volume) are shown as a function of the nanometer size. 
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Different P601 and P703 NPs preparations were incubated for 72 hours at 37°C, 5% CO2 
and 90% humidity to reproduce the actual experimental conditions. Table B.2 shows the 
data obtained from these NP preparations after DLS analysis; the mean NP diameters 
(Mean NP Ø) are reported in nanometers (nm).  
 
Table B.2: DLS measurements of CoFe2O4 P601 and P703 NP dilutions in dialyzed DEG (2% v/v), 
ultrapure water, basal media and complete culture media (100 µM) used in the toxicological studies. 
Only data on the main intensity peaks are shown. The standard deviation (SD) was used to assess 
variability in the measurements. 
± SD Mean NP Ø (nm)  by intensity ± SD
P601  in: 
DEG 0.160 0.020 35.6 1.08
ul trapure water 0.230 0.060 16.47 0.65
HAM 0.316 0.040 1593 151.26
MEM 0.361 0.030 1921 813.99
DMEM 0.293 0.040 2132 566.80
A549 complete 0.926 0.182 757.1 248.60
Balb3T3 complete 0.468 0.010 567.1 67.57
CaCo2 complete 0.580 0.040 784.0 118.20
HaCat complete 0.591 0.090 812.7 287.90
HepG2 complete 0.488 0.030 789.7 230.70
MDCKcomplete 0.542 0.040 623.2 96.89
P703  in:
DEG 0.180 0.050 59.5 10.64
ul trapure water 0.180 0.000 65.4 0.48
HAM 0.240 0.020 1642.0 465.95
MEM 0.390 0.100 1687.0 260.55
DMEM 0.400 0.080 1869.3 555.05
A549 complete 0.560 0.020 656.9 141.66
Balb3T3 complete 0.500 0.020 417.4 43.02
CaCo2 complete 0.330 0.040 381.7 23.22
HaCat complete 0.630 0.130 758.5 210.15
HepG2 complete 0.510 0.040 544.9 47.36
MDCK complete 0.470 0.040 423.5 55.69
Sample Name Polydispersity Index 
 
 
 
When NP samples were prepared in DEG or ultrapure water, the size of the NPs did not 
change from that stated on the synthesis data sheet (28.81 nm for P601 and 83.22 nm for 
P703 in DEG, and 13.56 nm for P601 and 63.62 nm for P703 in ultrapure water) and the 
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polidispersity index (PdI) was at the maximum 0.2. The PdI value that was used as a 
reference for monodispersity in this study was 0.1, in accordance with the International 
Organization for Standardization directive ISO 22412:2008(E) for Particle size analysis-
Dynamic Light Scattering (DLS). When NPs were diluted in basal media or in complete 
culture media and incubated for 72 hours, the size increased by several hundred 
nanometers. In particular, the largest NP diameters were found for NP dilutions in basal 
media (a maximum value of 2132 nm for P601 and 1869 nm for P703, both in DMEM), 
while the mean NP diameters found in complete culture media ranged from 300–800 nm. 
The PdI was greater than 0.3 in all these preparations. The comparison between mean NP 
diameter related to preparations in basal media with those in complete culture media 
suggested that serum proteins could stabilize the size of NPs. Figures B.13A and B.13B 
show the mean NP diameter (nm) for all preparations as histograms; standard deviations 
are given.  
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Figures B.13A and B.13B: DLS measurements of P601 and P703 NPs dilutions in dialyzed DEG (2% 
v/v), ultrapure water, basal media and complete culture media (100 µM expected test concentration) 
after 72 hours of incubation in standard culture conditions (37°C, 5% CO2, 90% humidity). The 
standard deviation (SD) is shown. Both CoFe2O4 NPs increase in size in the basal media environment 
(>1.5 µm); neither of the P601 and P703 preparations in dialyzed DEG and in ultrapure water 
increased in size. The PdI values for 2% v/v of P601 in dialyzed DEG and ultrapure water were 0.16 
± 0.02 and 0.23 ± 0.06, respectively. The PdI values for all other P601 preparations were ≥0.3. The 
PdI values for P703 preparations showed behaviour similar to that of P601 and corresponded to 
0.180 ± 0.05 in both dialyzed DEG and ultrapure water.  
 
The P601 and P703 preparations were also characterized after 0 and 24 hours of 
incubation in MEM and Balb3T3 complete culture medium. The results are shown in 
Figures B.14A and B.14B and were compared to those after 72 hours of incubation. The 
P601 NPs prepared in MEM basal medium increased in size during the incubation period, 
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while P601 samples prepared in Balb3T3 complete medium had constant dimensions of 
approximately 500 nm (Figure B.14A). 
The size of P703 NPs prepared in MEM basal medium increased to reach a maximum at 
24 hours (2045 nm), but decreased after 72 hours (1687 nm) (Figure B.14B). As with 
P601 NPs, the size of the P703 NPs in Balb3T3 complete medium at all the time points 
studied were lower than that of NPs in MEM (approximately 500 nm) and remained 
constant. This suggested that the size of NPs could be stabilized by serum proteins. 
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Figures B.14A and B.14B: DLS measurements of CoFe2O4 P601 and P703 NP (100 µM) dilutions in 
basal medium MEM and Balb3T3 complete culture medium after 0, 24 and 72 hours of incubation, 
under standard culture conditions (37°C, 5% CO2, 90% humidity). The standard deviation (SD) is 
shown. Both P601 and P703 NPs tended to form aggregates/agglomerates that were larger in medium 
without serum than those in the completed medium at all incubation time points studied. The PdI 
values for P601 were consistently >0.3; the PdI ranged between 0.361 ± 0.03 and 0.399 ± 0.04, and 
0.468 ± 0.01 and 0.587 ± 0.04 for samples in MEM and Balb3T3 complete medium, respectively. In 
contrast, the PdI values for P703 ranged between 0.289 ± 0.03 and 0.390 ± 0.10, and 0.378 ± 0.05 and 
0.500 ± 0.02 for MEM and Balb3T3 complete medium, respectively. 
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B.1.3 Determination of impurities and quantification of Co in stock suspensions and 
Co2+ ion release from CoFe2O4 NPs in culture medium  
Levels of cobalt in both the P601 and P703 NP stock suspensions were quantified using 
ICP-MS. The expected concentration (120 mM) of cobalt in the P601 NP stock 
suspension was similar to the real concentration (119 mM). In contrast, the cobalt 
concentration detected in the P703 NP stock suspension was lower than expected (98 mM 
vs. 118 mM). Therefore, P703 concentrations used in the biological studies that were 
supposedly in the range of 10–120 µM were actually lower. 
The comparison of expected and real concentrations for P703 NPs is shown in Table B.3. 
Real concentrations were calculated using 119 and 98 mM as stock suspension 
concentrations for P601 and P703 NPs, respectively, as determined by ICP-MS analysis 
of stock suspensions in this study. Expected concentrations were calculated using 120 
and 118 mM as stock suspension concentrations for P601 and P703 NPs, respectively, as 
stated by the manufacturer on the data sheets. Notably, the concentrations in Table B.3 
are expressed as micro Molarity (µM), micrograms of cobalt per milliliter (µg Co/mL), 
micrograms of CoFe2O4 per milliliter (µg CoFe2O4/mL) and the number of NPs per 
milliliter (No. NPs/mL).  
The number of NPs per mL was calculated under the assumption that all NPs in a sample 
were spherical and homogeneous in size (i.e., no agglomerates or aggregates present) and 
using the following formula (B.1): 
 
No. NPs/mL = a/ m         (B.1) 
where: 
a = Concentration of NPs as grams per litre (g/L)   
m = 1 NP mass as volume of a single spherical NP multiplied by the CoFe2O4 
density (1.06 g/cm3, as stated by the supplier for both P601 and P703 NPs), 
 
and using 16.5 nm and 65.4 nm as the hydrodynamic diameters of P601 and P703, 
respectively, as determined using DLS analysis in ultrapure water in this study. 
Finally, in the context of tested concentrations and related number of NPs employed, it 
should be noted that cells were treated with CoFe2O4 NPs diluted in complete culture 
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medium in the biological experiments. The volumes used were 100 µL, 3 mL, 6 mL and 
4 mL per well/Petri dish in the NR, CFE, CTA and CBMN assays, respectively (please 
see sections 2.5.1, 2.5.2, 2.5.3 and 2.5.4 for information on the protocols used for the 
biological assays). 
 
Table B.3: Conversion into different units of measure for P601 and P703 CoFe2O4 NP concentrations 
tested in the experiments described. Expected concentrations were calculated using 120 and 118 mM 
as stock suspension concentrations for P601 and P703 NPs, respectively, as stated by the 
manufacturer. Real concentrations were calculated using 119 and 98 mM as stock suspension 
concentrations for P601 and P703 NPs, respectively, as determined by ICP-MS analysis of the stock 
suspensions. The number of NPs per mL was calculated using formula B.1 and 16.5 nm and 65.4 nm 
as diameters of P601 and P703, respectively, as determined by DLS analysis in ultrapure water. 
 
expected real expected real expected real expected real
P601
10 9.92 0.59 0.59 2.35 2.33 9.41E+11 9.34E+11
20 19.83 1.18 1.17 4.69 4.65 1.88E+12 1.87E+12
30 29.75 1.77 1.76 7.04 6.98 2.82E+12 2.80E+12
40 39.67 2.36 2.34 9.38 9.30 3.77E+12 3.73E+12
50 49.59 2.95 2.93 11.73 11.63 4.71E+12 4.67E+12
60 59.53 3.54 3.51 14.07 13.96 5.65E+12 5.60E+12
80 79.34 4.72 4.68 18.77 18.61 7.53E+12 7.47E+12
100 99.17 5.90 5.85 23.46 23.26 9.41E+12 9.34E+12
120 119.05 7.08 7.02 28.15 27.93 1.13E+13 1.12E+13
P703
10 8.31 0.59 0.49 2.35 1.95 1.51E+10 1.26E+10
20 16.61 1.18 0.98 4.69 3.90 3.02E+10 2.51E+10
30 24.92 1.77 1.47 7.04 5.84 4.53E+10 3.77E+10
40 33.22 2.36 1.96 9.38 7.79 6.05E+10 5.02E+10
50 41.53 2.95 2.45 11.73 9.74 7.56E+10 6.28E+10
60 49.85 3.54 2.94 14.07 11.69 9.07E+10 7.54E+10
80 66.44 4.72 3.92 18.77 15.58 1.21E+11 1.00E+11
100 83.05 5.90 4.90 23.46 19.48 1.51E+11 1.26E+11
120 99.70 7.08 5.88 28.15 23.39 1.81E+11 1.51E+11
µM µg CoFe2O4 /mL No.NPs/mLµg Co /mL
 
 
 
The P601 and P703 NPs dilutions in complete (Balb3T3) and serum free (MEM) culture 
media of 1, 10 and 60 µM (for 0 and 24 hours of incubation) and of 20, 40, 60, 120 µM 
(for 0 and 72 hours of incubation) were prepared for analysis by ICP-MS to determine 
Co2+ ion leakage. In order to determine the release of Co2+ ions, the amount of Co was 
measured by ICP-MS in total and filtered fractions for each dilution after 0, 24 and 72 
hours. Data collected were then analysed to determine the Co2+ ions released. The Co2+ 
ion release was considered to be the difference between Co detected in filtered fractions 
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at 24 or 72 hours and the amount of Co detected in filtered fractions at time 0 hours 
(Tables B.4-B.7). The ion leakage was also expressed as percentage of the average of 
cobalt detected in total fractions. The expected values of Co in the total fractions were 
obtained using 119 and 98 mM as the concentration of P601 and P703, respectively. 
Hereafter, only results related to the MEM and Balb3T3 culture medium are presented 
because cytotoxicity was detected using CFE only in this instance. These data were later 
used to determine if cytotoxicity was induced by NPs or by Co2+ ions per se. 
The release in MEM appeared to be dose-dependent for both P601 and P703 NPs (Tables 
B.4 and B.5).  
 
Table B.4: Cobalt concentrations (µM) detected by ICP-MS in P601 CoFe2O4 samples prepared in 
MEM basal medium in total and filtered fractions, both at time 0 and after 24 and 72 hours of 
incubation under standard culture conditions (37°C, 5% CO2, 90% humidity). Expected 
concentrations in total fractions were calculated using 119 mM as concentration of the stock 
suspension for P601. The release of cobalt (Co2+) was calculated as the difference between the cobalt 
detected at 24 or 72 hours and at time 0 in filtered fractions. The percentage release was calculated 
using the corresponding average of the total fractions.   
 
t0 t24 t0 t24
P601
1.11 1.11 1.11 0.23 0.33 0.10 9.01
10.88 10.32 10.60 1.45 -
69.29 51.98 60.64 7.68 14.80 7.12 11.74
t0 t72 t0 t72
19.98 18.77 19.38 3.80 5.44 1.64 8.46
41.80 39.67 40.74 7.80 10.48 2.68 6.58
60.38 61.37 60.88 11.54 16.46 4.92 8.08
117.99 115.02 116.51 21.83 30.42 8.59 7.37
19.83
release
39.67
59.53
119.05
0.99
9.92
59.53
Concentration of Co (µM) in MEM
%
expected detected
average
detected
in total fractions in total fractions in filtered fractions
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Table B.5: Cobalt concentrations (µM) detected by ICP-MS in P703 CoFe2O4 samples prepared in 
MEM basal medium in total and filtered fractions, both at time 0 and after 24 and 72 hours of 
incubation under standard culture conditions (37°C, 5% CO2, 90% humidity). Expected 
concentrations in total fractions were calculated using 98 mM as concentration of the stock 
suspension for P703. The release of cobalt (Co2+) was calculated as the difference between the cobalt 
detected at 24 or 72 hours and at time 0 in filtered fractions. The percentage release was calculated 
using the corresponding average of the total fractions. 
   
t0 t24 t0 t24
P703
0.96 0.81 0.89 0.15 0.31 0.16 18.08
9.65 8.08 8.87 2.70 4.44 1.74 19.63
68.51 41 54.76 9.64 12.06 2.42 4.42
t0 t72 t0 t72
12.14 11.02 11.58 4.90 7.08 2.18 18.83
26.73 26.17 26.45 9.70 14.15 4.45 16.82
58.20 62.52 60.36 14.30 21.75 7.45 12.34
74.10 82.39 78.25 27.60 51.93 24.33 31.09
16.61
release
Concentration of Co (µM) in MEM
%
expected detected
average
detected
33.22
49.85
99.70
in total fractions in total fractions in filtered fractions
0.83
8.31
49.85
 
 
When comparing results related to P601 and P703 NPs dilutions in Balb3T3 culture 
medium (Tables B.6 and B.7), the release of Co2+ ions again appeared to be dose-
dependent for both NPs.   
 
Table B.6: Cobalt concentrations (µM) detected by ICP-MS in P601 CoFe2O4 samples prepared in 
Balb3T3 complete culture medium in total and filtered fractions, both at time 0 and after 24 and 72 
hours of incubation under standard culture conditions (37°C, 5% CO2, 90% humidity). Expected 
concentrations in total fractions were calculated using 119 mM as concentration of the stock 
suspension for P601. The release of cobalt (Co2+) was calculated as the difference between the cobalt 
detected at 24 or 72 hours and at time 0 in the filtered fractions. The percentage release was 
calculated using the corresponding average of the total fractions. 
 
release
t0 t24 t0 t24
P601
1.12 0.76 0.94 0.21 0.24 0.03 3.19
10.45 9.06 9.76 2.00 3.12 1.12 11.48
61.74 50.24 55.99 11.74 13.21 1.47 2.63
t0 t72 t0 t72
19.95 20.34 20.15 2.70 5.10 2.40 11.91
41.37 40.52 40.95 4.80 8.62 3.82 9.33
59.61 59.47 59.54 7.30 11.94 4.64 7.79
120.71 98.41 109.56 13.60 21.91 8.31 7.58
Concentration of Co (µM) in Balb3T3 culture medium
expected detected
average
detected
in total fractions in total fractions in filtered fractions
19.83
39.67
59.53
119.05
%
0.99
9.92
59.53
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Table B.7: Cobalt concentrations (µM) detected by ICP-MS in P703 CoFe2O4 samples prepared in 
Balb3T3 complete culture medium in total and filtered fractions, both at time 0 and after 24 and 72 
hours of incubation under standard culture conditions (37°C, 5% CO2, 90% humidity). Expected 
concentrations in total fractions were calculated using 98 mM as concentration of the stock 
suspension for P703. The release of cobalt (Co2+) was calculated as the difference between the cobalt 
detected at 24 or 72 hours and at time 0 in filtered fractions. The percentage release was calculated 
using the corresponding average of the total fractions. 
 
release
t0 t24 t0 t24
P703
0.86 0.72 0.79 0.22 0.24 0.02 2.53
8.67 8.48 8.58 1.87 3.78 1.91 22.27
61.95 38.39 50.17 11.39 18.74 7.35 14.65
t0 t72 t0 t72
16.96 14.95 15.96 2.90 5.00 2.10 13.16
33.01 30.14 31.58 5.80 10.07 4.27 13.52
50.69 47.37 49.03 8.60 12.68 4.08 8.32
92.79 81.72 87.26 16.80 27.78 10.98 12.58
in filtered fractions
99.70
16.61
33.22
49.85
Concentration of Co (µM) in Balb3T3 culture medium
detected
average
detected
%
expected
0.83
8.31
49.85
in total fractions in total fractions
 
 
The Co2+ released by P601 NPs in Balb3T3 complete medium was, on average, less than 
that released in MEM after 24 hours of incubation. In contrast, the Co2+ released by P601 
after 72 hours was slightly higher in Balb3T3 complete medium than in MEM (Tables 
B.6 and B.4). A similar comparison of Co2+ released in Balb3T3 and MEM media was 
also done for P703 NPs; the Co2+ released by P703 NPs was, on average, greater in 
Balb3T3 complete medium after 24 hours and in MEM after 72 hours of incubation 
(Tables B.7 and B.5).  
Both P601 and P703 NPs stock suspensions were analysed using ICP-MS to identify and 
quantify potential metal impurities. Table B.8 shows the metal impurities found in P601 
and P703 NPs as a percentage of the CoFe2O4 stock suspension, as well as their µM 
concentration in the CoFe2O4 stock suspension. The concentration of each metal 
contaminant related to the maximum concentration of CoFe2O4 tested (120 µM and 99.7 
µM for P601 and P703, respectively) is shown. At these levels, any of the impurities 
found have the potential to induce toxic effects on Balb3T3 cells, which appear to be the 
most sensitive of the cell lines used to test the CoFe2O4 NPs (Ponti, unpublished data).  
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Table B.8: Metal impurities detected by ICP-MS analysis in P601 and P703 CoFe2O4 stock 
suspensions. The metal amounts detected are reported as a percentage of the stock suspension (119 
mM and 98 mM stock concentrations for P601 and P703, respectively), the corresponding 
concentration as micromolarity and the maximum concentration present in the maximum dose of 
CoFe2O4 tested. At these levels, any of the impurities can potentially induce toxic effects after 72 
hours of treatment on Balb3T3 cells, which appear to be the most sensitive culture of the cell lines 
used to test the CoFe2O4 NPs (Ponti, unpublished data). 
 
P601 
metal  % Stock CoFe2O4 Concentration  in stock (µM) Max. concentration  in 
test (µM) 
     
Aluminium (Al)  1.8 0.0125 1.25x10-5 
Boron (B)  2.4 0.0409 4.09x10-5 
Magnesium (Mg)  1.1 0.0082 8.2x10-6 
Nickel (Ni)  3 0.0095 9.5x10-6 
     
P703 
metal  % Stock CoFe2O4 Concentration in stock (µM) Max. concentration  in 
test (µM) 
     
Aluminium (Al)  3 0.0122 1.24x10-5 
Magnesium (Mg)  1 0.0047 4.76x10-6 
     
 
B.1.4 Sedimentation  
Figure B.15A shows some of the 144 cycles completed during the sedimentation 
experiment with CoFe2O4 NPs P601 using the spectrophotometer. The absorbance was 
measured close to the upper end of the liquid column in the cuvette every 30 minutes 
over 72 hours, and decreased cycle by cycle. A similar solution was measured under the 
same conditions close to the lower end of the liquid column.  
Figure B.15B shows the absorption measured at 500 nm wavelength at the upper end of 
the column as a function of time, whilst Figure B.16A shows the temporal behaviour of 
the absorption at the lower end of the column. The figures show that the absorption 
towards the upper end of the column decreased (depletion regime), but increased at the 
lower end (accumulation regime), indicating that sedimentation/precipitation for P601 
NPs occurred. Similar measurements were made for CoFe2O4 NPs P703, but in this case 
only close to the bottom of the cuvette (see Figure B.16B). The increased absorption also 
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indicated accumulation of NPs at the bottom of the cuvette and suggested that 
sedimentation had occurred. 
It was concluded from these observations that the timescale for experiments involving the 
exposure of cell cultures at the bottom of a dish/well has to be considered carefully. In 
fact, if experiments are to be based on a timescale of minutes, sedimentation effects 
probably can be ignored, but should be taken into consideration in experiments using a 
treatment period of days. 
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Figures B.15A and B.15B: Some of the 144 cycles of the UV-Vis measurements in a CoFe2O4 P601 
sample (60 µM) in complete culture medium without Phenol Red at fixed height (upper cuvette 
region) made every 30 minutes over 72 hours (A), and normalized absorption of the same sample at 
500 nm (upper cuvette region) (B). 
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Figures B.16A and B.16B: Normalized absorption of a sample of CoFe2O4 P601 (A) and P703 (B) at a 
concentration of 60 µM in complete culture medium at fixed height (bottom cuvette region) in 
complete culture medium without Phenol Red at 500 nm. 
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B.2 Characterization of Ag NPs  
B.2.1 Zeta potential 
The Zeta potential values (Z-potential), expressed as mV ± SD, measured for dilutions of 
100 µM of NM-300, Ag 44 nm, Ag 84 nm, and Ag 100 nm in ultrapure water are shown 
in Table B.9. All the Ag NPs studied exhibited a negative surface charge and NM-300 
was the only Ag NP unstable in an aqueous environment because its Z-potential was in 
the range of +30 mV to -30 mV. 
 
Table B.9: Z-potential measurements of all Ag NPs evaluated in this study. The Ag NPs dilutions in 
ultrapure water were investigated to determine their surface charge. Values are expressed as mV ± 
standard deviation (SD). All Ag NPs had a negative surface charge, but only Ag 44 nm, Ag 84 nm 
and Ag 100 nm showed values lower than -30 mV, which indicated that they were stable in an 
aqueous environment. 
 
Sample name Zpot (mV) ± sd
NM-300 prepared in:
ultrapure water -11 ± 2.77
Ag 44 nm prepared in:
ultrapure water -54.5 ± 12.2
Ag 84 nm prepared in:
ultrapure water -49.4 ± 0.42
Ag 100 nm prepared in:
ultrapure water -45.3 ± 1.20
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B.2.2 Size distribution 
Table B.10 shows the results of DLS measurements of dilutions of each Ag NP studied 
in different media. The mean diameter of each NP measured by DLS at time 0 in 
ultrapure water confirmed the nominal sizes stated for Ag 44 nm, Ag 84 nm and Ag 100 
nm and determined after their synthesis. It should be noted that the diameter of a NM-300 
dilution in ultrapure water measured using DLS was 46 nm compared to the stated 
diameter of 20 nm obtained by TEM micrographs of the stock suspension. The difference 
in these two values may be explained by the fact that the TEM technique measures the 
NP core disregarding any surfactant effect, while DLS measures the hydrodynamic 
diameter. The hydrodynamic diameter may, therefore, includes molecules of the 
surfactant surrounding the particle. 
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Table B.10: The mean NP diameter (Mean NPs Ø) (nm) of all Ag NPs investigated in this study. The DLS 
measurements were done for Ag NP dilutions in ultrapure water, Phosphate Buffer Saline (PBS), MEM basal 
medium and Balb3T3 complete culture medium (100 µM for all Ag NPs investigated) at time 0 and after 24 and 
72 hours of incubation under standard culture conditions (37°C, 90% humidity, 5% CO2). The standard 
deviation (SD) was used to assess variability in the measurements. 
 
Sample Name Polydispersity Index ± SD Mean NPs Ø (nm) by intensity ± SD
Ag NM-300
time 0 hours
ul trapure water 0.502 0.002 46.0 1.31
PBS 0.232 0.151 62.1 5.17
MEM 0.395 0.199 174.5 61.33
Balb3T3 complete 0.279 0.008 41.9 10.64
time 24 hours
Balb3T3 complete 0.560 0.101 147.3 7.07
time 72 hours
Balb3T3 complete 0.476 0.068 117.8 16.58
Ag 44 nm
time 0 hours
ul trapure water 0.174 0.009 44.9 0.29
PBS 0.230 0.003 363.6 24.82
MEM 0.259 0.019 389.9 57.16
Balb3T3 complete 0.279 0.008 83.4 2.33
time 24 hours
Balb3T3 complete 0.286 0.011 99.6 1.05
time 72 hours
Balb3T3 complete 0.316 0.005 98.4 1.47
Ag 84 nm
time 0 hours
ul trapure water 0.146 0.006 83.7 0.84
PBS 0.271 0.026 173.7 28.01
MEM 0.278 0.012 283.0 29.99
Balb3T3 complete 0.157 0.005 112.5 0.95
time 24 hours
Balb3T3 complete 0.220 0.013 124.6 3.41
time 72 hours
Balb3T3 complete 0.274 0.005 120.6 0.90
Ag 100 nm
time 0 hours
ul trapure water 0.159 0.010 101.6 0.95
PBS 0.271 0.019 151.9 13.31
MEM 0.285 0.009 313.7 25.68
Balb3T3 complete 0.153 0.005 121.1 1.24
time 24 hours
Balb3T3 complete 0.179 0.008 146.4 1.14
time 72 hours
Balb3T3 complete 0.247 0.011 147.5 5.05
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Five of the samples shown in Table B.10 had a polydispersity index (PdI) >0.3, four of 
which were dilutions of NM-300 in ultrapure water and in MEM measured at time 0, and 
in Balb3T3 complete culture medium measured after 24 and 72 hours of incubation. The 
fifth sample (with a PdI >0.3) was Ag 44 nm diluted in Balb3T3 complete culture 
medium and was analysed after 72 hours of incubation. These PdI values indicated that 
samples were not monodispersed. As with CoFe2O4 NPs, all of the Ag NPs studied 
appeared to be stabilized by serum proteins in complete culture medium and achieved 
relatively constant dimensions during the incubation time, with exception of NM-300, 
which increased in size between 0 and 24 hours (Figures B.17A-B.17D). 
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In addition, samples of Ag NPs (100 µM) were prepared in ultrapure water and 
immediately analysed using Nanoparticle Tracking Analysis to determine their size 
distribution. The mean NP diameter (nm) of NM-300 was 56 nm, while those of Ag 44 
nm, Ag 84 nm and Ag 100 nm were 36 nm, 65 nm and 89 nm, respectively (Table B.11). 
 
Table B.11: Mean NP diameter (Mean NPs Ø) (nm) of 100 µM Ag NP samples prepared in ultrapure 
water and determined by Nanoparticle Tracking Analysis. Standard deviation (SD) is shown. 
 
Sample Name Mean NPs Ø (nm) by intensity ± SD
Ag NM-300 prepared in:
ultrapure water 56 ± 26
Ag 44 nm prepared in:
ultrapure water 36 ± 14
Ag 84 nm prepared in:
ultrapure water 65 ± 18
Ag 100 nm prepared in:
ultrapure water 89 ± 45
 
 
B.2.3 Determination of impurities and quantification of Ag in stock suspensions and 
Ag+ ion release from Ag NPs in culture medium  
Levels of metal impurities in the stock suspensions, as measured using ICP-MS, were 
lower than the instrument detection limit. For Ag quantification in stock suspensions, the 
nominal concentration was confirmed for all Ag NP stock suspensions. Table B.12 
shows the concentrations used in the biological experiments expressed as micromolarity 
(µM), micrograms of Ag per mL (µg Ag/mL) or number of Ag NPs per mL (No. 
NPs/mL). The number of NPs per mL (No. NPs/mL) was calculated using formula B.1 
and the hydrodynamic diameters measured in ultrapure water by DLS (46 nm, 44 nm, 84 
nm and 100 nm for NM-300, Ag 44 nm, Ag 84 nm and Ag 100 nm, respectively). The 
densities of Ag 44 nm, Ag 84 nm and Ag 100 nm were determined by weighing (AM50 
balance, Mettler Toledo) three samples of 500 µL of stock suspension for each Ag NP; 
the average densities were 0.9885, 0.9779 and 0.9773 g/cm3 for Ag 44 nm, Ag 84 nm and 
Ag 100 nm, respectively. The density considered for NM-300 was 1.113 g/cm3, as stated 
on the material data sheet. 
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Table B.12: The different units of measure by which Ag NP concentration can be expressed. The 
number of NPs per mL (No. NPs/mL) was calculated using formula B.1, the hydrodynamic diameters 
measured in ultrapure water by DLS (46 nm, 44 nm, 84 nm and 100 nm for NM-300, Ag 44 nm, Ag 
84 nm and Ag 100 nm, respectively) and the densities determined by weighing three samples of 500 
µL of stock suspension for each Ag NP (1.113, 0.9885, 0.9779 and 0.9773 g/cm3 for NM-300, Ag 44 
nm, Ag 84 nm and Ag 100 nm, respectively). 
 
NM-300
µM µg Ag/mL No.NPs/mL
0.01 0.00108 1.90E+07
0.1 0.01079 1.90E+08
0.5 0.05393 9.51E+08
1 0.10787 1.90E+09
2.5 0.26967 4.76E+09
5 0.53934 9.51E+09
10 1.07868 1.90E+10
Ag 44 nm
µM µg Ag/mL No.NPs/mL
0 .01 0.00108 2.45E+07
0.1 0.01079 2.45E+08
0.5 0.05393 1.22E+09
1 0.10787 2.45E+09
2.5 0.26967 6.12E+09
5 0.53934 1.22E+10
10 1.07868 2.45E+10
Ag 84 nm
µM µg Ag/mL No.NPs/mL
0.01 0.00108 3.56E+06
0.1 0.01079 3.56E+07
0.5 0.05393 1.78E+08
1 0.10787 3.56E+08
2.5 0.26967 8.89E+08
5 0.53934 1.78E+09
10 1.07868 3.56E+09
Ag 100 nm
µM µg Ag/mL No.NPs/mL
0 .01 0.00108 2.11E+06
0.1 0.01079 2.11E+07
0.5 0.05393 1.05E+08
1 0.10787 2.11E+08
2.5 0.26967 5.27E+08
5 0.53934 1.05E+09
10 1.07868 2.11E+09
 
 
Ag NP samples of 10 µM concentration (obtained by diluting stock suspensions in MEM 
and Balb3T3) medium were analysed using ICP-MS after 0, 24 and 72 hours of 
incubation under standard culture conditions (37°C, 5% of CO2, 90% of humidity). No 
Ag was detected in filtered fractions at any time point studied (results not reported but 
discussed in “Chapter 4: Discussion”).  
 
B.2.4 Imaging 
The Ag NP characterization profile previously determined using DLS and NTA was 
completed using a Scanning Electron Microscope; the images obtained from dried 
samples are shown in Figures B.18A-D. Qualitative analysis of the images confirmed the 
Appendix B: Results for the physicochemical  characterization of NPs 
 120 
stability of Ag NPs in ultrapure water because no aggregates of relevance were found 
(monodispersed NPs). 
 
 
 
Figures B.18A, B.18B, B.18C and B.18D: Scanning Electron Microscope images of 100 µM samples 
of Ag NM-300 (A), Ag 44 nm (B), Ag 84 nm (C) and Ag 100 nm (D) prepared in ultrapure water.  No 
aggregates/agglomerates of relevance were found in these preparations. 
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Chapter 4: Discussion 
 
The main objective of this Ph.D. research project was to study and elucidate the in vitro 
toxicological effects induced by NPs of industrial and biomedical interest, such as the 
nanoparticles of cobalt ferrites (CoFe2O4 NPs) and silver (Ag NPs). In particular, 
CoFe2O4 NPs were selected for study as part of the European Commission-funded 
STREP project “Cellular Interaction and Toxicology with Engineered Nanoparticles” 
(CellNanoTox) (FP6-2004-NMP-TI-4- 032731), while Ag NPs were chosen as part of 
“The Reactivity and Toxicity of Engineered Nanoparticles: Risks to the Environment and 
Human Health” project (NanoReTox), (NMP-2007-1.3-2). 
This experimental work was carried out at the NanoBioSciences Unit (NBS) in the 
Institute for Health and Consumer Protection (IHCP) of the Joint Research Centre (JRC) 
of the European Commission (EC) located in Ispra (Varese, Italy). The NBS focuses on 
nanotechnology research, both producing nanomaterials (NMs) (nanoparticles and 
nanosurfaces) and evaluating their potential in vitro toxicity using cell models as 
alternatives to animal models (Russell et al., 1959). The use of in vitro methods is 
supported by the “3 Rs” principle (Reduction of the number of animals used for 
experimental and scientific purposes; Refinement of the animal’s suffering during 
experimentation; Replacement of animals in the toxicological tests requested by law) 
(Russell et al., 1959), which inspired the EC Directive (86/609/EEC) regulating the use of 
animals for experimental purposes (Anon, 1986). 
Therefore, the toxicological profiles of CoFe2O4 NPs and Ag NPs were studied using in 
vitro mammalian cell cultures proposed either as possible examples of different targets of 
exposure to NMs (A549, CaCo2, HaCaT, HepG2 and MDCK cells) or chosen for their 
suitability for specific bioassays (Balb3T3 cells).  
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Some superparamagnetic NPs are already on the market and are used as contrast agents in 
magnetic resonance imaging (MRI), such as Lumirem®, Endorem® and Sinerem®. These 
NPs are classified into two groups according to their size, including particles larger than 
50 nm (superparamagnetic iron oxides, SPIOs) or smaller than 50 nm (ultrasmall 
superparamagnetic iron oxides, USPIOs) (Brigger et al., 2002). 
Potential NP candidates that can improve cancer therapy through targeted drug delivery, 
hyperthermia treatment and MRI of solid tumours are being sought and the magnetic 
CoFe2O4 NPs are of interest for these biomedical purposes. Nevertheless, these NPs must 
be both characterized and their potential biocompatibility assessed before they can be 
exploited safely as regards human health. 
For a thorough characterization, therefore, it has been suggested that each NM is studied 
for more than one property and by more than one technique (Stone et al., 2009; 
Bouwmeester et al., 2011). In addition, a reliable toxicity assessment is recommended 
using more than one in vitro toxicity assay so as to avoid artefacts and/or false 
positive/negative results due to the method used and its limitations (Ponti et al., 2010). 
Here, a series of tests was performed to define the physicochemical characteristics of 
CoFe2O4 NPs and to elucidate their behaviour in culture medium. 
Both CoFe2O4 NPs (P601 and P703) were positively charged and stable when dispersed 
in ultrapure water, but became unstable in a saline environment, such as the culture media 
with or without serum (Balb3T3 and MEM media, respectively). The CoFe2O4 NPs 
tended to aggregate/agglomerate immediately in MEM, the serum free medium 
considered as a reference, and became larger (reaching micrometre dimensions, 2 µm) as 
incubation time increased. 
In addition, both P601 and P703 NPs prepared in the complete culture medium 
containing 10% v/v of serum and used for Balb3T3 cells were shown to 
aggregate/agglomerate immediately; they reached a maximal size of 500 nm, which 
remained constant over 72 hours. In general this different behaviour of NPs in the culture 
medium, depending on serum content, was observed after 72 hours of exposure for both 
P601 and P703 NPs. Similar behaviour was also observed in the media used for culturing 
the other mammalian cell lines tested. These results support the hypothesis that serum 
proteins interact immediately with the NP surface and start to form the evolving protein 
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corona (Lynch et al., 2008), thereby stabilizing the NPs and preventing their 
aggregates/agglomerates from reaching 1 µm in size. 
The ICP-MS analysis of stock suspensions confirmed the theoretical concentration for 
P601 NPs, while the stock suspension concentration detected for P703 NPs was 17% 
lower than the expected concentration. Therefore, lower than expected concentrations 
were obtained during the preparation of P703 NPs samples for both the characterization 
and toxicity experiments. 
Some metal NPs are reported to release ions in biological media; therefore, distinguishing 
between the effects induced by NPs per se and those of the released ions is a critical issue 
for NP toxicology studies. The dissolution of metal or metal oxide NPs in biological 
media is of great interest to study so as to understand the observed toxicity effects better. 
The determination of Co ions release (Co2+) in complete Balb3T3 culture medium using 
ICP-MS showed that leakage from P601 and P703 NPs occurred at all the incubation 
times considered (24 and 72 hours); the Co2+ ions release from the NP was dose-
dependent for both P601 and P703. It was not possible, however, to measure the amount 
of Co2+ ions in the stock suspensions provided by the supplier, since neither filtration 
using Millipore membranes nor ultracentrifugation was effective in separating the NPs 
from the solvent phase. In fact, even after these attempts the NPs remained in suspension. 
Iron (Fe) ion release from CoFe2O4 NPs was previously found to be between 0–2% and 
not to be dose- or time-dependent (Mariani et al., 2011). 
Both CoFe2O4 NPs have shown to undergo sedimentation over 72 hours (Rauscher et al., 
2010). This observation appears to correspond with the instability and polydispersity of 
the NP preparations in complete culture medium as assessed by DLS. It is reasonable to 
suggest that the larger aggregates/agglomerates underwent sedimentation and reached the 
cells more quickly than the smaller aggregates/agglomerates, which precipitated later in 
the 72-hour incubation period. 
When studying the toxicity of CoFe2O4 NPs, the NP size, cell type and in vitro methods 
used are factors that are considered to potentially influence the outcomes of NP tests. In 
particular, two different sizes of CoFe2O4 NPs were investigated for in vitro cytotoxicity 
using six mammalian cell lines. The TEM images and measurements of both CoFe2O4 
NPs were presented in the first CellNanoTox project activity report and corresponded to 
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6-7 nm for P601 and 50 nm for P703, respectively, whilst the A549, Balb3T3, CaCo2, 
HaCaT, HepG2 and MDCK cell lines were selected as potential examples of target 
organs for 72 hours exposure to NPs. Two different in vitro assays were performed in 
parallel and compared, namely the colorimetric Neutral Red uptake (NR) test and the 
clonogenic Colony Forming Efficiency (CFE) assay. After the evaluation of the 
maximum dispersant (dialyzed DEG) concentration tolerated by the cells (0.1% v/v by 
NR and CFE), the dose range of CoFe2O4 NPs was set between 10–120 µM 
(corresponding to a dose range of 0.59–7.08 µg of Co/mL or 2.35–28.15 µg of 
CoFe2O4/mL), with the higher value representing the NP concentration with a maximum 
DEG content of 0.1% v/v.  
Under the experimental conditions in this study, a dose-effect relationship was not 
detected by NR for either size of CoFe2O4 NP in all cell lines showing a high level of 
viability which never decreased to 50%.  The statistical analysis of the NR results using 
one-way ANOVA highlighted no significantly different (p<0.05) viability compared to 
the DEG control for each cell line and CoFe2O4 NPs tested. In contrast, a dose-dependent 
effect was observed using CFE in the A549, Balb3T3 and CaCo2 cell lines for both sizes 
of CoFe2O4 NPs. The IC50 values were graphically derived for Balb3T3 fibroblasts (35 
µM or 2.06 µg Co/mL for P601, and 50 µM or 2.95 µg Co/mL expected concentration, 
corresponding to a real concentration of 41.5 µM or 2.45 µg Co/mL for P703). In 
contrast,  IC50 values were not graphically derived for the other cell lines because at the 
highest concentration tested, their CFE% values were still greater than 50. 
These observations reflect previous studies (Ceriotti et al., 2007; Ponti et al., 2010) 
showing that the CFE assay is more sensitive than the NR assay. The difference between 
the two methods may be due to the fact that the viability in the NR assay is measured 
immediately after treatment cessation, whilst cells are kept in culture for at least a week 
in the CFE assay. Since some NMs have been reported to interact with reagents used in 
most common colorimetric assays (Casey et al., 2007) and since CFE is usually one of 
the most sensitive in vitro assays to assess cytotoxicity, the CFE should be used to test 
the effect of NMs on adherent cell lines (Ponti et al., 2010). 
Of all the cell lines used, only the Balb3T3 cells allowed the IC50 value to be 
determined; this may be due to the different biotransformation ability of xenobiotics by 
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fibroblast cells compared to other cell types, such as HepG2 (Coecke et al., 2006).  In 
addition, normal cell lines have shown to be more sensitive to NMs than carcinoma cell 
lines in a clonogenic assay (Herzog et al., 2007). It has also been reported that 10 mg/mL 
of CoFe2O4 NPs (size not specified) tested in vivo for 7 weeks using ICR (Imprinting 
Control Region) mice did not show significant adverse effects on either the growth or the 
behaviour of the treated animal compared to the negative control group (Kim et al., 
2007). 
Here, the cytotoxicity in Balb3T3 cells after 24 hours of treatment using CFE was also 
evaluated. The IC50 values graphically determined for both CoFe2O4 NPs were in the 
range of 25–30 µM (i.e., in the range of 1.47–1.77 µg Co/mL and 5.86–7.04 µg 
CoFe2O4/mL, respectively). The ICP-MS measurements of cobalt ion release in complete 
Balb3T3 culture medium allowed the CFE results for the NPs to be compared with those 
reported previously when treating the same cell line with soluble cobalt chloride (CoCl2) 
(Ponti et al., 2009). After 24 hours of treatment, both P601 and P703 NPs were more 
toxic than the Co2+ ions released from the NPs. After treatment for 72 hours, the P601 NP 
was again more toxic than the Co2+ ions released, unlike P703, which was less toxic than 
the ions released. It is not possible, however, to exclude the possibility that the toxicity 
observed in NP treatments was induced by a combination of NPs and Co2+ ions. Ponti et 
al. reported similar conclusions for cobalt NP-induced cytotoxicity compared to that of 
CoCl2 treatments (Ponti et al., 2009). 
The uptake and intracellular distribution of CoFe2O4 NPs have been demonstrated by 
Synchrotron Radiation X-Ray Fluorescence (SR-XRF) in Balb3T3 cells as a function of 
the NP concentration (Marmorato et al., 2011). Based on the results of this study, it is 
reasonable to suggest that the ions released from NPs once they have entered the cell 
contribute to cytotoxicity according to the Trojan-horse theory proposed for metal NPs by 
Park et al. (Park et al., 2010a). Currently, little information is available on the in vitro and 
in vivo biocompatibility of CoFe2O4 NPs. The information that does exist relates to other 
sizes or doses of CoFe2O4 NPs and other in vitro methods or cell lines (see Section 1.8.1 
for examples), so it is difficult to directly compare published results with those found 
here. 
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Notably, however, Kim and co-workers have tested different ferrite particles (Fe-, Li-, 
Ni/Zn/Cu-, Ba-, Sr-, Co-, Co/Ni-ferrites) using MTT and agar diffusion assays in L929 
fibroblasts and found that the CoFe2O4 particles (170 nm in size) were not cytotoxic in 
either assay (Kim et al., 2005). Moreover, the biocompatibility of magnetic NPs, such as 
Fe3O4 (20-30 nm), ZnFe2O4 (15-30 nm) and NiFe2O4 (20-30 nm), was investigated using 
the colony forming assay and Trypan Blue exclusion method in HeLa cells. These NPs 
were not found to be cytotoxic at the lowest tested concentrations (10 µg/mL), although 
NiFe2O4 was cytotoxic at the highest tested concentration (100 µg/mL) (Tomitaka et al., 
2009).  
Here, the cytotoxicity studies on Balb3T3 fibroblasts assessed at 24 and 72 hours using 
CFE were the first step of the in vitro investigations on CoFe2O4 NPs. The dose-effect 
curves obtained after CFE analysis allowed the chosen concentrations to be tested by the 
Cell Transformation Assay (CTA; concentrations of 1, 5, 20, 60 µM corresponding to 
0.059, 0.295, 1.18 and 3.54 or 0.235, 1.175, 4.69 and 14.07 µg Co/mL and CoFe2O4/mL, 
respectively) and the Cytokinesis-Block-Micronucleus assay (CBMN; concentrations of 
1, 10, 60 µM corresponding to 0.059, 0.59 and 3.54 µg or 0.235, 2.35 and 14.07 µg 
Co/mL and CoFe2O4/mL, respectively). 
The Balb3T3 mouse fibroblasts, and specifically the A-31-1-1 clone, were used as a well-
established in vitro model in this study. These cells are suitable for not only the CFE, but 
also the CTA and CBMN assays. The advantage of using Balb3T3 fibroblasts, therefore, 
was using single cell type to generate a toxicological profile for the CoFe2O4 NPs that 
included potential cytotoxicity, cell transformation capacity and genotoxicity. The results 
showed that both CoFe2O4 NPs did not significantly induce type III foci formation or 
micronuclei under the experimental conditions of this study. 
Since there is no information available on the transformation capacity and genotoxic 
potential for CoFe2O4 NPs, data found here were compared to those of cobalt NPs and 
CoCl2. Cobalt and its compounds have been classified as possible human carcinogens 
(Group 2B) by the IARC (Agents classified by the IARC Monographs, Volumes 1-102; 
http://monographs.iarc.fr/ENG/Classification/index.php, last accessed in February 2011).  
Morphological transformation assessed with CTA and genotoxicity assessed with both 
the CBMN and Comet assays have been observed in Co NP-treated Balb3T3 cells; whilst 
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treating the same cell line with CoCl2 did not induce morphological effects, significant 
genotoxicity was found using the Comet assay (Ponti et al., 2009). In contrast, Colognato 
et al. found that Co NPs had a smaller genotoxic effect on human peripheral lymphocytes 
than CoCl2, indicated by the presence of micronuclei and a reduced cell proliferation 
index (Colognato et al., 2008). Clearly more investigations on the potential effects of 
CoFe2O4 NPs on DNA are required to determine if these particles are genotoxic or not. 
As yet, the transformation capacity of NPs has not been investigated often. Although 
there are a few reports on using the CTA to assess the transformation capacity of NPs 
(Ponti et al., 2009; Ponti et al., 2011), there are none on using CTA to test the CoFe2O4 
NPs. This study, therefore, is the first to report the use of CTA in assessing the cell 
transformation capacity of CoFe2O4 NPs. 
Other methods, such as the Soft Agar Colony Forming assay where the biomarker for 
neoplastic cell transformation is the loss of the anchorage-dependence for growth, can, 
however, be used to study the genotoxic potential of NPs on adherent cells. Previously, 
this type of test has been demonstrated as valid for the screening of antitumor drugs 
(Shoemaker et al., 1985), and it has also been used to assess the ability of NPs to act as 
drug delivery systems against cancer cell lines, detected as the inhibition of cell 
proliferation and thus non-formation of colonies (Bisht et al., 2007). Indeed, the 
transformation capacity of NPs could potentially be evaluated using the soft agar assay; 
the endpoint would be the detection of colonies formed in soft agar gel by transformed 
cells that have lost the anchor-dependence for growth after NP treatment. Anchorage-
independent transformation, for example, has been demonstrated in JB6 mouse epithelial 
cells after treatment with <20 nm alumina NPs (Al2O3 NPs) (Dey et al., 2008). The 
advantage of this method is the possibility of using Balb3T3 cells so that the 
transformation capacity of NPs can be determined both with this method and the CTA. 
In contrast, the genotoxic potential of NPs evaluated using the CBMN assay is well 
documented. The CBMN assay has been shown to give positive outcomes for a wide 
range of nanomaterials, such as Co NPs (100-500 nm), Co-Cr alloy NPs (30 nm), TiO2 
NPs (25; 10-20; ≤20 nm), SiO2 NPs (6.6, 8.2, 196 nm), polyaspartic acid-coated 
magnetite NPs (8.5 nm), water soluble C60 (7.1 nm) and mwCNTs (11.3 nm diameter, 
700 nm length) (Singh et al., 2009), using different cell types. 
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The Comet assay is an alternative in vitro assay for testing the genotoxicity of NPs; the 
genetic damage is identified as single and double DNA strand breaks (Rojas et al., 1999). 
A recent review on the use of the Comet assay in nanotoxicology investigations reported 
positive outcomes in A549 cells after 4 hours of treatment with 2-80 µg/mL of iron oxide 
NPs (e.g., Fe2O3 and Fe3O4 20-40 that are 30-60 nm in size, respectively) (Karlsson, 
2010). Numerous positive outcomes have been obtained using the Comet assay to test 
different NPs; this is unsurprising due to the high reactivity of NPs (Karlsson, 2010). 
Nevertheless, it cannot be excluded that the positive outcomes detected using the Comet 
assay for several NPs were due to NP-assay interactions, as observed for NPs, such as 
TiO2 and CuO (Karlsson, 2010). In addition, particles of iron oxide, which have shown to 
induce little DNA damage using the Comet assay, were seen in the comet head (Karlsson, 
2010). Therefore, a thorough investigation of the genotoxic potential of CoFe2O4 NPs 
using additional methods with protocols specifically adjusted for NP testing is clearly 
required. 
Oxidative stress studies must be considered when evaluating the genotoxicity of NPs 
because most NPs have been shown to induce oxidative stress, which itself appears to be 
involved in DNA damage that is associated with cancer formation (Karlsson, 2010). In 
this context, a modified version of the Comet assay using specific enzymes, such as 
formamidopyrimidine glycosylase (FPG) and endonuclease III, allows the detection of 
oxidative stress and repair. These enzymes recognize and nick the DNA in 
correspondence of oxidized purines and pyrimidines, thereby increasing the number of 
DNA fragments; information on oxidative stress is obtained by comparing the cells 
treated/untreated with these enzymes (Karlsson, 2010). 
Other assays that measure NP-induced production of reactive oxygen species (ROS) in 
the absence or presence of cells have been reported (Stone et al., 2009). In the absence of 
cells, however, NP ROS production is considered to be associated with the 
physicochemical characteristics of NPs, whilst ROS production in the presence of cells 
(both extracellular and intracellular) is considered to be a marker of oxidative stress 
(Stone et al., 2009). One assay which can detect intracellular ROS is the DCFH (2, 7-
dichlorofluorescein) assay; this exploits the conversion of a precursor into a fluorescent 
dye. Meanwhile, the cytochrome C assay allows the quantification of extracellular ROS, 
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such as superoxide anions produced by cells. Additional markers of oxidative stress in 
NP studies include changes in the ratio between the reduced (GSH) and oxidized (GSSG) 
forms of glutathione (GSH:GSSG), lipid peroxidation and mRNA expression of oxidative 
stress-dependent genes (Stone et al., 2009). Future studies following on from this work 
will include investigation of oxidative stress induced by the NPs tested here.  
The results found in this study differ depending on the assay and cell lines chosen when 
screening the toxicity of CoFe2O4 NPs. As regards the potential influence of CoFe2O4 NP 
size on the biocompatibility studies, there were no relevant differences in the toxicity 
induced by P601 and P703 CoFe2O4 NPs using the NR uptake, CFE, CTA and CBMN 
assays. The similar effects induced by the P601 and P703 NPs can be explained by the 
fact that both sizes were shown to behave similarly in terms of formation of 
aggregates/agglomerates, ion leakage and sedimentation when in media, such that cells 
would reasonably “see” and interact with P601 and P703 NPs in an analogous manner. 
Additional toxicity experiments comparing NPs that differ by more than 50 nm in size 
(e.g., 16 nm vs. 160 nm particles) would be necessary to clarify the role of the NPs size in 
toxicity. For example, Colognato et al. studied three different sizes of CoFe2O4 NPs (5.6 
nm, 10 µm and 120 µm) using the CBMN assay in order to assess the genotoxic potential 
of these NPs in human peripheral lymphocytes (Colognato et al., 2007). They showed 
that the smallest NPs induced significant toxicity and mutagenicity, while the 10 µm NPs 
induced significant mutagenicity only and no effects were induced by the largest NPs 
(Colognato et al., 2007).  
In order to hypothesize a mechanism of toxicity and explain the differences observed 
with CFE analysis of the six cell lines studied here, it might be of interest to assess the 
toxic potential of CoFe2O4 NPs with different surface properties (i.e., surface charge, 
presence of different coatings) that can influence the NP protein corona. Experiments that 
allow characterization of the protein corona of CoFe2O4 NPs would be useful in 
understanding the interaction of NPs with cells and subsequently their toxicology since 
the protein corona may be involved in the absorption of the NPs (Fischer et al., 2007).  
In vitro studies, such as those described in this work, are a good foundation for the safety 
assessment of CoFe2O4 NPs, but still have limitations and are insufficient when 
compared to complex in vivo conditions. Even if in vitro systems are in general relatively 
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inexpensive, time effective and easy to perform and interpret, they cannot reproduce, for 
example, either the NP changes or interactions among different cell types that occur in 
vivo (Stone et al., 2009). Fischer et al. highlighted the need for in vivo investigations to be 
carried out in the first step of NP toxicity research so as to identify the cells/organs that 
can take up the NPs, and thus the need to design more focused in vitro experiments 
(Fischer et al., 2007).  
Nevertheless, based on this work, it is clear that more studies are required to enable in 
vitro and in vivo results to be correlated. For example, a comparison of the concentrations 
of CoFe2O4 NPs used in our in vitro experimental conditions with the results of in vivo 
studies testing similar NPs is difficult and no direct correlation can be found. The 
superparamagnetic NP formulations already in use for MRI contain iron oxide NPs and 
their concentrations are usually expressed as µg of iron (Fe) or mL of NP suspension per 
kilogram (Kg) of weight. For example, Resovist®, a carboxydestran-coated iron oxide 
NP, is one of the superparamagnetic NPs used for MR imaging of liver lesions (Reimer et 
al., 2003). The hydrodynamic diameter of this NP ranges from 45–60 nm and the 
recommended dose for intravenous (IV) injection on the material data sheet is 0.9 mL 
(corresponding to 0.45 mmol of Fe) in patients weighing less than 60 kg, and 1.4 mL 
(corresponding to 0.7 mmol of Fe) in patients weighing 60 kg or more (http://radiologie-
uni-frankfurt.de/sites/radiologie-uni-
frankfurt.de/content/e43/e2321/e2331/resofinal_eng.pdf, last accessed in September 
2011).  
To enable the concentration of CoFe2O4 NPs used in this study to be compared with the 
Resovist® iron oxide NP doses, the Fe concentrations in toxicity experiments of this 
study could be calculated using the amount of Fe declared on the material data sheet (e.g., 
259.25 mM for P601 NPs) and the dilutions used during the toxicity tests with cells. 
Using this approach, the amount of Fe in P601 NP treatments was 2.2 µM–259 µM 
(corresponding to 0.12–14.50 µg Fe/mL). Since the usual dose of Resovist® to be injected 
IV into a patient weighing 60 kg or more corresponds to 0.7 mmol of Fe, an amount that 
should be distributed in a blood volume of approximately 4 litres (i.e., the blood volume 
of a person weighing 70 kg), the Resovist® blood concentration is 175 µM. This value 
can now be compared to the Fe amounts calculated as described above and supposedly 
Chapter 4: Discussion 
 131 
administered to the cells when testing P601 NPs in vitro. Specifically, the P601 CoFe2O4 
NP test concentration of 80 µM in this study corresponds to 173 µM of Fe, and reflects 
the recommended dose of Resovist® used in the IV injection. In order to compare the 
concentrations injected in vivo with those tested in vitro in this work, however, the 
amount of Fe that reaches a single cell should be measured. 
In addition, the dose of NP that actually reaches a target organ in vivo is influenced by the 
physicochemical characteristics of NPs and their changes when NPs enter the body (Elder 
et al., 2009). Even if NPs are specifically engineered to directly reach a target cell/organ, 
their metabolic fate is unknown, and thus the effects induced by altered/metabolized NPs 
are unpredictable (Fischer et al., 2007). In vivo studies reported by Kim et al. showed that 
in ICR (Imprinting Control Region) mice treated with an IV injection of 10 mg/mL of 
specific CoFe2O4 NPs for 7 weeks, the CoFe2O4 NPs were able to reach and be 
distributed in different organs, such as the heart, liver, kidney, stomach and spleen (Kim 
et al., 2007). The elimination of NPs may also depend on their physicochemical 
properties and affect the NP dose at a target site. For example, 20-25% of two dextran-
coated superparamagnetic oxide NPs of 80 nm and 30 nm in size and injected into rats is 
eliminated via urine and faeces within 19 days and 7 weeks, respectively (Kunzmann et 
al., 2010).  
 
In this study, four aqueous suspensions of Ag NPs, with different sizes and stabilizing 
agents, were characterized and assessed for their potential cytotoxicity (CFE), cell 
transformation capacity (CTA) and genotoxicity (CBMN) in Balb3T3 fibroblasts. Indeed, 
Balb3T3 fibroblasts are used to study NP toxicity because they are connective tissue cells 
and thus found throughout the body; therefore, they represent a potential target tissue and 
represent a model for evaluating the transformation capacity of chemicals. Fibroblasts in 
particular appear to be a good target cell model since Ag NPs of 25 nm can enter the 
body via damaged skin (Filon Larese et al., 2009) and many of the available consumer 
products containing Ag NPs involve skin application or contact. 
Recent attention has focused on Ag NPs because of the need for new antimicrobial 
substances to which microorganisms have not yet developed resistance (Rai et al., 2009). 
Because the Ag NPs are suitable for applications requiring antimicrobial or antiviral 
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effects, they have been used in many consumer products. Indeed, Ag NPs are the most 
common NPs used in nanotechnology-based products, as reported in the Woodrow 
Wilson inventory (http://www.nanotechproject.org/inventories/silver/, last accessed in 
February 2011). Concerns about the potential effects of Ag NPs and their derivatives on 
human and environmental health, however, have stimulated the need to identify and 
evaluate the toxicity induced by these NPs. 
The physicochemical characterization studies performed here showed that all Ag NPs 
considered in this study had a negatively-charged surface and were monodispersed in 
ultrapure water. The DLS measurements showed that the Ag NPs increased in size under 
conditions of both complete (Balb3T3) and serum free (MEM) culture media. In 
particular, all Ag NPs were found to be larger in MEM compared to Balb3T3 complete 
medium, again supporting the theory of an immediate size-stabilizing role of serum 
proteins (Lynch et al., 2008).  
A number of studies on the effects of Ag NPs on bacterial and eukaryotic cells have been 
reported (Panáček et al., 2006; Kim et al., 2007; Rai et al., 2009; Ahamed et al., 2010; 
Johnston et al., 2010). The available toxicity data are often related to different cellular 
models, methods employed or different Ag NP characteristics (e.g., surface charge, 
presence/absence of coatings, size, etc.). A distinction between the toxicity induced by 
either Ag NPs or released Ag+ ions, however, is not always clear. As mentioned above, 
some metal NPs, such as CoFe2O4, can release ions in the biological environment, so 
studies on particle solubility are important in understanding the toxicology of NPs. 
The toxicity induced by Ag NPs is related frequently to their potential of being oxidized, 
which subsequently produces Ag+ ions and ROS, such as H2O2 (Auffan et al. 2009; Rai et 
al., 2009). The ICP-MS is a powerful technique that can detect and measure traces of 
several elements in a sample: therefore, it was used here to assess Ag+ ion release 
induced by the NPs in media with/without serum. No Ag was detected in filtered fraction 
samples at any of the incubation times investigated (0, 24 and 72 hours); these results 
reflect those of Gaiser et al. (Ag NPs less than 1% soluble) (Gaiser et al., 2009). 
Nevertheless, Ag NPs can react with hydrochloric acid (HCl) to produce the insoluble 
salt, silver chloride (AgCl) (El-Ansary et al., 2009). For this reason, and in order to 
critically assess the Ag+ release data of this study, the MEM medium formulation should 
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be taken into account. In fact, the MEM medium itself contains three different soluble 
chloride salts, namely calcium (1.8 mM), potassium (5.33 mM) and sodium chloride 
(117.24 mM), which can be regarded as sources of Cl- ions that can react with and bind to 
Ag+ ions released by the NPs. Since the amount of Cl- ions in the culture medium is very 
high, the possibility of finding Ag+ ions in filtered fractions is low. Even if it assumed 
that the maximum dose of Ag NP administered to the cells (10 µM) is completely 
dissolved, this amount of Ag+ would be completely precipitated by the Cl- ions. In fact, 
for each chloride ion in the culture medium, the ionic product calculated for the reaction 
with Ag is higher than the silver chloride solubility product (corresponding to 1.7 x 10-10 
at 25°C), confirming the formation of AgCl precipitates (Gillespie et al., 1990). Due to its 
insoluble nature, any AgCl produced would be stopped by the filter membrane used in 
this study protocol for sample preparation, making it unavailable for detection using ICP-
MS. These observations suggest that the toxicity observed in Balb3T3 cells is associated 
with Ag NPs per se. Nevertheless, even if insoluble silver salts are not easily taken up by 
the body (Casarett & Doull, 2008), it would be interesting to perform experiments that 
clarify whether or not the AgCl could induce or participate in in vitro toxicity to cells.  
The release of Ag+ ions from Ag NPs can also be influenced by varying the chemical and 
physical parameters, such as pH and temperature (Liu et al., 2010). In this study, samples 
for the measurements of the ion release were incubated under standard cell culture 
conditions (37°C, 5% CO2, 90% humidity) and in the absence of cells. The cells were 
excluded from these experiments to avoid the loss of Ag due to the cellular uptake 
reported previously in both bacteria and eukaryotic cells (Panáček et al., 2006; Arora et 
al., 2009). Therefore, the pH changes were only those associated with the incubation 
conditions and pH changes in the medium caused by cellular metabolic activities were 
disregarded. Further investigations using protocols that have been optimized to detect and 
quantify AgCl would be valuable in refining the release experiments and clarifying the 
behaviour of Ag NPs in culture media.  
The Ag NPs in this study were associated with significant cytotoxicity at both incubation 
times considered (24 and 72 hours) compared to the respective dispersant controls; in 
contrast, no cytotoxicity associated with the dispersants was observed in the 
concentration range studied for NP testing. Based on the ICP-MS analysis of stock 
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suspensions, the effect of metal impurities that may have influenced the toxicity 
outcomes was disregarded. The cytotoxic effect of Ag NPs, however, could reasonably 
be explained by the Trojan-horse mechanism, which involves intracellular ion release by 
NPs as suggested previously for other NPs that easily release ions (Park et al., 2010a). 
As described previously (see Chapter 2: Materials and Methods), the concentrations of 
Ag NPs assessed in this study were selected based on data available in the literature. As 
for the CoFe2O4 NPs investigated, the concentrations of Ag NPs used here were reported 
both as µM and as µg/mL to allow the data to be compared to those of other research 
groups. It is very difficult, however, to compare the concentration of Ag NPs used in this 
study with that used in consumer products, particularly as the amounts of Ag NPs, their 
size, aggregation/agglomeration states and ion release capacity in these products are often 
not available (Wijnhoven et al., 2009).  
After treatment of Balb3T3 cells with Ag NPs for 72 hours, the graphically determined 
IC50 values were approximately 1.5 µM (0.162 µg/mL) for NM-300, 1.7 µM (0.184 
µg/mL) for Ag 44 nm, 1.9 µM (0.205 µg/mL) for Ag 84 nm, and 3.2 µM (0.346 µg/mL) 
for Ag 100 nm. Following 24 hours of treatment, only NM-300 showed an identifiable 
IC50 value that corresponded to 8 µM (0.864 µg/mL) in the concentration range studied. 
These results suggest that the smaller Ag NPs (e.g., NM-300 and Ag 44 nm) have a 
greater cytotoxic effect than the larger Ag NPs (e.g., Ag 100 nm). This may be due to 
their greater surface area and thus a greater potential to interact with cells or molecules. 
In addition, differences of NP surface chemistry, possibly due to different synthesis 
processes and dispersants (Johnston et al., 2010), may also explain the different toxicity 
results of NM-300 compared to Ag 100 nm.  
There is evidence showing Ag NP-induced cytotoxicity in fibroblasts, such as the human 
lung fibroblasts (IMR-90). Specifically, starch-coated Ag NPs 6-20 nm in size were 
tested on human lung fibroblasts (IMR-90) using several assays to assess cell viability, 
metabolic activity and oxidative stress. As a possible mechanism by which Ag NPs 
induce toxicity, was suggested the mitochondrial respiratory chain impairment, causing 
the production of ROS and inhibition of ATP synthesis (Asharani et al., 2009). Ahamed 
et al. have also reported mitochondrial-dependent toxicity on fibroblast cells (Ahamed et 
al., 2010). Moreover, Ag NPs 40 and 80 nm in size were found to damage the 
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mitochondrial membrane permeability of rat liver mitochondria, thus disrupting their 
function (Teodoro et al., 2011). The generation of ROS due to mitochondrial dysfunction, 
however, should not be considered as a toxic effect specific to Ag NPs because this effect 
has also been reported for other particles, for example, titanium dioxide (TiO2) (Freyre-
Fonseca et al., 2011).  
The cytotoxicity results of this study can be compared to data related to in vitro testing of 
Ag NPs on bacteria in order to understand if the test Ag NPs could be used safely as 
antimicrobial agents. Kim et al. have shown that the minimal inhibitory concentration 
required for the antimicrobial effect of 13.5 nm sized-Ag NPs on S. aureus after 24 hours 
of incubation was approximately 33 nM (Kim et al., 2007). This suggests that the Ag NPs 
investigated in this study could be used for their antimicrobial properties without 
cytotoxic effects on mammalian cells. Moreover, the antimicrobial effects of different 
sizes of Ag NPs (44, 50, 25 and 35 nm) after 24 hours of treatment on S. aureus have 
been shown to be size-dependent; however, the NP doses were not converted into the 
number of NPs per millilitre so the size-dependence toxicity conclusions must be 
confirmed (Panáček et al., 2006).    
One possible way to express the NP concentration proposed in this study is to consider 
the corresponding number of NPs per millilitre (No. NPs/mL). It was shown (Chapter 3: 
Results, Section 3.2.1, Figures 3.17A and B) that this approach would lead to different 
conclusions than those reported above because the number of NPs/mL is generally 
greater for smaller NPs than for larger ones for a fixed concentration, causing a shift in 
the dose-effect curves. This observation highlights the need for a standard method of 
conveniently expressing the amount of NPs used in experiments, thereby allowing data of 
different research groups to be compared (Stone et al., 2009).  
The toxicity of different sizes of Ag NPs (22, 42, 71 and 323 nm in diameter) following 
oral administration of 1 mg/kg to ICR mice over 14 days has also been investigated (Park 
et al., 2010b). Although there were no differences in the body or organ weight between 
the treated and the control groups, the smaller—but not the larger—Ag NPs were found 
to be distributed in several tissues (brain, lung, liver, kidney and testis) (Park et al., 
2010b). The same team has also shown that repeated doses of 42 nm bare Ag NPs 
induced significant inflammation (involving increased levels of cytokines produced), B-
Chapter 4: Discussion 
 136 
cell distribution and tissue infiltration of inflammatory cells (Park et al., 2010b). Another 
research group investigated the distribution and accumulation of three different sizes of 
Ag NPs (20, 80 and 110 nm) administered by IV injection to rats once daily for 5 days, 
and found that the smallest Ag NPs (20 nm) were distributed in the liver, kidneys and 
spleen, while larger Ag NPs (80 and 110 nm) were distributed in the spleen, liver and 
lung (Lankveld et al., 2010). The size-dependent distribution suggested that toxicity may 
be also size-dependent and the liver, lung, kidneys and spleen may be potential targets for 
Ag NPs (Lankveld et al., 2010). 
As regards the carcinogenic potential of Ag, the United States Environmental Protection 
Agency  has reported Ag as belonging to group D, thus “not classified as to human 
carcinogenicity” (US EPA, http://www.epa.gov/IRIS/subst/0099.htm, last accessed in  
September 2011). Since Ag NPs can induce oxidative stress and inflammation, conditions 
that may be associated with genetic damage, it is important to assess the transformation 
capacity and genotoxic potential of Ag NPs. In this work, therefore, the cell 
transformation capacity and genotoxicity of Ag NPs in Balb3T3 cells were evaluated 
using the CTA and CBMN assays, respectively. The data indicated that all the Ag NPs 
studied did not significantly induce type III foci or micronuclei formation compared to 
their dispersant controls under the applied experimental conditions. 
As yet, no studies on the transformation capacity of Ag NPs assessed using the CTA 
appear to have been reported. This study, therefore, is the first to report on the use of the 
CTA in evaluating Ag NPs. Nevertheless, as explained for the CoFe2O4 NPs, further 
experiments, including other both in vitro and in vivo methods, are required for a 
comprehensive evaluation of the potential of Ag NPs to damage DNA. Although neither 
in vitro nor in vivo experiments alone provide a definitive evaluation of NP toxicity, 
exploiting the advantages of both these approaches and combining in vitro–in vivo testing 
would produce more meaningful assessments of NP toxicity. 
Both in vitro and in vivo evaluations that focus on long-term treatments with NPs should 
also be done to clarify if chronic exposure with NPs can induce morphological cell 
transformation and carcinogenesis, respectively (Ng et al., 2010). The importance of such 
studies is confirmed by the fact that chronic exposure by subcutaneous administration of 
Ag NPs (1.75–2.5 mg/week) was found to cause malignant tumour formation at the 
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injection site in 31% of the rats which survived for more than 16 months; no tumours 
were found in rats treated with intramuscular injection of AgNPs (Wijnhoven et al., 
2009). 
Studies on Ag NP-induced DNA damage reported in the literature mostly concern the 
expression of DNA repair protein, micronuclei formation and DNA double strand 
breakage (Singh et al., 2009; Ahamed et al., 2010). For example, Ag NPs of similar size 
(25 nm), but different surface chemistry induce DNA damage in mouse embryonic stem 
cells and fibroblasts (Ahamed et al., 2008). In particular, the polysaccharide-coated Ag 
NPs induced greater DNA damage than uncoated particles, as demonstrated by 
measurements of the double strand breaks’ repair protein Rad51 (Ahamed et al., 2008). 
This type of test allows NP-induced genotoxicity to be evaluated by measuring a cellular 
response (changes in protein expression); therefore, it would be a useful test to 
complement the CBMN or Comet assays that measure DNA alteration (micronuclei or 
DNA fragmentation) in genotoxicity studies. 
In addition, Ag NPs <50 nm and at concentrations of 0.1, 1 and 10 µg/mL were shown to 
induce significant genotoxic effects on primary human mesenchymal stem cells (primary 
cells very proliferating) using Comet and chromosome aberration tests (Hackenberg et 
al., 2011). The chromosome aberration assay can be performed either in vitro or in vivo 
and detects alterations of both the number and structure of the chromosomes in 
metaphase-arrested cells. The metaphase stage occurs immediately prior to the separation 
of replicated chromosomes into newly-forming nuclei and cells can be arrested at this 
stage using a specific chemical (Singh et al., 2009). The advantage of this assay is that it 
provides information on the damaged chromosome that cannot be obtained using, for 
example, the CBMN or Comet assays. In contrast, no significant genotoxicity, indicated 
by micronuclei induction in erythrocytes of the bone marrow, was shown in in vivo 
studies involving the oral administration of 30, 300 and 1000 mg/kg Ag NPs of 60 nm in 
size for 28 days in Sprague-Dawley rats (Ng et al., 2010). 
Based on the reported genotoxic potential of Ag NPs, further investigations that use other 
methods to complement the CTA and CBMN assays are clearly needed to better elucidate 
the specific effects of Ag NPs on DNA. Oxidative stress studies, such as those mentioned 
above, should also be considered. Attention should particularly focus on distinguishing 
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between the effects induced by NPs per se and ion-induced effects. Indeed, oxidative 
stress and interference with intracellular zinc homeostasis were found in human skin 
fibroblasts after treatment with AgNO3, suggesting that oxidative stress observed in Ag 
NP-treated cells may be due to the Ag+ ions released by the NPs  (Cortese-Krott et al., 
2009). Additional experiments are required to clarify the mechanism by which Ag NPs 
exert their toxicity on cells. 
The in vitro studies and results of this research project highlight the advantages of using 
in vitro methods to elucidate the mechanism by which NPs exert their effects. The 
advantage of an in vitro approach in nanotoxicology with respect to human health is that 
different time points, types of NPs, NP doses and study endpoints can be investigated 
(Clift et al., 2011). In vitro methods have attracted increasing attention for NP testing 
(Stern & McNeil, 2008) and have also been promoted by the European Union for  
assessment of new cosmetics (Clift et al., 2011). The effects induced by NPs, however, 
cannot be explained simply by in vitro cytotoxicity assessments. In this context, priority 
research areas highlight the importance of studying carcinogenic potency, genotoxicity 
and toxicokinetics using in vitro tests (OECD, 2008). In vitro tests using human cell lines 
that mimic the in vivo situation are the most promising for toxicological studies. 
In vivo experiments, however, are required to identify target organs and NP kinetics, and 
include adsorption, distribution, metabolism and excretion studies. Nevertheless, it is still 
difficult to correlate in vitro toxic effects with in vivo data both for chemicals and NPs, 
and to predict the toxicological effects on humans from animal studies because of 
species’ differences. A qualitative in vitro/in vivo comparison is usually considered to be 
sufficient because it is difficult to establish a quantitative in vitro/in vivo relationship 
(Ekwall, 1992).  
Predictive toxicity models for nanotoxicology are also required. In particular, these 
models should be designed to predict how changes in the physicochemical characteristics 
of NPs may affect their potential toxicity in humans (Clark et al., 2011). However, much 
experimental work is required to achieve this objective because many high quality data 
are needed to develop predictive models, and information on NPs are usually collected 
using different methods (and thus endpoints) or materials, thereby preventing a thorough 
evaluation of NMs (Clark et al., 2011). 
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In this study, the CoFe2O4 and Ag NPs were found to induce cytotoxic, but not genotoxic 
effects on cells, and had no effect on cell transformation. This study, therefore, can be 
considered as the first screening study to suggest the potentially safe use of these NPs. 
Clearly, other assays using both in vitro and in vivo models must be considered when 
studying NPs based on their potential future applications (e.g., studies on the kinetics of 
NPs that may be used for drug delivery) to increase confidence in the safety of these 
materials. 
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Chapter 5: Conclusions  
This work contributes to nanotoxicology research by proposing a strategy for the 
evaluation of NM genotoxicity using in vitro studies. 
The study of CoFe2O4 and Ag NPs confirmed that a multidisciplinary approach is needed 
to understand NM toxicity. Nanotoxicology represents a complex research field; the main 
purpose is the identification of a relationship between the special physicochemical 
characteristics of the NMs and their effects on cells. Chemistry, physics and biology are 
just a few examples of the merging disciplines that are involved in NM research.  
Indeed, effects on cells induced by CoFe2O4 and Ag NPs cannot be explained without 
investigating the physicochemical properties of the particles (e.g., size, surface charge, 
ion release, etc.) and considering the different techniques/methods or cell lines used as 
parameters that can affect experimental outcomes. Here, it was demonstrated that 
differently-sized NPs of the same element (Ag) or compound (CoFe2O4) induce 
cytotoxicity in Balb3T3 fibroblasts; the smallest NPs appear to be the most cytotoxic. 
The correlation between NP size and cytotoxicity, however, should be investigated 
further because it was shown that the way in which NP concentrations are expressed can 
affect the conclusions. In addition, it was shown that differently-sized NPs immediately 
tend to form aggregates/agglomerates when in complete culture medium, reaching larger 
hydrodynamic dimensions that remain constant over the 72-hour incubation time 
investigated. In order to understand the role of aggregates/agglomerates on cellular 
toxicity, experiments designed to elucidate the NPs’ behaviour in complete culture 
medium should be done. 
Determination of ion release into the culture medium can be used to distinguish between 
toxicity induced by NPs per se and toxicity induced by the released ions. Moreover, it 
was verified here that the choice of cell type and in vitro assay (e.g., NR, CFE) can also 
influence results. The CFE assay detected the cell-specific toxicity of CoFe2O4 NPs in 
Balb3T3 fibroblasts; in contrast, the NR assay was less sensitive than the CFE in 
detecting the cytotoxic effect under the exposure conditions used. 
More techniques should be employed to complete the characterization of the NPs studied 
here. For example, studies on the surface changes of NPs in culture medium (e.g., 
oxidation, interaction with proteins, etc.) would generate a comprehensive array of 
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information that can be used to elucidate the toxicity data and formulate a hypothesis for 
the mechanism of action of CoFe2O4 and Ag NPs. 
Both the CoFe2O4 and Ag NPs did not significantly induce cell transformation and 
micronuclei in Balb3T3 cells, as measured using the CTA and CBMN assays. 
Nevertheless, although these results were generated using in vitro assays, the 
effectiveness of which had already been proven when testing for NP genotoxicity, they 
cannot be considered as sufficient to definitively discard the potential of these NPs to 
damage DNA. Thus, future investigations must include assessments of the ability of NPs 
to generate ROS on their surface or induce ROS production by cells would help to clarify 
the genotoxicity of NPs. 
The long-term exposure to NPs should also be investigated in future studies to determine 
whether chronic exposure can induce morphological transformation or carcinogenesis in 
vitro and in vivo, respectively. Moreover, additional genotoxicity endpoints should be 
considered for in vitro testing of NPs (e.g., measurements of repair protein expression, 
Comet and chromosomal aberration assays) and, whenever possible, these endpoints 
should also be investigated using in vivo models. In vitro tests cannot reproduce the in 
vivo environment that NPs encounter in the body and the alterations NPs may undergo 
due to metabolic processes; this reduces the correlation between in vitro and in vivo data. 
In summary, the use of in vitro tests is largely advantageous due to the simplicity of the 
systems and reproducibility of the data. In vitro tests, therefore, appear to be an 
acceptable compromise when studying NMs. Protocols for in vitro testing should, 
however, be optimized for each NM and the results compared to in vivo investigations.  
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